FURP.ORG / PUBLIC DATA EXPLORER

MASS GENERAL BRIGHAM INCORPORATED: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization
MASS GENERAL BRIGHAM INCORPORATED (EIN 04-2103591)
Tax period
2011-10-01 to 2012-09-30
Filed
2013-08-14
IRS object ID
201302269349302580
Schema version
2011v1.5
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2013-08-14T13:40:15-05:00Timestamp
Tax Period End Date2012-09-30TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1PRICEWATERHOUSECOOPERS LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line1125 HIGH STREETAddressLine1
CityBOSTONCity
StateMAState
ZIP Code02110ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2011-10-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN042103591EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1MASSACHUSETTS EYE & EAR INFIRMARYBusinessNameLine1
FieldValueIRS element (for citing)
In Care Of Name% CAROLANN WILLIAMSInCareOfName
Name ControlMASSNameControl
Phone6175733942Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line1243 CHARLES STREETAddressLine1
CityBOSTONCity
StateMAState
ZIP Code02114ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameCAROLANN WILLIAMSName
TitleVP FINANCE & CFOTitle
Date Signed2013-08-08DateSigned
Authorize Third PartytrueAuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NamePRICEWATERHOUSECOOPERS LLPName
Phone6175305000Phone
FieldValueIRS element (for citing)
Tax Year2011TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonCAROLANN WILLIAMSNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line1243 CHARLES STREETAddressLine1
CityBOSTONCity
StateMAState
ZIP Code02114ZIPCode
FieldValueIRS element (for citing)
Gross Receipts200212167GrossReceipts
Group Return For AffiliatesfalseGroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.MASSEYEANDEAR.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1827YearFormation
State Legal DomicileMAStateLegalDomicile
Activity Or Mission DescriptionSEE SCHEDULE O.ActivityOrMissionDescription
Nbr Voting Members Governing Body20NbrVotingMembersGoverningBody
Nbr Independent Voting Members17NbrIndependentVotingMembers
Total Nbr Employees1852TotalNbrEmployees
Total Nbr Volunteers240TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Contributions Grants Prior Year37417260ContributionsGrantsPriorYear
Contributions Grants Current Year33572100ContributionsGrantsCurrentYear
Program Service Revenue Prior Year153732051ProgramServiceRevenuePriorYear
Program Service Revenue CY150956667ProgramServiceRevenueCY
Investment Income Prior Year1186135InvestmentIncomePriorYear
Investment Income Current Year665789InvestmentIncomeCurrentYear
Other Revenue Prior Year12661110OtherRevenuePriorYear
Other Revenue Current Year15017611OtherRevenueCurrentYear
Total Revenue Prior Year204996556TotalRevenuePriorYear
Total Revenue Current Year200212167TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year6613142GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY15552737GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year91572396SalariesEtcPriorYear
Salaries Etc Current Year100490121SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year195441TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY256235TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year1554604TotalFundrsngExpCurrentYear
Other Expense Prior Year113907572OtherExpensePriorYear
Other Expenses Current Year84181529OtherExpensesCurrentYear
Total Expenses Prior Year212288551TotalExpensesPriorYear
Total Expenses Current Year200480622TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-7291995RevenuesLessExpensesPriorYear
Revenues Less Expenses CY-268455RevenuesLessExpensesCY
Total Assets BOY248076965TotalAssetsBOY
Total Assets EOY236179653TotalAssetsEOY
Total Liabilities BOY214774227TotalLiabilitiesBOY
Total Liabilities EOY210336333TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY33302738NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY25843320NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionSEE SCHEDULE O.MissionDescription
Significant New Program ServicesfalseSignificantNewProgramServices
Significant ChangefalseSignificantChange
Expense40995393Expense
Grants15552737Grants
Revenue150956667Revenue
DescriptionSEE SCHEDULE ODescription

Activity2 Activity2

FieldValueIRS element (for citing)
Expense3743884Expense
DescriptionSEE SCHEDULE ODescription

Activity3 Activity3

FieldValueIRS element (for citing)
Expense101574333Expense
DescriptionSEE SCHEDULE ODescription
FieldValueIRS element (for citing)
Total Program Service Expense146313610TotalProgramServiceExpense
Described In501 C3trueDescribedIn501C3
Schedule B RequiredtrueScheduleBRequired
Political ActivitiesfalsePoliticalActivities
Lobbying ActivitiestrueLobbyingActivities
Subject To Proxy TaxfalseSubjectToProxyTax
Donor Advised FundsfalseDonorAdvisedFunds
Conservation EasementsfalseConservationEasements
Collections Of ArttrueCollectionsOfArt
Credit CounselingfalseCreditCounseling
Term Or Permanent EndowmentstrueTermOrPermanentEndowments
Report Land Bldg EquiptrueReportLandBldgEquip
Report Invest Oth SecuritiesfalseReportInvestOthSecurities
Report Prog Rel InvestfalseReportProgRelInvest
Report Other AssetstrueReportOtherAssets
Report Other LiabilitiestrueReportOtherLiabilities
Report Fin48 FootnotetrueReportFin48Footnote
Independent Audit Financial StmtfalseIndependentAuditFinancialStmt
Consolidated Audit Financial StmttrueConsolidatedAuditFinancialStmt
SchoolfalseSchool
Foreign OfficefalseForeignOffice
Foreign ActivitiestrueForeignActivities
More Than5000 K To OrganizationstrueMoreThan5000KToOrganizations
More Than5000 K To IndividualsfalseMoreThan5000KToIndividuals
Professional FundraisingtrueProfessionalFundraising
Fundraising ActivitiesfalseFundraisingActivities
GamingfalseGaming
HospitaltrueHospital
Financial Stmt AttachedtrueFinancialStmtAttached
Grants To OrganizationstrueGrantsToOrganizations
Grants To IndividualsfalseGrantsToIndividuals
Schedule J RequiredtrueScheduleJRequired
Tax Exempt BondstrueTaxExemptBonds
Invest Tax Exempt BondsfalseInvestTaxExemptBonds
Escrow AccountfalseEscrowAccount
On Behalf Of IssuerfalseOnBehalfOfIssuer
Excess Benefit TransactionfalseExcessBenefitTransaction
Prior Excess Benefit TransactionfalsePriorExcessBenefitTransaction
Loan To Officer Or DQPtrueLoanToOfficerOrDQP
Grant To Related PersonfalseGrantToRelatedPerson
Bsnss Rltnshp With OrganizationtrueBsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family MemberfalseBsnssRltnshpThruFamilyMember
Officer Entity With Bsnss RltnshpfalseOfficerEntityWithBsnssRltnshp
Deductible Non Cash ContributionsfalseDeductibleNonCashContributions
Deductible Contributions Of ArtfalseDeductibleContributionsOfArt
TerminatedfalseTerminated
Partial LiquidationfalsePartialLiquidation
Disregarded EntityfalseDisregardedEntity
Related EntitytrueRelatedEntity
Related Org Controlled EntitytrueRelatedOrgControlledEntity
Transaction Related EntitytrueTransactionRelatedEntity
Transfers To Exempt Non Chrtbl OrgtrueTransfersToExemptNonChrtblOrg
Activities Conducted PartnershipfalseActivitiesConductedPartnership
Schedule O RequiredtrueScheduleORequired
Number Forms Transmitted With1096235NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup WitholdingtrueComplianceWithBackupWitholding
Number Of Employees1852NumberOfEmployees
Employment Tax Returns FiledtrueEmploymentTaxReturnsFiled
Unrelated Business IncomefalseUnrelatedBusinessIncome
Foreign Financial AccountfalseForeignFinancialAccount
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTrans
Taxable Party NotificationfalseTaxablePartyNotification
Non Deductible ContributionsfalseNonDeductibleContributions
Quid Pro Quo ContributionsfalseQuidProQuoContributions
Form8282 Property Disposed OffalseForm8282PropertyDisposedOf
Funds To Pay PremiumsfalseFundsToPayPremiums
Premiums PaidfalsePremiumsPaid
Indoor Tanning ServicesfalseIndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members20NbrVotingGoverningBodyMembers
Number Independent Voting Members17NumberIndependentVotingMembers
Family Or Business RelationshipfalseFamilyOrBusinessRelationship
Delegation Of Management DutiesfalseDelegationOfManagementDuties
Changes To Organizing DocsfalseChangesToOrganizingDocs
Material Diversion Or MisusefalseMaterialDiversionOrMisuse
Members Or StockholdersfalseMembersOrStockholders
Election Of Board MemberstrueElectionOfBoardMembers
Decisions Subject To ApprovaltrueDecisionsSubjectToApproval
Minutes Of Governing BodytrueMinutesOfGoverningBody
Minutes Of CommitteestrueMinutesOfCommittees
Officer Mailing AddressfalseOfficerMailingAddress
Local ChaptersfalseLocalChapters
Form990 Provided To Governing BodytrueForm990ProvidedToGoverningBody
Conflict Of Interest PolicytrueConflictOfInterestPolicy
Annual Disclosure Covered PersonstrueAnnualDisclosureCoveredPersons
Regular Monitoring EnforcementtrueRegularMonitoringEnforcement
Whistleblower PolicytrueWhistleblowerPolicy
Document Retention PolicytrueDocumentRetentionPolicy
Compensation Process CEOtrueCompensationProcessCEO
Compensation Process OthertrueCompensationProcessOther
Investment In Joint VenturefalseInvestmentInJointVenture
States Where Copy Of Return Is FiledMAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNYStatesWhereCopyOfReturnIsFiled
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

FieldValueIRS element (for citing)
Name PersonCAROLANN WILLIAMSNamePerson
Telephone Number6175733012TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line1243 CHARLES STREETAddressLine1
CityBOSTONCity
StateMAState
ZIP Code02114ZIPCode
FieldValueIRS element (for citing)
Info In Schedule O Part VIIXInfoInScheduleOPartVII

Form990 Part VII Section A Form990PartVIISectionA (41 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployeeFormerFormer
JOHN R FERNANDEZ
PRESIDENT36.0XX7515500173740
WYCLIFFE GROUSBECK
CHAIR4.0XX000
JONATHAN UHRIG
TREASURER4.0XX000
LILY H BENTAS
SECRETARY4.0XX000
RICHARD H ALDRICH
DIRECTOR2.0X000
DEWALT PETE ANKENY
DIRECTOR2.0X000
JAMES CARLISLE
DIRECTOR2.0X000
CHARLES DE GUNZBERG
DIRECTOR2.0X000
SAMUEL FLEMING
DIRECTOR2.0X000
HARVEY FREISHTAT
DIRECTOR2.0X000
JOSEPH W HALEY
DIRECTOR (UNTIL 12/7/11)2.0X000
LYLE HOWLAND
DIRECTOR2.0X000
DIANE E KANEB
DIRECTOR2.0X000
JONATHAN KUTCHINS
DIRECTOR2.0X000
VICTORIA MCCULLOUGH
DIRECTOR2.0X000
JOAN W MILLER MD
DIRECTOR27.0X073192956018
JOSEPH B NADOL JR MD
DIRECTOR29.0X077510663215
ANNETTE NOVA
DIRECTOR2.0X000
WILLIAM ROMAN
DIRECTOR2.0X000
FREDERICK THORNE
DIRECTOR2.0X000
KATHRYN VECELLIO
DIRECTOR2.0X000
SUSAN WILLIAMS
ASST SEC/GENERAL COUNSEL50.0X261351018750
MAUREEN KELLEY
ASST SECRETARY (AS OF 4/25/11)50.0X000
CAROLANN WILLIAMS
VP FINANCE & CFO60.0X19281304368
BARBARA J SCULLY
DIR PROFESSIONAL BILLING30.0164057032592X
EILEEN O LOWELL
CHIEF NURSING OFFICER60.0163490032109X
ALAN K LONG
VP RESEARCH (AS OF 4/4/11)50.019450703363X
CHRISTINE REGAN
VP HUMAN RESOURCES50.0217725023136X
KENNETH HOLMES
CFO MEEA30.0236595038361X
JEAN E MACQUIDDY
VP OTOLARYNGOLOGY30.0248764031061X
ALEC CHELOFF
VP INFORMATION SYSTEMS50.0242327037530X
JEFFREY J PIKE
CHIEF OPERATING OFFICER60.0254342016993X
JAVIER BALLOFFET
VP OPHTHALMOLOGY40.0292312035924X
GAYLE A FISHMAN UNTIL 1112
FORMER EVP QUALITY CARE50.025444508031X
JENNIFER STREET
VP COMMUNICATIONS43.0257174037317X
MICHAEL SOUZA UNTIL 32912
VP NETWORK DEVELOPMENT50.0243727010468X
MELISSA M PAUL
VP DEVELOPMENT50.0224795040328X
GLENN W BUNTING
VOICE & SPEECH CLINICAL DIR50.0176754034700X
GREGORY J DONNELLY
EXEC DIR CLINICAL SERVICES50.0157790030511X
PETER J CHINETTI
FORMER VP FINANCE60.0365089022615X
ROBERT M BIGGIO
FORMER VP FACILITIES50.0165423024148X
FieldValueIRS element (for citing)
Total Reportable Comp From Org5065030TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs1507035TotalReportableCompFrmRltdOrgs
Total Other Compensation775278TotalOtherCompensation
Number Individuals GT100 K148NumberIndividualsGT100K
Formers ListedtrueFormersListed
Total Comp GT150 KtrueTotalCompGT150K
Compensation From Other SourcesfalseCompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
TSOIKOBUS ASSOCIATES
1 BRATTLE SQUARE PO BOX 9114CAMBRIDGEMA02238ARCHITECT1468032
CG ASSOCIATES
7 CHUCK DRIVEDRACUTMA01826General Contractor542471
FISH RICHARDSON PC
PO BOX 3295BOSTONMA02241ATTORNEY421614
DLA PIPER LLP
PO BOX 64029BALTIMOREMD21264ATTORNEY391781
JG ASSOCIATES
8 SUMMIT RDLEXINGTONMA02421ARCHITECTS412503
FieldValueIRS element (for citing)
Number Of Contractors GT100 K14NumberOfContractorsGT100K
Related Organizations8471314RelatedOrganizations
Government Grants16300782GovernmentGrants
All Other Contributions8800004AllOtherContributions
Total Contributions33572100TotalContributions

Program Service Revenue ProgramServiceRevenue (5 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncome
INPATIENT AND OUTPATIENT900099131715018131715018
MISCELLANEOUS REVENUE90009966833976683397
RESEARCH OVERHEAD90009961192546119254
HEARING AID CENTERS90009934793863479386
CAFETERIA/FOOD SERVICE72221017578491757849

Total Oth Program Service Revenue TotalOthProgramServiceRevenue

FieldValueIRS element (for citing)
Total Revenue Column1201763TotalRevenueColumn
Related Or Exempt Function Income1201763RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Program Service Revenue150956667TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column147872TotalRevenueColumn
Exclusion$147,872ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

FieldValueIRS element (for citing)
Total Revenue Column0TotalRevenueColumn
Exclusion$0ExclusionAmount

Royalties Revenue RoyaltiesRevenue

FieldValueIRS element (for citing)
Total Revenue Column15017611TotalRevenueColumn
Exclusion$15,017,611ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities517917Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities517917Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column517917TotalRevenueColumn
Exclusion$517,917ExclusionAmount

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

FieldValueIRS element (for citing)
Total Revenue Column0TotalRevenueColumn
Exclusion$0ExclusionAmount

Net Income From Gaming NetIncomeFromGaming

FieldValueIRS element (for citing)
Total Revenue Column0TotalRevenueColumn
Exclusion$0ExclusionAmount

Net Income Or Loss NetIncomeOrLoss

FieldValueIRS element (for citing)
Total Revenue Column0TotalRevenueColumn
Exclusion$0ExclusionAmount
FieldValueIRS element (for citing)
Total Other Revenue0TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column200212167TotalRevenueColumn
Related Or Exempt Function Income150956667RelatedOrExemptFunctionIncome
Exclusion$15,683,400ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total15506749Total
Program Services15506749ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Foreign Grants ForeignGrants

FieldValueIRS element (for citing)
Total45988Total
Program Services45988ProgramServices

Benefits To Members BenefitsToMembers

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total6412136Total
Program Services875610ProgramServices
Management And General5536526ManagementAndGeneral

Comp Disqual Persons CompDisqualPersons

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total72346219Total
Program Services57048103ProgramServices
Management And General14474563ManagementAndGeneral
Fundraising823553Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total1277318Total
Program Services940077ProgramServices
Management And General323401ManagementAndGeneral
Fundraising13840Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total15099678Total
Program Services11113020ProgramServices
Management And General3823055ManagementAndGeneral
Fundraising163603Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total5354770Total
Program Services3940989ProgramServices
Management And General1355763ManagementAndGeneral
Fundraising58018Fundraising

Fees For Services Management FeesForServicesManagement

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total1387345Total
Program Services1064839ProgramServices
Management And General322506ManagementAndGeneral

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total444891Total
Program Services253184ProgramServices
Management And General191707ManagementAndGeneral

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total198209Total
Program Services0ProgramServices
Management And General198209ManagementAndGeneral

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total256235Total
Fundraising256235Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total765445Total
Program Services662642ProgramServices
Management And General90974ManagementAndGeneral
Fundraising11829Fundraising

Advertising Advertising

FieldValueIRS element (for citing)
Total769649Total
Program Services667ProgramServices
Management And General768982ManagementAndGeneral
Fundraising0Fundraising

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total1517064Total
Program Services961111ProgramServices
Management And General479373ManagementAndGeneral
Fundraising76580Fundraising

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total2308630Total
Program Services0ProgramServices
Management And General2308630ManagementAndGeneral

Royalties Royalties

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Occupancy Occupancy

FieldValueIRS element (for citing)
Total6340830Total
Program Services910959ProgramServices
Management And General5429871ManagementAndGeneral

Travel Travel

FieldValueIRS element (for citing)
Total884874Total
Program Services743234ProgramServices
Management And General121513ManagementAndGeneral
Fundraising20127Fundraising

Travel Entrtnmnt Public Officials TravelEntrtnmntPublicOfficials

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Interest Interest

FieldValueIRS element (for citing)
Total1857204Total
Program Services1122681ProgramServices
Management And General734523ManagementAndGeneral

Payments To Affiliates PaymentsToAffiliates

FieldValueIRS element (for citing)
Total0Total
Program Services0ProgramServices

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total15746081Total
Program Services9518518ProgramServices
Management And General6227563ManagementAndGeneral

Insurance Insurance

FieldValueIRS element (for citing)
Total1335075Total
Program Services34978ProgramServices
Management And General1300097ManagementAndGeneral

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
MEDICAL SUPPLIES2905773928989552681870
PHYSICIANS ADMINISTRATION6723189667379249397
MISCELLANEOUS665064822729594269035108654
ALL OTHER EXPENSES81946563633958453853322165

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total200480622Total
Program Services146313610ProgramServices
Management And General52612408ManagementAndGeneral
Fundraising1554604Fundraising

Cash Non Interest Bearing CashNonInterestBearing

FieldValueIRS element (for citing)
BOY765636BOY
EOY84562EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY23704890BOY
EOY20951960EOY

Receivables From Officers Etc ReceivablesFromOfficersEtc

FieldValueIRS element (for citing)
BOY30000BOY
EOY20000EOY

Receivables From Disqual Persons ReceivablesFromDisqualPersons

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Inventories For Sale Or Use InventoriesForSaleOrUse

FieldValueIRS element (for citing)
BOY2554277BOY
EOY2155473EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY3557013BOY
EOY3862909EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis352043873LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec218775617LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY114804214BOY
EOY133268256EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Investments Other Securities InvestmentsOtherSecurities

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Investments Program Related InvestmentsProgramRelated

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Intangible Assets IntangibleAssets

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY102660935BOY
EOY75836493EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY248076965BOY
EOY236179653EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY62773223BOY
EOY80079903EOY

Grants Payable GrantsPayable

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY52857085BOY
EOY37959380EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

FieldValueIRS element (for citing)
BOY89368557BOY
EOY86480956EOY

Escrow Account Liability EscrowAccountLiability

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Loans From Officers Directors LoansFromOfficersDirectors

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Unsecured Notes Loans Payable UnsecuredNotesLoansPayable

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY9775362BOY
EOY5816094EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY214774227BOY
EOY210336333EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY33302738BOY
EOY25843320EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY0BOY
EOY0EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY33302738BOY
EOY25843320EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY248076965BOY
EOY236179653EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses-268455ReconcilationRevenueExpenses
Reconcilation Other Changes-7190963ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or ReviewfalseAccountantCompileOrReview
FS AuditedtrueFSAudited
Audit CommitteetrueAuditCommittee
Financial Statement ConsolidatedXFinancialStatementConsolidated
Federal Grant Audit RequiredtrueFederalGrantAuditRequired
Federal Grant Audit PerformedtrueFederalGrantAuditPerformed

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Hospital170b1 AiiiXHospital170b1Aiii

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbying
Total Direct LobbyingTotalDirectLobbying
Total Lobbying ExpendituresTotalLobbyingExpenditures
Other Exempt Purpose ExpendituresOtherExemptPurposeExpenditures
Total Exempt Purpose ExpendituresTotalExemptPurposeExpenditures
Lobbying NontaxableLobbyingNontaxableAmount
Grassroots NontaxableGrassrootsNontaxableAmount
Tot Lobbying Grassroot Minus Non TxTotLobbyingGrassrootMinusNonTx
Tot Lobby Expend Mns Lobbying NontxTotLobbyExpendMnsLobbyingNontx
VolunteersfalseVolunteers
Paid Staff Or ManagementtruePaidStaffOrManagement
Media AdvertisementsfalseMediaAdvertisements
Mailings MemberstrueMailingsMembers
Publications Or BroadcastfalsePublicationsOrBroadcast
Grants Other OrganizationsfalseGrantsOtherOrganizations
Direct Contact LegislatorstrueDirectContactLegislators
Direct Contact Legislators$198,290DirectContactLegislatorsAmount
Rallies DemonstrationsfalseRalliesDemonstrations
Other ActivitiesfalseOtherActivities
Total Lobbying Expenditures IIB198290TotalLobbyingExpendituresIIB
Not Described In501c3falseNotDescribedIn501c3

Form990 Schedule C Part IV Form990ScheduleCPartIV

FieldValueIRS element (for citing)
IdentifierSCHEDULE C, PART II-B, LINE 1(I):Identifier
ExplanationDURING THE FISCAL YEAR ENDED SEPTEMBER 30, 2012, THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") PAID A CONSULTANT TO ASSIST THE INFIRMARY ON BEHALF OF ITSELF AND ITS AFFILIATES, WITH DEVELOPING MEETINGS WITH THE MEMBERS OF THE MASSACHUSETTS LEGISLATURE AND EXECUTIVE BRANCH FOR PURPOSES OF DISCUSSION AROUND STATE HEALTHCARE PAYMENT REFORM, DISCUSSION AROUND MASSACHUSETTS EYE AND EAR REAL ESTATE DEVELOPMENT PLANNING, ASSIST IN PREPARING TESTIMONY FOR PRESENTATION BEFORE ALL RELEVANT COMMITTEES OF THE MASSACHUSETTS GENERAL COURT; DEVELOP LEGISLATIVE STRATEGIES; SERVE AS LIAISON TO GOVERNMENT AGENCIES AS NECESSARY AND MONITOR AND REPORT ON GOVERNMENT PROGRAMS RELATIVE TO HEALTHCARE FINANCING, INCLUDING STATE APPROPRIATIONS AND GRANTS. THE INFIRMARY IS A MEMBER OF CERTAIN TRADE ASSOCIATIONS THAT MAY LOBBY ON ITS BEHALF.Explanation

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmtsArtPublicExhibitionAmts
Held Works Of Art AmtsHeldWorksOfArtAmts
Collect Used For Public ExhibitionXCollectUsedForPublicExhibition
Collect Used For Scholar ResearchXCollectUsedForScholarResearch
Collect Used For PreservationXCollectUsedForPreservation
Collect Used For Loan Or Exch PrgrmsXCollectUsedForLoanOrExchPrgrms
Solicited Assets For SalefalseSolicitedAssetsForSale

Current Year CurrentYear

FieldValueIRS element (for citing)
Beginning Of Year Balance86399272BeginningOfYearBalance
Contributions1269332Contributions
Investment Earnings Or Losses6139492InvestmentEarningsOrLosses
Other Expenditures2803513OtherExpenditures
Administrative Expenses1280042AdministrativeExpenses
End Of Year Balance89724541EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

FieldValueIRS element (for citing)
Beginning Of Year Balance60472244BeginningOfYearBalance
Contributions29640100Contributions
Investment Earnings Or Losses1622561InvestmentEarningsOrLosses
Other Expenditures4005052OtherExpenditures
Administrative Expenses1330581AdministrativeExpenses
End Of Year Balance86399272EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

FieldValueIRS element (for citing)
Beginning Of Year Balance60355993BeginningOfYearBalance
Contributions736023Contributions
Investment Earnings Or Losses4138384InvestmentEarningsOrLosses
Other Expenditures3579845OtherExpenditures
Administrative Expenses1178311AdministrativeExpenses
End Of Year Balance60472244EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

FieldValueIRS element (for citing)
Beginning Of Year Balance60792309BeginningOfYearBalance
Contributions993556Contributions
Investment Earnings Or Losses3611396InvestmentEarningsOrLosses
Other Expenditures3713026OtherExpenditures
Administrative Expenses1328242AdministrativeExpenses
End Of Year Balance60355993EndOfYearBalance
FieldValueIRS element (for citing)
Board Designated EOY Balance0.09412BoardDesignatedEOYBalance
Permanent Endowment EOY Balance0.36212PermanentEndowmentEOYBalance
Term Endowment EOY Balance0.54376TermEndowmentEOYBalance
Endowments Held By Unrelated OrgsfalseEndowmentsHeldByUnrelatedOrgs
Endowments Held By Related OrgstrueEndowmentsHeldByRelatedOrgs
Are Related Orgs Listed Schedule RtrueAreRelatedOrgsListedScheduleR

Land Land

FieldValueIRS element (for citing)
Other Cost Or Other Basis535324OtherCostOrOtherBasis
Book Value535324BookValue

Buildings Buildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis169297480OtherCostOrOtherBasis
Depreciation99569833Depreciation
Book Value69727647BookValue

Leasehold Improvements LeaseholdImprovements

FieldValueIRS element (for citing)
Other Cost Or Other Basis599406OtherCostOrOtherBasis
Depreciation584426Depreciation
Book Value14980BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis159363438OtherCostOrOtherBasis
Depreciation118576585Depreciation
Book Value40786853BookValue

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis22248225OtherCostOrOtherBasis
Depreciation44773Depreciation
Book Value22203452BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings133268256TotalOfBookValueLandBuildings

Other Assets OtherAssets (9 entries)

DescriptionDescriptionBook ValueBookValue
DUE FROM AFFILIATES17068763
FUNDS HELD FOR RESEARCH28527687
CONSTRUCTION FUND17518288
DEBT SERVICE FUND107449
SPECIAL CASH & CAPITAL RESERVE5153493
DEBT SERVICE RESERVES FUND5262038
DEFERRED FINANCING COSTS1629506
CAPITALIZED INTEREST64
TAX DEFERRED PLAN ASSETS569205
FieldValueIRS element (for citing)
Total Book Value Other Assets75836493TotalBookValueOtherAssets
Federal Income Tax Liability0FederalIncomeTaxLiability

Other Liabilities OtherLiabilities (5 entries)

DescriptionDescriptionAmountAmount
DUE TO AFFILIATES$125,261
ESTIMATE THIRD PARTY SETTLEMENTS$4,206,868
PROFESSIONAL LIABILITY RESERVE$585,715
ASSET RETIREMENT OBLIGATION$329,045
TAX DEFERRED LIABILITY$569,205
FieldValueIRS element (for citing)
Total Of Amounts5816094TotalOfAmounts

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (2 entries)

IdentifierIdentifierExplanationExplanation
SCHEDULE D, PART III, LINE 4:THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN EACH SPECIALTY OF THE EYE AND EAR AND BOOKS PURCHASED LATER WITH FUNDS FROM ENDOWMENTS SET UP BY THE PEOPLE WHO DONATED THE ORIGINAL COLLECTIONS. THE RARE BOOKS ARE AVAILABLE TO THE SCIENTIFIC, MEDICAL AND ACADEMIC COMMUNITY FOR PURPOSES OF RESEARCH AND EDUCATION. SCHEDULE D, PART V, LINE 4: THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS ARE SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE.
SCHEDULE D, PART X, LINE 2:THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS PARENT, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION"), AND AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedtrueGrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (2 entries)

RegionRegionType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
Europe (Including Iceland and Greenland)Program ServicesResearch45988
Central America and the CaribbeanInvestments23000
FieldValueIRS element (for citing)
Subtotal Amount Spent68988SubtotalAmountSpent
Total Amount Spent68988TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS

FieldValueIRS element (for citing)
RegionEurope/Iceland/GreenlandRegion
Amount Of Cash Grant45988AmountOfCashGrant
Manner Of Cash DisbursementCHECKMannerOfCashDisbursement
Amount Of Non Cash Assistance0AmountOfNonCashAssistance
FieldValueIRS element (for citing)
Total Number Of501c3 Orgs1TotalNumberOf501c3Orgs
Transfer To Foreign CorpfalseTransferToForeignCorp
Interest In Foreign TrustfalseInterestInForeignTrust
Own Foreign CorptrueOwnForeignCorp
Passive Foreign Invest CofalsePassiveForeignInvestCo
Foreign PartnershipfalseForeignPartnership
Boycott CountriesfalseBoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

FieldValueIRS element (for citing)
IdentifierSCHEDULE F, PART I, LINE 2:Identifier
ExplanationSUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE INFIRMARY ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A STATISFACTORY PACE. SCHEDULE F, PART I, LINE 3, COLUMN(F) AND PART II, LINE 1: THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPERATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER.Explanation

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsXMailSolicitations
Email SolicitationsXEmailSolicitations
In Person SolicitationsXInPersonSolicitations
Solicitation Of Non Govt GrantsXSolicitationOfNonGovtGrants
Solicitation Of Govt GrantsXSolicitationOfGovtGrants
Special Fundraising EventsXSpecialFundraisingEvents
Agreement Ref FundraisingtrueAgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation (2 entries)

Name Of IndividualNameOfIndividualAddress Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeActivityActivityFundraiser Control Of FundsFundraiserControlOfFundsAmount Retained By ContractorAmountRetainedByContractor
PURSUANT5151 BELT LINE ROAD 900DALLASTX75254ANNUAL FUNDfalse105983
BRAKELEY BRISCO85 CAMP AVENUESTAMFORDCT06907CAPITAL CAMPAIGNfalse150496
FieldValueIRS element (for citing)
Total Retained By Contractors256479TotalRetainedByContractors
Licensed StatesMELicensedStates
Licensed StatesMALicensedStates
Licensed StatesNYLicensedStates

Form990 Schedule G Part IV Form990ScheduleGPartIV

FieldValueIRS element (for citing)
IdentifierSCHEDULE G, PART I, LINE 2B, COLUMN (V):Identifier
ExplanationDURING THE FISCAL YEAR ENDED SEPTEMBER 30, 2012, THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH PURSUANT, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE INFIRMARY'S MAILING COMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PATIENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH BRAKELEY BRISCOE TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN.Explanation

Schedule H IRS990ScheduleH

FieldValueIRS element (for citing)
Charity Care PolicytrueCharityCarePolicy
Written PolicytrueWrittenPolicy
FPG Reference Free CaretrueFPGReferenceFreeCare

Other Percentage OtherPercentage

FieldValueIRS element (for citing)
OtherXOther
Free Other Percentage400.FreeOtherPercentage
FieldValueIRS element (for citing)
FPG Reference Discounted CaretrueFPGReferenceDiscountedCare
Pcent400XPcent400
Free Disc Care Medically IndigenttrueFreeDiscCareMedicallyIndigent
Amounts Budgeted For Charity CaretrueAmountsBudgetedForCharityCare
Expenses Exceeded BudgettrueExpensesExceededBudget
Unable To Provide CarefalseUnableToProvideCare
Annual Community Benefit ReporttrueAnnualCommunityBenefitReport
Report Publically AvailabletrueReportPublicallyAvailable

Charity Care At Cost CharityCareAtCost

FieldValueIRS element (for citing)
Total Community Benefit Expense3049351TotalCommunityBenefitExpense
Direct Offsetting Revenue0DirectOffsettingRevenue
Net Community Benefit Expense3049351NetCommunityBenefitExpense
Percent Of Total Expense0.01540PercentOfTotalExpense

Unreimbursed Medicaid UnreimbursedMedicaid

FieldValueIRS element (for citing)
Total Community Benefit Expense12049331TotalCommunityBenefitExpense
Direct Offsetting Revenue10106769DirectOffsettingRevenue
Net Community Benefit Expense1942562NetCommunityBenefitExpense
Percent Of Total Expense0.00980PercentOfTotalExpense

Unreimbursed Costs UnreimbursedCosts

FieldValueIRS element (for citing)
Total Community Benefit Expense3298605TotalCommunityBenefitExpense
Direct Offsetting Revenue3194532DirectOffsettingRevenue
Net Community Benefit Expense104073NetCommunityBenefitExpense
Percent Of Total Expense0.00050PercentOfTotalExpense

Total Charity Care TotalCharityCare

FieldValueIRS element (for citing)
Total Community Benefit Expense18397287TotalCommunityBenefitExpense
Direct Offsetting Revenue13301301DirectOffsettingRevenue
Net Community Benefit Expense5095986NetCommunityBenefitExpense
Percent Of Total Expense0.02570PercentOfTotalExpense

Community Health Services CommunityHealthServices

FieldValueIRS element (for citing)
Total Community Benefit Expense126831TotalCommunityBenefitExpense
Direct Offsetting Revenue0DirectOffsettingRevenue
Net Community Benefit Expense126831NetCommunityBenefitExpense
Percent Of Total Expense0.00060PercentOfTotalExpense

Health Professions Education HealthProfessionsEducation

FieldValueIRS element (for citing)
Total Community Benefit Expense6540327TotalCommunityBenefitExpense
Direct Offsetting Revenue1365874DirectOffsettingRevenue
Net Community Benefit Expense5174453NetCommunityBenefitExpense
Percent Of Total Expense0.02570PercentOfTotalExpense

Subsidized Health Services SubsidizedHealthServices

FieldValueIRS element (for citing)
Number Of Activities Or Programs2NumberOfActivitiesOrPrograms
Persons Served541PersonsServed
Total Community Benefit Expense1882900TotalCommunityBenefitExpense
Direct Offsetting Revenue1366928DirectOffsettingRevenue
Net Community Benefit Expense515972NetCommunityBenefitExpense
Percent Of Total Expense0.00260PercentOfTotalExpense

Research Research

FieldValueIRS element (for citing)
Total Community Benefit Expense34976320TotalCommunityBenefitExpense
Direct Offsetting Revenue1323707DirectOffsettingRevenue
Net Community Benefit Expense33652613NetCommunityBenefitExpense
Percent Of Total Expense0.16990PercentOfTotalExpense

Cash And In Kind Contributions CashAndInKindContributions

FieldValueIRS element (for citing)
Total Community Benefit Expense488083TotalCommunityBenefitExpense
Direct Offsetting Revenue0DirectOffsettingRevenue
Net Community Benefit Expense488083NetCommunityBenefitExpense
Percent Of Total Expense0.00250PercentOfTotalExpense

Total Other Benefits TotalOtherBenefits

FieldValueIRS element (for citing)
Number Of Activities Or Programs2NumberOfActivitiesOrPrograms
Persons Served541PersonsServed
Total Community Benefit Expense44014461TotalCommunityBenefitExpense
Direct Offsetting Revenue4056509DirectOffsettingRevenue
Net Community Benefit Expense39957952NetCommunityBenefitExpense
Percent Of Total Expense0.20130PercentOfTotalExpense

Total Community Benefits TotalCommunityBenefits

FieldValueIRS element (for citing)
Number Of Activities Or Programs2NumberOfActivitiesOrPrograms
Persons Served541PersonsServed
Total Community Benefit Expense62411748TotalCommunityBenefitExpense
Direct Offsetting Revenue17357810DirectOffsettingRevenue
Net Community Benefit Expense45053938NetCommunityBenefitExpense
Percent Of Total Expense0.22700PercentOfTotalExpense
FieldValueIRS element (for citing)
Bad Debt Expense ReportedtrueBadDebtExpenseReported
Bad Debt Expense$2,422,885BadDebtExpenseAmount
Amount Attributable To63483AmountAttributableTo
Amount Reimbursed By Medicare35496754AmountReimbursedByMedicare
Cost Of Care Reimbursed By Medicare35778188CostOfCareReimbursedByMedicare
Medicare Surplus Or Shortfall-281434MedicareSurplusOrShortfall

Costing Methodology Used CostingMethodologyUsed

FieldValueIRS element (for citing)
Cost Accounting SystemXCostAccountingSystem
FieldValueIRS element (for citing)
Written Debt Collection PolicytrueWrittenDebtCollectionPolicy
Provision For Charity CaretrueProvisionForCharityCare
Number Of Hospital Facilities1NumberOfHospitalFacilities

Form990 Schedule H Part V Section A Form990ScheduleHPartVSectionA

FieldValueIRS element (for citing)
Facility Number1FacilityNumber

Name Name

FieldValueIRS element (for citing)
Business Name Line1MASSACHUSETTS EYE & EAR INFIRMARYBusinessNameLine1

Address Address

FieldValueIRS element (for citing)
Address Line1243 CHARLES STREETAddressLine1
CityBOSTONCity
StateMAState
ZIP Code02114ZIPCode
FieldValueIRS element (for citing)
Licensed HospitalXLicensedHospital
Teaching HospitalXTeachingHospital
Research FacilityXResearchFacility
Er24 HoursXEr24Hours

Form990 Schedule H Part V Section B Form990ScheduleHPartVSectionB

Hospital Facility Name HospitalFacilityName

FieldValueIRS element (for citing)
Business Name Line1MASSACHUSETTS EYE & EAR INFIRMARYBusinessNameLine1
FieldValueIRS element (for citing)
Hospital Facility Number1HospitalFacilityNumber
Eligibility Criteria ExplainedtrueEligibilityCriteriaExplained
Uses FPG FreetrueUsesFPGFree
FPG Free Percent400.FPGFreePercent
Uses FPG DiscountedtrueUsesFPGDiscounted
FPG Discount Percent400.FPGDiscountPercent
Explains BasistrueExplainsBasis
Income LevelXIncomeLevel
Asset LevelXAssetLevel
Medical IndigencyXMedicalIndigency
Insurance StatusXInsuranceStatus
Uninsured DiscountXUninsuredDiscount
Medicaid MedicareXMedicaidMedicare
State RegulationXStateRegulation
Explains Application MethodtrueExplainsApplicationMethod
Includes Publicity MeasurestrueIncludesPublicityMeasures
Posted On WebsiteXPostedOnWebsite
Attached To InvoicesXAttachedToInvoices
Posted In Emergency RoomXPostedInEmergencyRoom
Posted In Admission OfficeXPostedInAdmissionOffice
Provided On AdmissionXProvidedOnAdmission
Available On RequestXAvailableOnRequest
Actions On NonpaymenttrueActionsOnNonpayment
Collection ActivitiesfalseCollectionActivities
Nondiscrim Emergency Care PolicytrueNondiscrimEmergencyCarePolicy
Used Other MethodXUsedOtherMethod
Amounts Generally BilledfalseAmountsGenerallyBilled
Gross ChargesfalseGrossCharges

Form990 Schedule H Part V Section C Form990ScheduleHPartVSectionC

FieldValueIRS element (for citing)
Number Of Other Facilities6NumberOfOtherFacilities

Other Facilities OtherFacilities (6 entries)

Address Line1Address/AddressLine1CityAddress/CityStateAddress/StateZIP CodeAddress/ZIPCodeFacility TypeFacilityType
MASSACHUSETTS EYE & EAR STONEHAM
ONE MONTVALE AVENUESTONEHAMMA02180LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR E BRDIGEWATER
ONE COMPASS WAY SUITE 100E BRIDGEWATERMA02333LICENSED OUTPATIENT LOCATION
MEEI VESTIBULAR CENTER AT BRAINTREE
250 POND STREET 1ST FLOORBRAINTREEMA02184LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR QUINCY
500 CONGRESS STREETQUINCYMA02169LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR AT JOSLIN
1 JOSLIN PLACEBOSTONMA02215LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR CONCORD
54 BAKER AVE EXTENSION 3RD FL STECONCORDMA01742LICENSED OUTPATIENT LOCATION

Form990 Schedule H Part VI Form990ScheduleHPartVI (16 entries)

IdentifierIdentifierExplanationExplanation
SCHEDULE H, PART II:THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND IT'S AFFILIATED ORGANIZATIONS (COLLECTIVELY "MEEI") PROVIDED COMMUNITY BUILDING HEALTH IMPROVEMENT ADVOCACY BY PROVIDING EDUCATIONAL OPPORTUNITIES AND SUPPORT, INCLUDING HOSTED SUPPORT GROUPS, FOCUSING ON HEALTH CONDITIONS IN OUR SPECIALTIES TO PATIENTS AND THE PUBLIC. PLEASE SEE PAGE 16 OF THE COMMUNITY BENEFITS PLAN POSTED ON THE MEEI WEBSITE, WWW.MASSEYEANDEAR.ORG, FOR DETAILS.
SCHEDULE H, PART III, LINE 4:BAD DEBTS ARE WRITTEN OFF AT GROSS CHARGES. FOR UNINSURED CLAIMS (SELF-PAY), BAD DEBTS ARE DISCOUNTED TO COST USING THE HOSPITAL COST ACCOUNTING SYSTEM. ACCOUNTS RECEIVABLE RELATED TO CO-PAYS, DEDUCTIBLES, AND COINSURANCE THAT IS WRITTEN OFF AS BAD DEBT IS ALREADY REPORTED AT COST AND IS DEDUCTED FROM THE INSURANCE-ALLOWED AMOUNT.
SCHEDULE H, PART III, LINE 8:THE SHORTFALL REPORTED ON PART III, LINE 7 SHOULD BE CONSIDERED COMMUNITY BENEFIT BECAUSE REIMBURSEMENT FROM MEDICARE DOES NOT COVER THE COST OF TREATING PATIENTS. MEEI HAS A POLICY TO TREAT ALL PATIENTS, REGARDLESS OF THE PAYER. AS A PRIMARILY OUT-PATIENT FACILITY, WITH ONLY TWO SPECIALTIES, MEEI CANNOT BENEFIT FROM RELATIVELY HIGHER MEDICARE PAYMENTS FOR SOME SPECIALTIES OR HIGHER INPATIENT MEDICARE REIMBURSEMENT. WITHOUT COMPROMISING PATIENT CARE, MEEI HAS LIMITED MEANS FOR REDUCING COSTS. MEEI USES A COST ACCOUNTING SYSTEM THAT IS COMPRISED OF A STEP-DOWN METHODOLOGY FOR ALLOCATING HOSPITAL OVERHEAD THAT IS SIMILAR TO THAT USED FOR THE MEDICARE COST REPORT. ALL INDIRECT COSTS ARE ALLOCATED TO PATIENT CARE COST CENTER, TEACHING AND RESEARCH. FULLY-LOADED PATIENT CARE COSTS ARE ALLOCATED TO PATIENTS USING BILLED UNITS, UNIT COSTS, AND ALLOCATION ALGORITHMS SPECIFIC TO EACH COST CENTER.
SCHEDULE H, PART III, LINE 9B:PATIENTS ARE NOTIFIED ON ALL BILLING STATEMENTS OF THE AVAILABILITY OF FINANCIAL ASSISTANCE AND THE CONTACT INFORMATION OF THE APPROPRIATE STAFF MEMBERS WHO ARE AVAILABLE TO ASSIST IN THE PROCESS. MEEI'S POLICY INCORPORATES SPECIFIC BILLING PRACTICES RELATING TO PATIENTS WHO ARE ELGIBILE FOR FINANCIAL ASSISTANCE.
SCHEDULE H, PART V, LINE 19D:CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE INFIRMARY'S THREE LARGEST PAYERS.
SCHEDULE H, PART VI, LINE 2:MEEI ENGAGED THE SERVICES OF CONSULTANTS TO WORK CLOSELY WITH THE COMMUNITY BENEFITS (BC) WORKING GROUP THROUGHOUT THE ASSESSMENT AND PLANNING PROCESS, WHICH TOOK PLACE DURING THE FALL 2012/WINTER 2013. DURING THE ASSESSMENT AND PLANNING PROCESSES, THE CB WORKING GROUP MET REGULARLY AND ENGAGED THE FULL COMMITTEE AS NEEDED FOR PROGRESS UPDATES AND INPUT. AFTER THE PLAN WAS DEVELOPED AND APPROVED, MEETINGS DECREASED IN FREQUENCY AND THE GROUPS MET ON AN AS-NEEDED BASIS. FOR MOST MASSACHUSETTS HOSPITALS, COMMUNITY-LEVEL DATA AVAILALBE THROUGH THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH AND BOSTON PUBLIC HEALTH COMMISSION ARE USEFUL IN UNDERSTANDING THE SPECIFIC HEALTH NEEDS OF COMMUNITIES AND THOSE IN WHICH DISPARITIES EXIST. THESE DATA ARE TYPICALLY USED TO SELECT VULNERABLE COMMUNITIES AND POPULATIONS AND TO TARGET SERVICES TO ADDRESS PARTICULAR HEALTH ISSUES AND DISPARITIES. BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, MEEI'S CB COMMITTEE HAD TO RELY ON ITS OWN PATIENT DATA, CENSUS DATA, AND GUIDANCE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEFINE ITS TARGET COMMUNITIES AND POPULATIONS AND TO FORMULATE OBJECTIVES FOR ITS COMMUNITY BENEFITS PLAN.
SCHEDULE H, PART VI, LINE 3:MEEI, AS A FACILITY, WORKS TO ACTIVELY INFORM PATIENTS OF PROGRAMS AND RESOURCES AVAILABLE TO THEM TO HELP WITH FINANCIAL ASSISTANCE. BILLING BROCHURES ARE AVAILABLE IN ALL DEPARTMENTAL WAITING AREAS, WHICH EXPLAIN THE BILLING PROCESS AND THE PATIENT'S OPTIONS FOR FINANCIAL ASSISTANCE. IN ADDITION, THE MEEI EXTERNAL WEBSITE CONTAINS A LINK WHICH HIGHLIGHTS THE BASIC FEDERAL PROGRAMS AND ACCESS TO MEEI'S FINANCIAL COUNSELORS. THE FINANCIAL COUNSELING PROCESS IS DESIGNED TO EVALUATE THE PATIENTS' FINANCIAL ABILITY TO PAY AND TO RECOMMEND AND ASSIST THE PATIENT WITH ENROLLING IN ANY APPLICABLE GOVERNMENT OR PRIVATE PROGRAMS. WHEN ALL AVENUES HAVE BEEN EXHAUSTED, CHARITABLE CARE CRITERIA ARE REVIEWED.
SCHEDULE H, PART VI, LINE 4:STEP 1: IDENTIFY MEEI'S TARGET AREA AND POPULATIONS FOR ITS COMMUNITY BENEFITS PLAN THE ASSESSMENT TO INFORM THE NEXT MEEI COMMUNITY BENEFIT PLANS BEGAN WITH ANALYSIS OF 12 MONTHS OF PATIENT DATA (APRIL 1, 2011 THROUGH MARCH 31, 2012) TO BETTER UNDERSTAND THE POPULATION SERVED. PATIENTS FROM OUTSIDE OF MASSACHUSETTS WERE EXCLUDED FROM ANALYSES, LEAVING A REPRESENTATIVE SAMPLE OF 65,429 PATIENTS. BELOW, OBSERVATIONS ABOUT PATIENTS' SEX, RACE/ETHNICITY, AGE, SOCIO-ECONOMIC STATUS, AND THEIR GEOGRAPHIC LOCATIONS ARE PROVIDED. THESE DATA WERE USED TO GUIDE THE SELECTION OF COMMUNITIES AND/OR POPULATIONS OF FOCUS. DEMOGRAPHIC CATEGORIES & STATISTICS: SEX: OVER HALF (53.4%) OF PATIENTS INCLUDED IN THE DATA SET ARE FEMALE. RACE/ETHNICITY: ROUGHLY 75% OF PATIENTS IN THE SAMPLE ELECTED TO PROVIDE DATA ABOUT THEIR RACE AND ETHNICITY AT THE TIME OF REGISTRATION AT THE HOSPITAL. FIGURE 1 BELOW SHOWS THE RACIAL/ETHNIC BREAKDOWN OF PATIENTS IN THE DATA SET, THE MAJORITY OF WHOM (60.2%) ARE WHITE. RACIAL/ETHNIC BREAKDOWN: (NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS) AMERICAN INDIAN/ALASKA NATIVE: 125; 0.2% ASIAN: 2,196; 3.4% BLACK/AFRICAN AMERICAN: 4,684; 7.2% HISPANIC: 1,090; 1.7% PACIFIC ISLANDER: 25; <1% WHITE: 39,392; 60.2% OTHER: 1,148; 1.7% UNKNOWN: 16,769; 25.6% TOTAL: 65,429; 100% BECAUSE THERE IS SO MUCH MISSING INFORMATION ABOUT RACE/ETHNICITY, THE DATA WERE NOT PARTICULARLY USEFUL IN IDENTIFYING VULNERABLE POPULATIONS. GEOGRAPHY: NOTE THAT WITHIN DATA SET, SOME PATIENTS WERE LISTED AS LIVING IN BOSTON WITH NO SPECIFIED NEIGHBORHOOD, WHEREAS OTHERS WERE LISTED AS LIVING IN ONE OF BOSTON'S 21 NEIGHBORHOODS. IN FACT, DATA WERE AVAILABLE FOR 11 OF THE 21 NEIGHBORHOODS. RATHER THAN ROLL THE DATA FOR THE 11 NEIGHBORHOODS INTO THE BOSTON NUMBERS, THE CONSULTANTS KEPT THE DATA SEPARATE TO UNDERSTAND WHICH NEIGHBORHOODS HAVE SIGNIFICANT NUMBERS OF MEEI PATIENTS. HOWEVER, IT SHOULD BE NOTED THAT THE ACTUAL NUMBERS ASSOCIATED WITH THOSE NEIGHBORHOODS SHOULD BE HIGHER, AS SOME PATIENTS LIVING IN THOSE NEIGHBORHOODS ARE SIMPLY CLASSIFIED AS LIVING IN BOSTON. OTHER NEIGHBORHOODS OF BOSTON MAY ALSO BE HOME TO LARGE NUMBERS OF MEEI PATIENTS BUT, BECAUSE THEY ARE NOT BROKEN OUT, WE DO NOT KNOW HOW MANY PATIENTS RESIDE IT THOSE NEIGHBORHOODS. OF THE 65,429 MASSACHUSETTS PATIENTS IN THE DATA SET, NEARLY 30% LIVE IN BOSTON AND NEARLY HALF (49.2%) LIVE IN COMMUNITIES INSIDE ROUTE 128 (INCLUDING BOSTON). THE VAST MAJORITY (82.8%) OF PATIENTS ARE FROM COMMUNITIES INSIDE OF ROUTE 495. PERCENT OF MEEI PATIENTS LIVING IN GEOGRAPHIC AREAS OF MASSACHUSETTS: BOSTON/BOSTON NEIGHBORHOODS: 29.5% WITHIN 128 (EXCEPT BOSTON): 19.7% NORTH SHORE: 3.2% INSIDE 495 (BEYOND 128): 30.4% OUTSIDE 495 - CENTRAL: 6.6% OUTSIDE 495 - NORTH: 4.5% WESTERN MA: 5.1% CAPE/ISLANDS: <1% TO IDENTIFY POPULATION CENTERS, THE CONSULTANTS LOOKED FOR THE COMMUNITIES/NEIGHBORHOODS IN WHICH THE LARGEST NUMBERS OF MEEI PATIENTS LIVE. FIFTEEN COMMUNITIES/NEIGHBORHOODS ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS. NEARLY HALF (49.9%) LIVE IN THESE 15 COMMUNITIES. MASSACHUSETTS COMMUNITIES/NEIGHBORHOODS WITH HIGHEST PROPORTION OF MEEI PATIENTS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS; GEOGRAPHIC AREA) BOSTON (NO COMMUNITY SPECIFIED): 12,575; 19.2%; BOSTON JAMAICA PLAIN: 1,007; 1.5%; BOSTON WEST ROXBURY: 817; 1.2%; BOSTON ROSLINDALE: 789; 1.2%; BOSTON HYDE PARK: 780; 1.2%; BOSTON ALLSTON/BRIGHTON: 1,414; 2.2%; BOSTON CHARLESTOWN: 1,188; 1.8%; BOSTON CAMBRIDGE: 4,037; 6.2%; WITHIN 128 LYNN: 3,941; 6.0%; WITHIN 128 WAKEFIELD: 911; 1.4%; WITHIN 128 WOBURN: 933; 1.4%; WITHIN 128 READING/N. READING: 1,180; 1.8%; INSIDE 495 ANDOVER/N. ANDOVER: 1,356; 2.1%; INSIDE 495 FRAMINGHAM: 941; 1.4%; INSIDE 495 WORCESTER: 752; 1.1%; OUTSIDE 495 AGE: THE MASSACHUSETTS ATTORNEY GENERAL IS INTERESTED IN HAVING THE HOSPITAL COMMUNITY BENEFITS PLANS TARGET VULNERABLE POPULATIONS. MEEI HAS CLINICAL EXPERTISE IN SERVING ELDERS AND CHILDREN, POTENTIALLY VULNERABLE POPULATIONS SELECTED BY THE COMMUNITY BENEFITS STEERING COMMITTEE AS PRIORITY POPULATIONS FOR MEEI'S COMMUNITY BENEFITS PLAN BECAUSE OF THE IMPACT OF HEARING/VISION IMPAIRMENT ON CHILDREN'S DEVELOPMENT AND HEARING/VISION IMPAIRMENT AND BALANCE ISSUES ON THE HEALTH AND SAFETY OF ELDERS. THE MEAN AGE OF MEEI PATIENTS IS 46.81 YEARS, WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 106 YEARS OF AGE. PATIENTS AGED 65 AND OVER MAKE UP 23.5% OF THOSE SEEN DURING THE SELECTED TIMEFRAME, WHEREAS THOSE 18 OR YOUNGER CONSTITUTE 13.7% OF THE POPULATION. BELOW SHOWS THE PROPORTION OF PATIENTS IN VARIOUS AGE GROUPS: (AGE GROUP: PERCENTAGE OF TOTAL) <1 YEAR TO 18 YEARS OLD: 13.7% 19 TO 24 YEARS OLD: 5.4% 25 TO 34 YEARS OLD: 10.6% 35 TO 44 YEARS OLD: 12.2% 45 TO 54 YEARS OLD: 16.3% 55 TO 64 YEARS OLD: 18.3% 65 AND OVER: 23.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBER OF MEEI'S SENIOR (65 YEARS AND OLDER) POPULATION. THESE TEN COMMUNITIES ARE HOME TO 34% OF MEEI SENIORS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,820; 11.8% CAMBRIDGE: 1,015; 6.6% DORCHESTER: 540; 3.5% LYNN: 386; 2.5% BRIGHTON: 298; 1.9% FRAMINGHAM: 261; 1.7% JAMAICA PLAIN: 238; 1.5% PEABODY: 237; 1.5% SAUGUS: 227; 1.5% WOBURN: 227; 1.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO ARE LESS THAN 1 YEAR OF AGE THROUGH AGE 18. NEARLY 30% OF THE CHILDREN SERVED BY MEEI DURING THE DESIGNATED TIME PERIOD LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 883; 9.9% LYNN: 370; 4.1% CAMBRIDGE: 350; 3.9% SAUGUS: 192; 2.1% CHARLESTOWN: 175; 2.0% WOBURN: 169; 1.9% HAVERHILL: 143; 1.6% ANDOVER: 141; 1.6% DORCHESTER: 131; 1.4% READING: 129; 1.4% SOCIO-ECONOMIC STATUS: SOCIO-ECONOMIC (SES) IS ANOTHER VARIABLE ASSOCIATED WITH VULNERABLE POPULATIONS. PATIENTS' HEALTH INSURANCE CAN BE USED AS A PROXY FOR SES BECAUSE THERE ARE INCOME ELIGIBILITY REQUIREMENTS IN PLACE FOR PUBLIC PAYERS THAT ALLOW US TO MAKE ASSUMPTIONS ABOUT WHICH PATIENTS ARE LOW INCOME. IT IS IMPORTANT TO NOTE THAT THE NUMBER OF LOW-INCOME PATIENTS SERVED BY MEEI IS LIKELY MUCH HIGHER. IT IS NOT POSSIBLE TO KNOW HOW MANY MASSHEALTH PATIENTS, FOR EXAMPLE, ARE INSURED THROUGH A COMMERCIAL CARRIER WITH A MANAGED CARE CONTRACT WITH MASSHEALTH. ADDITIONALLY, IT IS NOT POSSIBLE TO KNOW WHICH PORTION OF THE SENIORS USING MEDICARE PRODUCTS TO PAY FOR THE SERVICES THEY RECEIVE AT MEEI ARE LOW-INCOME AND WHICH ARE NOT. ALTHOUGH AN IMPERFECT METHOD FOR DETERMINING THE SES OF PATIENTS, THESE ARE THE BEST DATA AVAILABLE FOR THIS PURPOSE. USING PAYER AS PROXY, IT APPEARS THAT JUST OVER 11% OF THE MEEI PATIENTS ARE LOW-INCOME, BROKEN DOWN AS FOLLOWS:
(PUBLIC PAYER: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL)MASSHEALTH: 3,672; 7.1% HEALTH SAFETY NET: 796; 1.2% MEDICAID: 287; 0.4% BMC HEALTH NET: 143; 0.2% NETWORK HEALTH: 1,493; 2.3% THE AVERAGE AGE OF THESE LOW-INCOME PATIENTS IS 37 WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 96 YEARS OF AGE. IT IS IMPORTANT TO NOTE THAT THE VAST MAJORITY OF SENIORS (65+) ARE EXCLUDED FROM THE ANALYSES BECAUSE MOST SENIORS USE MEDICARE PRODUCTS TO PAY FOR THEIR CARE. TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO HAVE LOW SES. NEARLY 50% OF THE PATIENTS WITH LOW SES LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,102; 17.2% LYNN: 504; 7.9% CAMBRIDGE: 440; 6.9% DORCHESTER: 248; 3.8% LAWRENCE: 198; 3.1% CHARLESTOWN: 160; 2.5% EAST BOSTON: 163; 2.2% SAUGUS: 129; 2.0% LOWELL: 127; 2.0% WORCESTER: 123; 1.9% MEEI SERVES A POPULATION WITH A LARGE AGE RANGE, INCLUDING SIGNIFICANT SENIOR (65+) AND PEDIATRIC (LESS THAN ONE YEAR THROUGH AGE 18) POPULATIONS. USING PATIENT PAYER AS A PROXY FOR SES, AT LEAST 11.2% OF THE PATIENTS HAVE LOW SES. NEARLY HALF OF MEEI'S PATIENTS LIVE IN COMMUNITIES WITHIN ROUTE 128, INCLUDING BOSTON AND SELECT NEIGHBORHOODS. ELEVEN OF THE 15 COMMUNITIES THAT ARE HOME TO THE LARGEST CONCENTRATION OF MEEI PATIENTS ARE WITHIN THIS GEOGRAPHIC AREA. THERE IS OVERLAP IN THE TOP COMMUNITIES FOR THE GENERAL POPULATION OF PATIENTS SEEN DURING THE DESIGNATED TIMEFRAME AND THE VULNERABLE POPULATIONS. THREE ARE AMONG THE TOP COMMUNITIES FOR THE OVERALL POPULATION AND ELDERS, CHILDREN AND THOSE WITH LOW-SES: BOSTON, CAMBRIDGE AND LYNN. TWO OTHERS (DORCHESTER AND SAUGUS) ARE AMONG THE TOP TEN FOR ALL THREE VULNERABLE GROUPS. IT MAY BE POSSIBLE TO MAXIMIZE RESOURCES FOR ADDRESSING THE NEEDS OF PATIENTS OVERALL AND AMONG THE VULNERABLE POPULATIONS BY CONCENTRATING EFFORTS IN COMMUNITIES/NEIGHBORHOODS WITHIN 128, ESPECIALLY THOSE WHERE SUCH OVERLAPS EXIST. A 2010 CENSUS MAP PRODUCED BY THE BOSTON GLOBE AND AVAILABLE ON-LINE SHOWS THAT THE LARGEST CONCENTRATION OF PEOPLE OF COLOR IN MASSACHUSETTS IS IN THE METRO BOSTON AREA. A SIMILAR 2010 CENSUS MAP SHOWS THAT, ALTHOUGH METRO BOSTON IS HOME TO SOME OF THE COMMONWEALTH'S WEALTHIEST COMMUNITIES, IT IS ALSO HOME TO SOME OF THE LOWEST INCOME COMMUNITIES. A THIRD MAP CREATED BY THE GERONTOLOGY INSTITUTE AT THE MCCORMACK GRADUATE SCHOOL OF POLICY AND GLOBAL STUDIES AT THE UNIVERSITY OF MASSACHUSETTS BOSTON SHOWS THAT THE POPULATION OF SENIORS LIVING WITHIN THE METRO BOSTON AREA EXCEEDS THE STATEWIDE AVERAGE. ACCORDING TO THE 2010 CENSUS, 13.8% OF MASSACHUSETTS RESIDENTS ARE AGED 65 AND OLDER. WITHIN THE MAJORITY OF METRO BOSTON COMMUNITIES, SENIORS COMPRISE BETWEEN 15.1% AND 20% OF THE CITY/TOWN POPULATIONS. CONCLUSIONS: BASED ON THE MOST RECENT CENSUS DATA AND MEEI'S OWN PATIENT DATA, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT, ALTHOUGH MEEI CARES FOR PATIENTS FROM ALL OVER THE COMMONWEALTH, THE HOSPITAL'S PRIMARY SERVICE AREA INCLUDES THE COMMUNITIES IN THE METRO-BOSTON AREA (WITHIN THE ROUTE 128 BELT). ANALYSES ALSO SHOWED THAT LARGE NUMBERS OF VULNERABLE (I.E., CHILDREN, ELDERLY AND LOW-INCOME) PATIENTS RESIDE WITHIN THE METRO-BOSTON/128 AREA. THE COMMITTEE FURTHER CONCLUDED THAT, GIVEN THE NUMBER OF LOW INCOME COMMUNITIES AND PROPORTION OF PEOPLE OF COLOR RESIDING WITHIN ITS PRIMARY SERVICE AREA, MEMBERS OF MEEI'S TARGET POPULATION ARE VERY LIKELY TO EXPERIENCE BARRIERS TO CARE RELATED TO DIVERSITY (E.G., LANGUAGE) AND SOCIO-ECONOMIC FACTORS. BECAUSE OF THE FACTORS THAT MAKE CHILDREN, SENIORS AND LOW-INCOME INDIVIDUALS PARTICULARLY VULNERABLE, THESE GROUPS WILL BE PRIORITIZED WITHIN THE COMMUNITY BENEFITS PLAN. ALTHOUGH THE PLAN SHOULD NOT EXCLUDE THOSE LIVING OUTSIDE THE METRO-BOSTON AREA, IT SHOULD EMPHASIZE SERVICES FOR THOSE LIVING WITHIN IT BECAUSE RESIDENTS ARE SO LIKELY TO EXPERIENCE BARRIERS TO CARE. MEEI SHOULD BUILD UPON A SOLID FOUNDATION OF OUTREACH AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN. AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN.
STEP 2: ASSESS UNMET NEEDS IN METRO BOSTON AND AMONG THE TARGETPOPULATIONS THE CB WORKING GROUP, OTHER MEMBERS OF THE COMMUNITY BENEFITS COMMITTEE, OTHER PROVIDERS AND STAFF AT MEEI, AND EXTERNAL PARTNERS AT ORGANIZATIONS SERVING THE TARGET POPULATIONS AND COMMUNITIES WORKED TOGETHER TO UNDERSTAND THE UNMET NEEDS THAT, AS AN INSTITUTION, MEEI IS UNIQUELY POSITIONED TO ADDRESS BECAUSE OF ITS CLINICAL SERVICES AND EXPERTISE. THROUGH ON-GOING DIALOG AND CONVERSATIONS OVER THE SUMMER AND FALL OF 2012, THE CB WORKING GROUP LED THE PROCESS TO IDENTIFY THE RESOURCE NEEDS. THE NEEDS ARE CONSISTENT WITH THOSE IDENTIFIED IN THE 2010 COMMUNITY BENEFITS PLAN: -TO EXTEND VISION SCREENING AND HEARING EXAMINATIONS AND FOLLOW UP CARE TO INDIVIDUALS WHO HAVE NO OR VERY LIMITED ACCESS TO SUCH SERVICES. -FOR RECONSTRUCTIVE SURGICAL SERVICES FOR SURVIVORS OF DOMESTIC VIOLENCE WHO EXPERIENCED PHYSICAL INJURIES TO THE HEAD AND/OR NECK AS A RESULT OF ABUSE. -FOR EDUCATION, SCREENING AND SUPPORT FOR HEAD AND NECK CANCERS. -FOR EDUCATION AND SUPPORT RELATED TO FACIAL PARALYSIS AND CONDITIONS THAT AFFECT SMELL AND TASTE. -FOR RESOURCES TO IMPROVE ACCESS TO CARE FOR MEMBERS OF THE TARGET COMMUNITIES WHO WOULD BENEFIT FROM MEEI SERVICES BUT WHO ARE UNABLE TO GET THE CARE THEY NEED DUE TO LINGUISTIC OR FINANCIAL ISSUES, LACK OF TRANSPORTATION, OR A LACK OF KNOWLEDGE ABOUT THEIR CONDITIONS AND THE SERVICES TO ADDRESS THEM. -FOR FINANCIAL SUPPORT OF COMMUNITY-BASED NON-PROFITS ENGAGED IN UNIQUE AND HIGH QUALITY WORK TO ADDRESS VISION, HEARING OR OTHER CONCERNS OF THE HEAD AND NECK IN THE TARGET COMMUNITIES AND/OR AMONG THE TARGET POPULATIONS. WITH GROWTH IN THE SENIOR POPULATION, THE INCREASE IN POVERTY OVER THE LAST SEVERAL YEARS, AND THE SMALL NUMBER OF INSTITUTIONS OFFERING THE CLINICAL EXPERTISE AND SERVICES AVAILABLE AT MEEI WITHIN METRO BOSTON, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE NEEDS ARE LIKELY TO PERSIST FOR MANY YEARS TO COME. SOME OF THE IDENTIFIED NEEDS (I.E., THOSE RELATED TO AWARENESS AND EDUCATION) AFFECT LARGE NUMBERS OF PEOPLE IN THE TARGET AREA. OTHERS AFFECT SMALLER GROUPS OF PEOPLE, EITHER BECAUSE POCKETS OF PEOPLE EXPERIENCE IMPEDED ACCESS TO SERVICES THAT ARE OTHERWISE GENERALLY AVAILABLE OR BECAUSE A CLINICAL CONDITION IS RARE AND THE RESOURCES TO ADDRESS IT ARE EXTREMELY LIMITED. CONCLUSION: THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE UNMET NEEDS IDENTIFIED DURING THE METRO BOSTON ASSESSMENT WERE ALIGNED WITH THE CAPABILITIES OF MEEI AND ITS COMMUNITY PARTNERS AND SHOULD BE USED TO FORMULATE GOALS FOR MEEI'S COMMUNITY BENEFITS PLAN. FORMULATE GOALS FOR MEEI'S COMMUNITY BENEFITS PLAN. STEP 3: ASSESS NEEDS IN MISSION HILL AS NOTED EARLIER, MEEI DECIDED TO BROADEN ITS COMMUNITY BENEFITS WORK TO PROVIDE TARGETED PROGRAMMING IN MISSION HILL, THE NEIGHBORHOOD IN WHICH ITS NEW OUT-PATIENT FACILITY IS LOCATED. MISSION HILL IS ONE SQUARE MILE, THREE-QUARTERS OF WHICH IS RESIDENTIAL. THE OTHER QUARTER IS COMPRISED OF THE LONGWOOD MEDICAL AREA. ACCORDING TO A REPORT BASED ON 2010 CENSUS DATA, MISSION HILL IS HOME TO 16,305 RESIDENTS, 19.7% OF WHOM ARE HISPANIC/LATINO. JUST UNDER 46% OF THE POPULATION IS A RACE OTHER THAN WHITE. ROUGHLY 21% OF THE MISSION HILL POPULATION IS 19 YEARS OF AGE OR YOUNGER AND 9.1% IS 65 YEARS OF AGE OR OLDER. AN AMERICAN COMMUNITY SURVEY (2005-2009) ESTIMATE REPORT ESTIMATES THAT 3,711 OR 28.1% OF MISSION HILL RESIDENTS WERE BORN OUTSIDE OF THE U.S. AND THAT 48.5% OF THOSE ARE NOT CURRENTLY U.S. CITIZENS. JUST OVER 44% OF RESIDENTS SPEAK A LANGUAGE OTHER THAN OR IN ADDITION TO ENGLISH. OF THOSE WHO SPEAK A LANGUAGE OTHER THAN ENGLISH, 33.2% ARE LINGUISTICALLY ISOLATED BECAUSE THEY SPEAK LITTLE OR NO ENGLISH. IN 2009, AN ESTIMATED 19.3% OF MISSION HILL RESIDENTS EARNED LESS THAN $10,000 A YEAR. MORE THAN HALF (53.6%) EARNED LESS THAN $40,000 PER YEAR. IN CONTRAST, 12.6% EARNED $100,000 OR MORE IN THE SAME 12 MONTHS. ACCORDING TO THE 2010 CENSUS, OF THE 6,332 OCCUPIED HOUSING UNITS IN MISSION HILL, ONLY 11.4% ARE OWNER-OCCUPIED AND 33.6% ARE OCCUPIED BY FAMILIES. SEVERAL HUNDRED HOUSING UNITS IN MISSION HILL ARE OWNED AND RENTED BY THE BOSTON HOUSING AUTHORITY. SENIORS (65+) RESIDE IN 17.8% OF MISSION HILL HOUSEHOLDS WHILE CHILDREN UNDER THE AGE OF 18 ARE IN 16.9% OF HOUSEHOLDS. MISSION HILL IS HOME TO MORE THAN 20 HEALTH CARE, RESEARCH AND ACADEMIC INSTITUTIONS. MISSION HILL IS A SMALL BUT DIVERSE COMMUNITY. ALTHOUGH, HOME TO SOME OF THE CITY'S LARGEST EMPLOYERS AND SEVERAL HUNDRED MIDDLE AND UPPER INCOME RESIDENTS, MISSION HILL IS PRIMARILY A NEIGHBORHOOD OF LOWER-INCOME FAMILIES. SENIORS AND CHILDREN MAKE UP ROUGHLY 30% OF THE MISSION HILL POPULATION. TO LEARN ABOUT MEEI'S PATIENTS WHO RESIDE IN MISSION HILL, THE CONSULTANTS ANALYZED DATA FROM THE LARGER DATA SET FOR PATIENTS WHOSE ZIP CODE IS 02120 (THE ZIP CODE FOR MISSION HILL). DURING THE TIMEFRAME FROM WHICH PATIENT DATA WERE DRAWN, MEEI CARED FOR 263 PATIENTS WHO LIVE IN MISSION HILL (1.6% OF THE MISSION HILL POPULATION). WITH THE NEW FACILITY IN MISSION HILL AND A CONCENTRATED EFFORT TO PROVIDE SERVICES TO THE NEIGHBORHOOD THROUGH ITS COMMUNITY BENEFITS PROGRAMMING, WE EXPECT THAT NUMBER TO RISE OVER THE NEXT THREE YEARS. (SEE FIGURE 11 IN THE OFFICIAL MEEI COMMUNITY BENEFITS REPORT FOR THE DEMOGRAPHICS OF MEEI'S PATIENTS WHO LIVE IN MISSION HILL.) AFTER PROFILING THE DEMOGRAPHICS OF THE NEIGHBORHOOD, THE CONSULTANTS INTERVIEWED MICHELLE KEENAN AND JOHN MCGONAGLE, SENIOR MANAGERS FOR COMMUNITY BENEFITS AT BRIGHAM AND WOMEN'S HOSPITAL (BWH). BWH IS LOCATED IN THE LONGWOOD MEDICAL AREA, NEIGHBORING MISSION HILL, AND HAS AN EXTENSIVE COMMUNITY BENEFITS PROGRAM THAT INVOLVES NUMEROUS INITIATIVES IN THE MISSION HILL. BOTH MS. KEENAN AND MR. MCGONAGLE HAVE SIGNIFICANT EXPERIENCE WORKING IN MISSION HILL AND WERE ABLE TO PROVIDE AN OVERVIEW OF BWH'S EXPERIENCE IN THE NEIGHBORHOOD. MS. KEENAN AND MR. MCGONAGLE SHARED A SYNOPSIS OF FINDINGS FROM THEIR OWN COMMUNITY BENEFITS NEEDS ASSESSMENT IN MISSION HILL. TO GAIN A BETTER UNDERSTANDING OF NEEDS IN MISSION HILL SPECIFICALLY, THE CONSULTANTS WORKED WITH THE MEEI CB WORKING GROUP AND WITH BRIGHAM AND WOMEN'S HOSPITAL COMMUNITY BENEFITS LEADERS TO IDENTIFY MISSION HILL SERVICE PROVIDERS, ADVOCATES AND EDUCATORS POSITIONED TO SPEAK TO THE NEEDS OF THE COMMUNITY. THE CONSULTANTS THEN CONDUCTED TEN IN-DEPTH INTERVIEWS WITH THE IDENTIFIED KEY INFORMANTS. AMONG THEM WAS CHRISTINE DWYER OF THE NEW ENGLAND BAPTIST HOSPITAL, WHICH OPERATES A SMALLER BUT HIGHLY REGARDED COMMUNITY BENEFITS PROGRAM TARGETING MISSION HILL. THE EXPERIENCES OF THE BWH AND NEW ENGLAND BAPTIST PROVIDED GREAT INSIGHTS THAT INFORMED THE ASSESSMENT AND PLANNING PROCESSES DESCRIBED BELOW. THE FOLLOWING IS A LIST OF THE KEY INFORMANT INTERVIEW PARTICIPANTS AND THEIR ORGANIZATIONAL AFFILIATIONS. MAGGIE COHN, EXECUTIVE DIRECTOR, MISSION HILL HEALTH MOVEMENT MAGGIE CASEY, COORDINATOR, MISSION HILL YOUTH COLLABORATIVE ROXANNE HAECKER, VP, BOARD OF DIRECTORS, ROXBURY TENANTS OF HARVARD ALEXANDRA OLIVER-DAVILA, EXECUTIVE DIRECTOR, SOCIEDAD LATINA PAT FLAHERTY, SENIOR PROJECT DIRECTOR, BOARD OF DIRECTORS, MISSION HILL NEIGHBORHOOD HOUSING SERVICES CARMEN POLA, FOUNDER, MISSION HILL LEGACY PROJECT JOHN JACKSON, PROGRAM SUPERVISOR, TOBIN COMMUNITY CENTER RICHARD ROUSE, EXECUTIVE DIRECTOR, MISSION HILL MAIN STREETS CHERYL WATSON-HARRIS, PRINCIPAL, MAURICE J. TOBIN SCHOOL CHRISTINE DWYER, DIRECTOR, PUBLIC AFFAIRS AND COMMUNITY RELATIONS, NEW ENGLAND BAPTIST HOSPITAL THE INTERVIEWS YIELDED IMPORTANT AND USEFUL INFORMATION ABOUT NEIGHBORHOOD CHARACTERISTICS, METHODS FOR BUILDING AND SUSTAINING STRONG RELATIONSHIPS IN MISSION HILL, THE NEEDS OF THE NEIGHBORHOOD, AND PARTNERSHIP OPPORTUNITIES. THE INTERVIEW DATA WERE ANALYZED FOR COMMON AND DIVERGENT THEMES, WHICH ARE SUMMARIZED BELOW. MISSION HILL WAS DESCRIBED AS A COMMUNITY OF HIGH ECONOMIC NEED AND ONE IN WHICH JOB CREATION, JOB TRAINING, AND YOUTH EMPLOYMENT ARE HIGH PRIORITIES. THE KEY INFORMANTS DESCRIBED MISSION HILL RESIDENTS AS CULTURALLY AND LINGUISTICALLY DIVERSE WITH LARGE POPULATIONS OF HISPANIC, CHINESE, RUSSIAN, SOMALI, AND ETHIOPIAN RESIDENTS. THE COMMUNITY IS ALSO HOME TO A NUMBER OF HIGHLY DEDICATED ADVOCATES WHO ARE DEEPLY COMMITTED TO WORKING WITH INSTITUTIONAL NEIGHBORS TO BENEFIT THE NEIGHBORHOOD AND TO RESOLVE ISSUES AS THEY ARISE. MEEI IS VIEWED IN A POSITIVE LIGHT AND WAS OVERWHELMINGLY WELCOMED TO THE NEIGHBORHOOD. ALL OF THE KEY INFORMANTS EXPRESSED A SINCERE DESIRE TO HELP MEEI AS THE HOSPITAL BECOMES FAMILIAR WITH THE COMMUNITY AND INTRODUCES COMMUNITY BENEFITS PROGRAMS.
MISSION HILL RESIDENTS ACCESS ROUTINE HEALTH CARE SERVICES FROM MANYSOURCES, INCLUDING THE LOCAL HOSPITAL PRIMARY CARE PRACTICES, COMMUNITY HEALTH CENTERS AND HOSPITAL EMERGENCY ROOMS. DIABETES WAS IDENTIFIED AS A PARTICULAR HEALTH ISSUE OF CONCERN IN MISSION HILL. THE KEY INFORMANTS REPORTED THAT VISION AND HEARING ISSUES ARE NOT ADDRESSED IN A COMPREHENSIVE MANNER IN THE COMMUNITY AND THAT A NEED FOR SUCH CARE EXISTS. THE KEYS TO BUILDING AND SUSTAINING STRONGLY RELATIONSHIPS IN THE COMMUNITY WERE DESCRIBED AS: -BEING A GOOD AND RESPECTFUL NEIGHBOR TO THOSE WHO ABUT THE NEW MEEI FACILITY, INCLUDING HAVING REGULAR DIALOGUE WITH THEM. -HAVING A PRESENCE IN MISSION HILL BY ATTENDING EVENTS. -HAVING A POINT PERSON/LIAISON TO THE NEIGHBORHOOD BEING RESPONSIVE AS NEEDS OR ISSUES ARISE -BEING INCLUSIVE, WORKING TO SERVE THE BROADER COMMUNITY RATHER THAN SPECIFIC ORGANIZATIONS WITHIN IT. -TAKING ADVANTAGE OF OPPORTUNITIES TO PARTNER WITH ORGANIZATIONS AND ADVOCATES IN MISSION HILL, INCLUDING MIKE ROSS, BOSTON CITY COUNCILMAN, WHO LIVES IN MISSION HILL. THE INFORMANTS RECOMMENDED THAT MEEI NOT "SPREAD ITSELF TOO THIN" IN ITS COMMUNITY BENEFITS OFFERINGS, INSTEAD SUGGESTING THAT THE HOSPITAL "DO LESS, BUT DO IT WELL." THE KEY INFORMANTS IDENTIFIED A NUMBER OF NEEDS THAT ARE CONSISTENT WITH MEEI'S CLINICAL EXPERTISE AND COMMUNITY BENEFITS MISSION, INCLUDING: -VISION/HEARING SCREENINGS FOR SENIORS AND FOR CHILDREN (TO COMPLEMENT SCREENINGS OFFERED BY THE BOSTON PUBLIC SCHOOLS) -FOLLOW UP CARE FOR SENIORS AND CHILDREN, INCLUDING FREE/REDUCED COST EYE GLASSES AND HEARING AIDS -EDUCATIONAL PROGRAMS/MATERIALS: -SENIORS: VISION CARE, ESPECIALLY RELATED TO DIABETES, BALANCE/FALLS PREVENTION, HEAD AND NECK ISSUES -YOUTH: HEARING ISSUES RELATED TO PORTABLE DEVICES AND HEADPHONES -TEACHERS: DETECTING HEARING AND VISION ISSUES AMONG STUDENTS AND THE RELATIONSHIP BETWEEN HEARING AND SPEECH. THE INTERVIEW PARTICIPANTS ALSO TALKED ABOUT THE NEED FOR ADDITIONAL JOB TRAINING/EMPLOYMENT OPPORTUNITIES, PARTICULARLY FOR YOUTH. SUGGESTIONS INCLUDED SUMMER JOBS FOR YOUTH, PAID INTERNSHIPS FOR YOUNG PEOPLE, EMPLOYMENT FOR MISSION HILL RESIDENTS AT THE MEEI MAIN CAMPUS AND THE MISSION HILL LOCATION, AND SCHOLARSHIP CONTRIBUTIONS. THE KEY INFORMANTS RECOMMENDED THAT MEEI "PIGGY BACK" ON EXISTING EFFORTS IN MISSION HILL TO REACH THE TARGET POPULATION FOR COMMUNITY BENEFITS INITIATIVES, GOING TO THE PLACE WHERE YOUTH AND SENIORS ALREADY TEND TO MEET (E.G., THE TOBIN COMMUNITY CENTER). THEY ALSO RECOMMENDED WORKING WITH ORGANIZATIONS THAT REPRESENT SENIORS AND CHILDREN FROM ACROSS MISSION HILL (E.G., THE LEGACY PROJECT, THE MISSION HILL YOUTH COLLABORATIVE) TO REACH THE MAXIMUM NUMBER OF YOUNG PEOPLE AND ELDERS IN THE COMMUNITY. THE ORGANIZATIONS IN MISSION HILL HAVE WELL-ESTABLISHED METHODS FOR COMMUNICATING WITH ONE ANOTHER AND WITH RESIDENTS ABOUT EVENTS IN THE COMMUNITY. ALTHOUGH SEVERAL USE EMAIL TO COMMUNICATE WITH THEIR COLLEAGUES IN OTHER ORGANIZATIONS, MOST ALSO DISSEMINATE FLYERS IN THE COMMUNITY TO ADVERTISE PROGRAMMING TO RESIDENTS. SOME ALSO USE PHONE TREES AND GO DOOR TO DOOR. NEWSLETTERS, CALENDARS, MONTHLY ORGANIZATION MEETINGS, AND THE LOCAL NEWSPAPER, THE MISSION HILL GAZETTE, ARE OTHER METHODS FOR SPREADING THE WORD IN MISSION HILL. ALL OF THE KEY INFORMANTS OFFERED TO HELP MEEI PUBLICIZE ITS COMMUNITY BENEFITS OFFERINGS THROUGH THEIR ESTABLISHED LINES OF COMMUNICATION. CONCLUSIONS: BASED ON THE FINDINGS FROM THE NEEDS ASSESSMENT IN MISSION HILL, THE COMMUNITY BENEFITS COMMITTEE DECIDED THAT IN EACH OF THE NEXT THREE YEARS, THE HOSPITAL'S COMMUNITY BENEFITS STRATEGIES IN THE NEIGHBORHOOD WILL INCLUDE THE FOLLOWING: -OFFER A FREE VISION SCREENING TO AT LEAST 25 SENIORS AT ITS NEW LONGWOOD CENTER -PROVIDE A FREE EDUCATIONAL SESSION FOR YOUTH ON HEARING LOSS PREVENTION AT THE TOBIN COMMUNITY CENTER LOCATION. (FOR THE FIRST TWO STRATEGIES LISTED, YEAR 1 OF THE PLAN WILL INCLUDE EITHER A VISION SCREENING OR THE HEARING LECTURE. YEARS 2 AND 3 WILL INCLUDE BOTH. IF IN YEARS 2 AND 3 OF THE PLAN, MEEI AND ITS COMMUNITY PARTNERS DETERMINE THAT SOMETHING DIFFERENT THAN THE ANNUAL VISION SCREENING FOR SENIORS OR HEARING EDUCATION EVENT FOR YOUTH IS NEEDED/PREFERABLE, THE PLAN WILL BE EDITED TO REFLECT SUCH CHANGES. THE OTHER COMMUNITY BENEFITS STRATEGIES ARE LIKELY TO OCCUR IN EACH OF THE THREE YEARS OF THE PLAN.) -PROVIDE AN INTERNSHIP OPPORTUNITY TO A YOUNG PERSON IN MISSION HILL AT THE LONGWOOD FACILITY. -CONTINUE TO SUPPORT THE MISSION HILL MAIN STREET ROAD RACE (IN THE FORM OF AN ANNUAL $1000 SPONSORSHIP. -PARTICIPATE IN THE MISSION HILL HEALTH FAIR THAT IS HELD IN JUNE TO PROVIDE INFORMATION ON THE HOSPITAL AND PREVENTION AND TREATMENT OF CLINICAL ISSUES OF THE HEAD AND NECK. -ASSIST THOSE IN NEED OF FOLLOW UP CARE, INCLUDING HEARING AIDS AND GLASSES, TO OBTAIN COVERAGE FOR WHICH THEY ARE ELIGIBLE OR TO ACCESS ASSISTANCE THROUGH THE HOSPITAL (E.G., CHARITABLE CARE, FREE/REDUCE COST EYEGLASSES OR HEARING AID PROGRAMS). MEEI FILES AN ANNUAL COMMUNITY BENEFITS REPORT WITH THE MASSACHUSETTS ATTORNEY GENERAL. WHEN THE REPORTS ARE POSTED, THEY ARE AVAILABLE HERE: HTTP://WWW.MASSEYEANDEAR.ORG/ABOUT-US/OUTREACH/
SCHEDULE H, PART VI, LINE 5:MEEI'S COMMUNITY BENEFITS STRATEGIES FOR ACHIEVING ITS OBJECTIVES AND ANNUAL TARGETS PROGRAM FALL INTO FOUR MAJOR CATEGORIES: 1. SCREENING AND CLINICAL SERVICES 2. EDUCATION AND SUPPORT 3. ACCESS TO SERVICES/RESOURCES 4. SPONSORSHIPS CATEGORIES 1 AND 2 DRAW ON MEEI'S BROAD CLINICAL AND TEACHING EXPERTISE AND ENCOMPASS THE NEW JOB READINESS STRATEGIES. CATEGORY 3 RESPONDS TO BARRIERS AND OBSTACLES THAT LIMIT ACCESS TO SERVICES. CATEGORY 4 REPRESENTS MEEI'S OPPORTUNITY TO SUPPORT PARTNERS WHOSE MISSIONS ARE ALIGNED WITH THOSE OF MEEI AND WHO ARE PROVIDING SERVICES TO MEEI'S PRIORITY PATIENT GROUPS AND/OR GEOGRAPHIC AREAS. EACH CATEGORY BELOW OFFERS A DESCRIPTION OF THE ASSOCIATED STRATEGIES AND PARTNERSHIPS AND CONCLUDES WITH AN AT-A-GLANCE TABLE THAT DESCRIBES THE NUMBER OF INDIVIDUALS, TARGET AUDIENCE AND GEOGRAPHIC AREA SERVED, THE ATTORNEY GENERAL'S COMMUNITY BENEFITS CATEGORIES ADDRESSED, AND THE COSTS/RESOURCES EXPENDED FOR THE REPORTABLE YEAR FOR EACH STRATEGY IN THE CATEGORY. CATEGORY 1: SCREENING & CLINICAL SERVICES MEEI PROVIDES SCREENING AND CLINICAL SERVICES TO A WIDE RANGE OF INDIVIDUALS AND GROUPS, FROM LOW-INCOME CHILDREN TO SENIORS TO SURVIVORS OF DOMESTIC VIOLENCE. SPECIFIC INITIATIVES ARE AS DESCRIBED BELOW: NEIGHBORHOOD HOUSE CHARTER SCHOOL (NHCS) NHCS WAS FOUNDED IN 1995 TO PROVIDE A BETTER EDUCATIONAL OPTION FOR LOW-INCOME BOSTON FAMILIES AND TO INCUBATE INNOVATIVE PRACTICES THAT HAVE THE POTENTIAL TO IMPROVE PUBLIC EDUCATION FOR ALL STUDENTS. TODAY, NHCS SERVES 400 STUDENTS AND IS ONE OF THE MOST SOUGHT AFTER SCHOOLS IN THE CITY, SUCCESSFULLY SERVING A DIVERSE COMMUNITY OF CHILDREN IN GRADES PRE-K THROUGH 8 FROM DORCHESTER AND SURROUNDING BOSTON NEIGHBORHOODS. MEEI'S DEPARTMENTS OF AUDIOLOGY AND OPHTHALMOLOGY PARTNERED WITH NHCS'S SCHOOL NURSE TO OFFER VISION AND HEARING SCREENING TO ALL STUDENTS. CHILDREN WHO NEED FOLLOW-UP CARE RECEIVE IT, FREE IF NECESSARY, AT MEEI. WORKING WITH NHCS' SCHOOL NURSE, MARY MCNULTY-ANGLIN, WE SET A GOAL OF SCREENING ALL CHILDREN IN ADVANCE OF FLU SEASON TO MAXIMIZE THE NUMBER OF CHILDREN IN ATTENDANCE.
CAMP HARBOR VIEW: CREATED IN 2008 TO OFFER BOSTON CHILDREN A TRUESUMMER CAMP EXPERIENCE, CAMP HARBOR VIEW IS AN INITIATIVE OF THE NOT-FOR-PROFIT CAMP HARBOR VIEW FOUNDATION, INC. IN PARTNERSHIP WITH THE CITY OF BOSTON AND THE BOYS & GIRLS CLUBS OF BOSTON. THE CAMP OFFERS CHILDREN AGES 11 TO 14 LIVING IN BOSTON'S AT-RISK NEIGHBORHOODS THE OPPORTUNITY TO LEAVE THE CITY DURING THE DAY AND PARTICIPATE IN A FOUR-WEEK SUMMER CAMP PROGRAM. RECOGNIZING MEEI'S EXPERTISE IN VISION SCREENING, MAYOR MENINO REQUESTED THAT MEEI PLAY A ROLE AT CAMP HARBOR VIEW. MEEI HAS BEEN PARTNERING WITH THE CAMP SINCE ITS FIRST SEASON. MEEI STAFF MEMBERS TRAVELED TO CAMP HARBOR VIEW TO CONDUCT ON-SITE VISION SCREENINGS AND IDENTIFY THOSE IN NEED OF FOLLOW-UP CARE. VISION COALITION/YEAR UP BOSTON: THE MISSION OF VISION COALITION MASSACHUSETTS IS TO REMOVE POOR VISION AS AN IMPEDIMENT TO LITERACY, EDUCATION, AND A BETTER WAY OF LIFE. VISION COALITION PROVIDES FREE VISION SCREENINGS AND FREE EYEGLASSES. MEEI PARTNERS WITH VISION COALITION MASSACHUSETTS BY PERFORMING FULL EYE EXAMS AND PROVIDING MEDICAL CARE FOR PARTICIPANTS IN YEAR UP BOSTON, WHICH THE VISION COALITION IDENTIFIED THROUGH SCREENING AS NEEDING VISION CARE. YEAR UP SERVES YOUNG URBAN ADULTS, PROVIDING THEM WITH THE SKILLS, EXPERIENCE, AND SUPPORT THAT WILL EMPOWER THEM TO REACH THEIR POTENTIAL THROUGH PROFESSIONAL CAREERS AND HIGHER EDUCATION. MEEI STAFF MEMBERS GIVE EYE EXAMS TO THESE YOUNG ADULTS, PROVIDE THOSE WHO NEED THEM WITH EYE GLASSES (WHICH ARE PURCHASED AT COST BY VISION COALITION), AND ENSURE THAT THOSE WHO NEED FOLLOW-UP CARE ARE LINKED TO SERVICES. HEAD AND NECK CANCER SCREENING/LECTURE: MEEI'S DEPARTMENTS OF ENT AND SOCIAL WORK COLLABORATE TO OFFER CANCER SCREENING TO THE GENERAL PUBLIC AND TO PROVIDE SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER. SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER HAS A SUPPORT GROUP CHAPTER AT MASSACHUSETTS GENERAL HOSPITAL. MEEI COLLABORATES WITH THIS GROUP AND WITH THE HEAD AND NECK CANCER ALLIANCE TO RAISE AWARENESS DURING ORAL, HEAD AND NECK CANCER AWARENESS WEEK BY HOSTING AN EDUCATION TABLE. R.O.S.E. FUND COLLABORATION: THE R.O.S.E. FUND (REGAINING ONE'S SELF ESTEEM) IS A NON-PROFIT ORGANIZATION CHARTERED TO BREAK THE SILENCE AND THE CYCLE OF DOMESTIC VIOLENCE AND TEEN DATING VIOLENCE AND ABUSE. AMONG ITS MANY ACTIVITIES, THE R.O.S.E. FUND SCREENS AND REFERS TO MEEI SURVIVORS OF DOMESTIC VIOLENCE IN NEED OF RECONSTRUCTIVE SURGERY. MEEI'S SURGEONS PERFORM THESE LIFE-ALTERING SURGERIES FREE OF CHARGE.
CATEGORY 2: EDUCATION & SUPPORTMEEI'S CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS COPING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES (E.G., SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS) AND ALSO REACH OUT TO PROVIDERS WHO INTERACT WITH SENIORS ACROSS THE COMMONWEALTH. DETAILS ON THESE EDUCATIONAL AND SUPPORT STRATEGIES ARE PRESENTED BELOW: PUBLIC FORUM ON HEARING AND HEARING LOSS: MEMBERS OF MEEI'S AUDIOLOGY DEPARTMENT PRESENTED AN 11TH ANNIVERSARY HAVE YOU HEARD? PUBLIC FORUM FEATURING EDUCATIONAL SESSIONS AND LECTURES ON HEARING AND HEARING LOSS. THIS YEAR'S SESSIONS FOCUSED ON THE MEDICAL AND SURGICAL MANAGEMENT OF HEARING LOSS, AUDIOLOGIC EVALUATION AND MANAGEMENT OF HEARING LOSS, AND SCIENTIFIC ADVANCES IN UNDERSTANDING HEARING AND HEARING LOSS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS AND INDIVIDUALS WITH HEARING LOSS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND THROUGH MEEI PARTNERSHIP WITH THE MASSACHUSETTS COUNCIL ON AGING. MEEI SURVEYS FORUM PARTICIPANTS AND WILL USE THEIR SUGGESTIONS TO DEVELOP THE EDUCATIONAL PROGRAM FOR NEXT YEAR. PUBLIC FORUM ON CONDITIONS THAT AFFECT SMELL AND TASTE: THIS YEAR, MEMBERS OF MEEI'S DEPARTMENT OF ENT OFFERED A SERIES OF LECTURES ON SINUSITIS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND VIA MEEI'S PARTNERSHIP WITH THE MASSACHUSETTS COMMISSION ON AGING. BOSTON CURED CANCER CLUB SUPPORT GROUP: THE BOSTON CURED CANCER GROUP FOR LARYNGECTOMEES SUPPORTS THE REHABILITATION OF LARYNGECTOMEES AND HELPS OFFER UNDERSTANDING TO PATIENTS AND THEIR LOVED ONES. MEEI HAS A STRONG COLLABORATIVE RELATIONSHIP WITH THIS ORGANIZATION, PROVIDING MEETING SPACE AND SPEAKERS FOR THE GROUPS. THE BOSTON CURED CANCER GROUP COMES AND MEETS WITH NEW LARYNGECTOMEES, PROVIDING SUPPORT TO MEEI PATIENTS. PARTICIPANTS IN THE GROUPS, MOSTLY OLDER PEOPLE, ARE LARGELY FROM METRO BOSTON, BUT SOME COME FROM GREATER DISTANCES. FACIAL PARALYSIS SUPPORT GROUP: THE FACIAL PARALYSIS SUPPORT GROUP IS A FORUM FOR INDIVIDUALS WITH FACIAL PARALYSIS AND THOSE CLOSE TO THEM TO MEET AND SHARE THEIR EXPERIENCES AND TO DISCUSS SUPPORT, TREATMENT, COPING AND SELF IMAGE. MEEI HOSTS THIS GROUP MONTHLY, PROVIDING MEETING SPACE AND SOCIAL WORK AND PHYSICIAN SUPPORT. WHILE THE GROUP IS OPEN TO ALL INDIVIDUALS WITH FACIAL PARALYSIS AND THEIR FAMILIES, PARTICIPANTS ARE GENERALLY FROM METRO BOSTON. MEEI PUBLICIZES THE SUPPORT GROUP VIA SOCIAL MEDIA AND THROUGH A PARTNERSHIP WITH THE FACIAL PARALYSIS SUPPORT NETWORK. GLAUCOMA SUPPORT GROUP: THE GLAUCOMA FOUNDATION FUNDS GROUNDBREAKING RESEARCH AND EDUCATES THE PUBLIC ABOUT GLAUCOMA AND THE IMPORTANCE OF EARLY DETECTION TO PREVENT BLINDNESS. THE NEW ENGLAND CHAPTER OF THE GLAUCOMA FOUNDATION HOSTS A SUPPORT GROUP FOR PEOPLE WITH GLAUCOMA, THEIR CAREGIVERS, PROFESSIONALS, AND OTHERS DEDICATED TO IMPROVING THE LIVES OF THOSE WITH THIS DISEASE. MEEI PARTNERS WITH THE GLAUCOMA FOUNDATION TO PROVIDE FREE MEETING SPACE AND PUBLICITY. MEMBERS OF MEEI'S DEPARTMENT OF OPHTHALMOLOGY ARE AVAILABLE AS SPEAKERS FOR THE GROUP. MEEI HELPS PROMOTE THE GROUP BY DISTRIBUTING FLYERS IN THE HOSPITAL'S CLINICS. ATTENDEES ARE GENERALLY SENIORS FROM METRO BOSTON. HEAR @ BOSTON: HEAR@BOSTON, A CHAPTER OF THE HEARING LOSS ASSOCIATION OF AMERICA, IS A COMMUNITY ORGANIZATION THAT HELPS EMPOWER PEOPLE WHO HAVE HEARING LOSS BY FACILITATING OPPORTUNITIES FOR SOCIAL ENGAGEMENT, EDUCATION AND SKILL DEVELOPMENT. MEEI DONATES MONTHLY MEETING SPACE AND MEEI CLINICIANS SERVE AS SPEAKERS FOR MEETINGS AND EVENTS. MANY OF HEAR@BOSTON'S MEMBERS ARE YOUNG PROFESSIONALS BETWEEN THE AGES OF 20 AND 45, BUT THE GROUP ENCOURAGES PEOPLE OF ALL AGES TO JOIN. BOOMERS AND SENIORS EXPO: THE BOOMERS AND SENIORS EXPO IS AN ANNUAL EVENT AT THE SEAPORT WORLD TRADE CENTER THAT FEATURES INFORMATION ON A WIDE RANGE OF TOPICS, FROM TRAVEL AND FINANCIAL PLANNING TO HEALTH AND WELLNESS. MEEI PRESENTED INFORMATION ABOUT HEARING AND HEARING LOSS IN TO AN AUDIENCE OF BOOMERS AND SENIORS, AGED 65+. SUFFOLK UNIVERSITY HEALTH FAIR: MEEI PARTICIPATED IN THE SUFFOLK UNIVERSITY HEALTH FAIR. THE GOAL OF PARTICIPATING IN THE EVENT WAS TO INCREASE AWARENESS ABOUT ALL MEEI SERVICES AND LOCATIONS AND TO EMPHASIZE OUR FOCUS ON QUALITY OF LIFE. WE HIGHLIGHTED MANY OF OUR SERVICES THAT WOULD BE OF INTEREST TO COLLEGE STUDENTS, SUCH AS OUR OPTICAL SHOP, COMPREHENSIVE EYE SERVICES, CONTACT LENS AND LASER VISION CORRECTION, AS WELL AS OUR HEARING AID CENTER , AND GENERAL ENT AND ED SERVICES. THYROID EYE DISEASE SUPPORT GROUP: THE MASSACHUSETTS EYE AND EAR INFIRMARY OFFERS A THYROID EYE DISEASE (GRAVES' DISEASE) SUPPORT GROUP, WHICH WILL ALLOW MEMBERS TO EXPRESS THEIR CONCERNS ABOUT THIS CHRONIC ILLNESS TO HELP FORM A SOCIAL CONNECTION WITH OTHERS AND IMPROVE COPING SKILLS. THE OPEN FORUM GIVES MEMBERS THE OPPORTUNITY TO EXCHANGE INFORMATION ABOUT GRAVES' DISEASE AND GIVES PHYSICIAN SPEAKERS A CHANCE TO INFORM MEMBERS OF THE LATEST TREATMENTS. MEEI DONATES MEETING SPACE FOR THIS GROUP, WHICH MEETS QUARTERLY. VISION REHABILITATION: IN THE AREA OF VISION REHABILITATION EDUCATION, MEEI STAFF RESPONDED TO A NUMBER OF REQUESTS FROM ORGANIZATIONS SERVING SENIORS TO PROVIDE SUPPORTIVE EDUCATION RELATED TO VISION REHABILITATION, INCLUDING THE FOLLOWING PRESENTATIONS: -ADVANCED TECHNOLOGY FOR THE VISUALLY IMPAIRED AT THE WINTHROP LOW VISION SUPPORT GROUP AT THE WINTHROP SENIOR CENTER. -VISION REHABILITATION MODEL AT MEEI AT THE JEWISH COMMUNITY CENTER LOW VISION SUPPORT GROUP, MARBLEHEAD -VISION REHABILITATION SERVICES AT MEEI AND ASSISTING SENIORS WITH AGE-RELATED MACULAR DEGENERATION FOR SENIOR HEALTHWISE AT MASSACHUSETTS GENERAL HOSPITAL. MEEI ALSO ASSISTED IN HEALTH SCREENINGS FOR SENIORS AT SENIOR HEALTHWISE AT MASSACHUSETTS GENERAL HOSPITAL. BACK ON MY FEET: BACK ON MY FEET (BOMF) IS A NATIONAL NONPROFIT ORGANIZATION THAT USES RUNNING TO HELP THOSE EXPERIENCING HOMELESSNESS TO BUILD SELF-ESTEEM, CHANGE THE WAY THEY SEE THEMSELVES, AND BEGIN TO CREATE REAL CHANGES IN THEIR LIVES THAT RESULT IN EMPLOYMENT AND INDEPENDENT LIVING. MEEI PROVIDES FINANCIAL SUPPORT TO THE BOSTON CHAPTER OF BOMF TO HELP ADVANCE ITS WORK IN WORKFORCE DEVELOPMENT AMONG HOMELESS ADULTS. DRESS FOR SUCCESS: THE MISSION OF DRESS FOR SUCCESS BOSTON IS TO PROMOTE THE ECONOMIC INDEPENDENCE OF DISADVANTAGED WOMEN. THEY DO THIS BY PROVIDING PROFESSIONAL ATTIRE, A NETWORK OF SUPPORT AND THE CAREER DEVELOPMENT TOOLS TO HELP WOMEN THRIVE IN WORK AND IN LIFE. MEEI MAKES AN ANNUAL DONATION TO THIS ORGANIZATION TO HELP ADVANCE ITS EFFORTS IN WORKFORCE DEVELOPMENT AMONG LOW-INCOME WOMEN. 1 TOUCH: MEEI PROVIDES FACILITIES AND SUPPORT FOR THIS ORGANIZATION'S SPECIAL SELF-DEFENSE GROUP THAT ENABLES THE BLIND AND VISUALLY IMPAIRED TO DEFEND THEMSELVES AND NAVIGATE THE WORLD WITH CONFIDENCE. CATEGORY 3: ACCESS TO SERVICES/RESOURCES THIS CATEGORY DESCRIBES MEEI STRATEGIES TO MAKE SERVICES AND RESOURCES AVAILABLE TO INDIVIDUALS WHO MIGHT NOT OTHERWISE BE ABLE TO ACCESS THEM. THESE SERVICES AND RESOURCES ARE AS FOLLOWS:
TRANSPORTATION FOR NEEDY PATIENTS: MEEI PROVIDES FREE TAXITRANSPORTATION FOR PATIENTS AND FAMILIES IN EMERGENCY SITUATIONS. FREE EYEGLASSES PROGRAM: SOCIAL WORK STAFF, PATIENT FINANCIAL COUNSELORS, AND OPTICAL SHOP STAFF COLLABORATE TO PROVIDE FREE GLASSES TO MEEI PATIENTS WHO MEET INCOME AND OTHER ELIGIBILITY GUIDELINES AND ARE UNABLE TO PAY FOR GLASSES. CONSULTATION FOR NON-MEEI PATIENTS: MEEI'S SOCIAL WORK STAFF PROVIDES INFORMATION AND REFERRAL FOR FINANCIAL RESOURCES, VISION AND HEARING RESOURCES, HOMECARE, AND EDUCATION TO NON-MEEI PATIENTS. SOCIAL WORK CONSULTATIONS FOR PATIENTS NEEDING FINANCIAL ASSISTANCE: THE STAFF FROM MEEI'S DEPARTMENT OF SOCIAL WORK ASSISTS PATIENTS IN SECURING LODGING, MEAL VOUCHERS, PARKING VOUCHERS, AND OTHER SMALL NECESSITIES THAT MAKE IT POSSIBLE FOR PATIENTS AND FAMILIES TO RECEIVE TREATMENT AT MEEI. FINANCIAL COUNSELING ASSISTANCE: THE HOSPITAL'S FINANCIAL COUNSELORS WORK WITH PATIENTS TO ASSESS INSURANCE COVERAGE, IDENTIFY COVERAGE OPTIONS FOR WHICH THE UN/UNDER-INSURED MAY BE ELIGIBLE, AND TO PROVIDE ASSISTANCE IN APPLYING FOR AND ACCESSING COVERAGE. HOWE LIBRARY: MEEI'S RESEARCH LIBRARY STAFF ASSISTS PATIENTS WHO ARE SEEKING INFORMATION ABOUT THEIR MEDICAL CONDITIONS. SERVICES INCLUDE COMPUTER SEARCHING AND RETRIEVAL OF ARTICLES, FINDING BOOKS FOR USERS, AND PROVIDING COMPUTERS, COPIERS, PRINTERS, AND ASSISTANCE TO PEOPLE IN USING THEM. THE HEARING AID CENTER: THE MEEI HEARING AID CENTER PROVIDES SUPPORT, INCLUDING EDUCATION AND EQUIPMENT, TO PATIENTS WITH HEARING LOSS. FOR PATIENTS WHO MEET INCOME GUIDELINES, THESE SERVICES ARE PROVIDED AT NO CHARGE OR AT A REDUCED RATE. FREE PARKING: MEEI OFFERS FREE PARKING TO PATIENTS AND THEIR FAMILIES THAT ENABLES THEM TO COME FOR CARE AND PARTICIPATE IN SUPPORT GROUPS. MEEI ALSO EXTENDS FREE PARKING TO PARTICIPANTS AT COMMUNITY BOATING, A LOCAL NONPROFIT, AND TO SUPPORT GROUPS SUCH AS THE GLAUCOMA SUPPORT GROUP AND HEAR @ BOSTON. CHARITABLE CARE: EACH YEAR, MEEI PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. THIS YEAR THE HOSPITAL PROVIDED $198,116 IN FREE OR DISCOUNTED CARE TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. MEEI MAKES EVERY EFFORT TO IDENTIFY APPROPRIATE INSURANCE COVERAGE FOR PATIENTS AND TO HELP THEM ACCESS THE COVERAGE FOR WHICH THEY ARE ELIGIBLE. HOWEVER, EACH YEAR MEEI PROVIDES CARE TO PATIENTS THAT IS NOT FULLY REIMBURSED. IN 2012, MEEI'S NET CHAIRTY CARE TOTALLED $2,981,138, WHICH INCLUDES THE HEALTH SAFETY NET (HSN) ASSESSMENT AND SHORTFALL, HSN DENIED CLAIMS, AND FREE OR DISCOUNTED CARE PROVIDED TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. THE NET CHARITY CARE PROVIDED EACH YEAR IS A REFLECTION OF MEEI'S AND THE COMMUNITY BENEFITS COMMITTEE'S COMMITMENT TO THE DELIVERY OF HIGH-QUALITY CARE TO PATIENTS AND IS AN IMPORTANT STRATEGY FOR ENSURING ACCESS TO CARE IN THE MEEI COMMUNITY BENEFITS PLAN. CATEGORY 4: SPONSORSHIPS MEEI DESIGNATES A PORTION OF ITS COMMUNITY BENEFITS RESOURCES TO PROVIDE FINANCIAL SUPPORT IN THE FORM OF SPONSORSHIPS TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH THOSE OF MEEI AND ITS COMMUNITY BENEFITS GOALS, INCLUDING THOSE WHO ADDRESS ISSUES AFFECTED THE TARGET COMMUNITIES AND POPULATIONS OF THE HOSPITAL'S COMMUNITY BENEFIT PLAN. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH.
SCHEDULE H, PART VI, LINE 7:LIST OF STATES RECEIVING COMMUNITY BENEFIT REPORT: MA

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records MaintainedtrueRecordsMaintained

Recipient Table RecipientTable (26 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrant
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVEBOSTONMA02115042774441501(C)(3)40694RESEARCH
GEORGE MASON UNIVERSITY
10900 UNIVERSITY BLVDMANASSASVA20109540836354501(C)(3)91528RESEARCH
BOSTON UNIVERSITY
85 E NEWTOWN ST M-921BOSTONMA02118042103547501(C)(3)85220RESEARCH
BRIGHAM & WOMAN'S HOSPITAL
75 FRANCIS STBOSTONMA02115042312909501(C)(3)460458RESEARCH
OHIO UNIVERSITY
1 PARK PLACEATHENSOH45701316402113501(C)(3)66273RESEARCH
JOHNS HOPKINS UNIVERSITY
600 N WOLF STBALTIMOREMD21218520595110501(C)(3)5343RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STBOSTONMA02114042697983501(C)(3)973518RESEARCH
MIT DIVISION OF HEALTH
77 MASS AVECAMBRIDGEMA02139042103594501(C)(3)192670RESEARCH
MAYO CLINIC
200 1ST ST SWROCHESTERMN55905416011702501(C)(3)9346RESEARCH
HARVARD UNIVERSITY
MASS HALLCAMBRIDGEMA02138042103580501(C)(3)544860RESEARCH
PUBLIC HEALTH FOUNDATION
12801 CRSRD PKWY SCTY OF INDSTRYCA91745952557063501(C)(3)45090RESEARCH
UNIVERSITY OF OKLAHOMA
1000 STANTON YNG BLVDOK CITYOK73117951642394501(C)(3)63615RESEARCH
UNIVERISITY OF SOUTHERN CALIFORNIA
3720 S FLOWER STLOS ANGELESCA90089951642394501(C)(3)109839RESEARCH
VANDERBILT MEDICAL CENTER
211 KIRKLAND HALLNASHVILLETN37240620476822501(C)(3)48475RESEARCH
WORCESTER POLYTECHNIC INSTITUTE
100 INSTITUTE RDWORCESTERMA01609042121659501(C)(3)114011RESEARCH
SCHEPENS EYE RESEARCH INSTITUTE
20 STANIFORD STBOSTONMA02114042129889501(C)(3)709308RESEARCH
UNIVERSITY OF MIAMI
1400 NW 10TH AVEMIAMIFL33136590624458501(C)(3)61653RESEARCH
UNIVERSITY OF MISSISSIPPI
2500 N STATE STJACKSONMS39216646001159501(C)(3)156803RESEARCH
BROAD INSTITUTE
7 CAMBRIDGE CENTERCAMBRIDGEMA02142263428781501(C)(3)22971RESEARCH
MEDICAL COLLEGE OF WISCONSIN
8701 WATERTOWN PLANK RDMILWAUKEEWI53226390806261501(C)(3)87154RESEARCH
CARES
5000 S 5TH AVEHINESIL60141363334177501(C)(3)161921RESEARCH
DREXEL UNIVERSITY
3201 ARCH ST 100PHILADELPHIAPA19104231352630501(C)(3)102750RESEARCH
TUFTS UNIVERSITY
136 HARRISON AVEBOSTONMA02111042163634501(C)(3)42511RESEARCH
LAWRENCE LIVERMORE NATIONAL SECURITY LLC
MS L 397 7000 E AVELIVERMORECA9455020562438610800RESEARCH
CIRCLE COMPANY INC
243 CHARLES STREETBOSTONMA02114042801797501(C)(25)1000000
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
243 CHARLES STREETBOSTONMA02114222658209501(C)(3)10299939
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants23TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations1TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierSCHEDULE I, PART I, LINE 2:Identifier
ExplanationSUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE MEEI ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A STATISFACTORY PACE.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeXCompensationCommittee
Independent ConsultantXIndependentConsultant
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance PaymenttrueSeverancePayment
Supplemental Nonqual Retire PlantrueSupplementalNonqualRetirePlan
Equity Based Comp ArrangementfalseEquityBasedCompArrangement
Comp Based On Revenue Of Filing OrgfalseCompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related OrgsfalseCompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing OrgfalseCompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate OrgsfalseCompBasedNetEarningsRelateOrgs
Any Non Fixed PaymentstrueAnyNonFixedPayments
Initial Contract ExceptionfalseInitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (22 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
JOHN R FERNANDEZ
59916001440000839001455740281660925290000
JOAN W MILLER MD
0617189096998017742033860022158078794700
JOSEPH B NADOL JR MD
0676291072973025842033860029355083832100
SUSAN WILLIAMS
22120502308501706109584091660280101000
CAROLANN WILLIAMS
18268701000001260348608820197181000
BARBARA J SCULLY
159003048640190098560227360196649000
EILEEN O LOWELL
162870000620075940245150195599000
ALAN K LONG
1328000446190170880268006830197870000
CHRISTINE REGAN
19506202065902004095970135390240861000
KENNETH HOLMES
213689056000173060105580278030274956000
JEAN E MACQUIDDY
226349019725026900187370123240279825000
ALEC CHELOFF
21911802171001499095670279630279857000
JEFFREY J PIKE
235612018401032907862091310271335000
JAVIER BALLOFFET
2102960631530188630126720232520328236000
JENNIFER STREET
2289030277190552092740280430294491000
MICHAEL SOUZA UNTIL 32912
2264020001732508723017450254195000
MELISSA M PAUL
1752950325140169860119140284140265123000
GLENN W BUNTING
1731780293006460122520224480211454000
GREGORY J DONNELLY
154033036220135061330243780188301000
PETER J CHINETTI
179957000185132018656039590387704000
ROBERT M BIGGIO
165185000238070930170550189571000
GAYLE A FISHMAN UNTIL 1112
1952760005916906672013590262476000

Form990 Schedule J Part III Form990ScheduleJPartIII

FieldValueIRS element (for citing)
IdentifierSCHEDULE J, PART I, LINE 4A:Identifier
ExplanationIN CONNECTION WITH HIS DEPARTURE EFFECTIVE MAY 1, 2011, PETER CHINETTI RECEIVED 12 MONTHS OF SALARY AND BENEFITS CONTINUATION. IN CONNECTION WITH HER DEPARTURE EFFECTIVE SEPTEMBER 30, 2011, GAYLE A. FISHMAN RECEIVED 3 MONTHS SALARY. SCHEDULE J, PART I, LINE 4B: EFFECTIVE APRIL 18, 2011, JOHN FERNANDEZ ENTERED INTO A DEFERRED COMPENSATION ARRANGEMENT WITH MASSACHUSETTS EYE AND EAR INFIRMARY UNDER THE AGREEMENT, MR. FERNANDEZ WILL BE CREDITED $120,000 EACH YEAR. EACH ANNUAL CREDIT WILL VEST ON THE FOURTH ANNIVERSARY OF THE DATE SUCH CREDIT WAS MADE OR UPON (1) THE ATTAINMENT OF THE AGE OF 65 WHILE EMPLOYED; (2) TERMINATION WITHOUT CAUSE OR RESIGNATION FOR GOOD REASON; (3) DEATH; (4) DISABILITY; OR (5) CHANGE OF CONTROL OF MASSACHUSETTS EYE AND EAR INFIRMARY WITHIN THE MEANING OF SECTION 409A OF THE INTERNAL REVENUE CODE. SCHEDULE J, PART I, LINE 7: THE BOARD OF TRUSTEES OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, UPON RECOMMENDATIONS OF THE COMPENSATION COMMITTEE, APPROVED A BONUS PROGRAM FOR CERTAIN INDIVIDUALS LISTED ON SCHEDULE J. THE PROGRAM REQUIRES THAT SUPERVISORY PERSONNEL MAKE THE DETERMINATION OF (I) ELIGIBILITY AND (II) AMOUNT OF BONUS DOLLARS BASED ON OVERALL JOB PERFORMANCE. THE CHIEF EXECUTIVE OFFICER OF THE INFIRMARY HAS THE AUTHORITY TO (I) OVERRULE RECOMMENDATIONS MADE BY SUPERVISORS AND (II) MAKE BONUS DETERMINATIONS FOR VICE PERSIDENT LEVEL PERSONNEL. THE COMPENSATION COMMITTEE OF THE BOARD HAS THE FINAL AUTHORITY FOR BONUSES PAID TO THE CEO AS WELL AS THE VICE PRESIDENTS. TOTAL COMPENSATION FOR LISTED INDIVIDUALS, INCLUDING BONUS PAYMENTS, WAS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS, DETERMINED TO BE REASONABLE COMPENSATION, AND APPROVED BY THE BOARD. NO COMPENSATION PAYMENT CAN BE MADE IN EXCESS OF THESE AMOUNTS.Explanation

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (3 entries)

Issuer EINIssuerEINCUSIP NumberCUSIPNumberDate IssuedDateIssuedIssue PriceIssuePriceDescription Of PurposeDescriptionOfPurposeDefeasedDefeasedOn Behalf Of IssuerOnBehalfOfIssuerPool FinancingPoolFinancing
MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES
04245601157586EWL12010-09-2963156092FACILITY IMPROVEMENTSfalsefalsefalse
MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES
04245601157586ELD12007-03-2220000000FACILITY IMPROVEMENTSfalsefalsetrue
MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES
04245601157586ELD12005-02-2513695000FACILITY IMPROVEMENTSfalsefalsetrue

Form990 Schedule K Part II Form990ScheduleKPartII (3 entries)

Amount RetiredAmountRetiredAmount Bond DefeasedAmountBondDefeasedTotal ProceedsTotalProceedsAmount In Reserve FundAmountInReserveFundCapitalized InterestCapitalizedInterestRefunding EscrowRefundingEscrowIssuance Costs From ProceedsIssuanceCostsFromProceedsCredit EnhancementCreditEnhancementWorking Capital ExpendituresWorkingCapitalExpendituresCapital ExpendituresCapitalExpendituresOther Spent ProceedsOtherSpentProceedsAmount UnspentAmountUnspentCurrent RefundingCurrentRefundingAdvance RefundingAdvanceRefundingFinal Allocation MadeFinalAllocationMadeAdequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaindYear Of Subst CompletionYearOfSubstCompletion
006315609250354495191170014574750033953710017518288falsefalsefalsetrue
629200002000000013862300129211001973216600falsefalsetruetrue2010
5026287013695000876500087134001352021600falsefalsetruetrue2009

Form990 Schedule K Part III Form990ScheduleKPartIII (3 entries)

Owning Bond Financed PropertyOwningBondFinancedPropertyAny Lease ArrangementsAnyLeaseArrangementsMngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprtyAny Research AgreementsAnyResearchAgreementsPrcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthersPost Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
falsefalsefalsefalse0true
falsefalsefalsefalse0true
falsefalsefalsefalse0true

Form990 Schedule K Part IV Form990ScheduleKPartIV (3 entries)

Form8038 T FiledForm8038TFiledVariable Rate IssueVariableRateIssueHedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecdsGross Proceeds Invested In GICGrossProceedsInvestedInGICBusiness Name Line1NameOfGICProvider/BusinessNameLine1Gross Proceeds InvestedGrossProceedsInvestedException To RebateExceptionToRebate
0
falsefalsefalsefalse0falsefalse
0
truetruefalsefalse0falsefalse
0
truetruefalsefalse0falsefalse

Schedule L IRS990ScheduleL

Loan Table LoanTable

FieldValueIRS element (for citing)
Name PersonKENNETH HOLMESNamePerson
Purpose Of LoanHOUSINGPurposeOfLoan
Loan From OrganizationXLoanFromOrganization
Original Principal$50,000OriginalPrincipalAmount
Balance Due20000BalanceDue
DefaultfalseDefault
Approved By BoardfalseApprovedByBoard
Written AgreementtrueWrittenAgreement
FieldValueIRS element (for citing)
Total Balance Due20000TotalBalanceDue

Form990 Schedule L Part IV Form990ScheduleLPartIV

Name Of Interested Person NameOfInterestedPerson

FieldValueIRS element (for citing)
Name PersonJOAN MILLER MDNamePerson
FieldValueIRS element (for citing)
RelationshipDRCTR IS LICENSOR TO ORGRelationship
Amount Of Transaction297325AmountOfTransaction
Description Of TransactionPATENT LICENSE PROCEEDSDescriptionOfTransaction
Sharing Of RevenuesfalseSharingOfRevenues

Form990 Schedule L Part V Form990ScheduleLPartV

FieldValueIRS element (for citing)
IdentifierSCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONSIdentifier
Explanation(A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY.Explanation

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (21 entries)

IdentifierIdentifierExplanationExplanationReturn ReferenceReturnReference
FORM 990, PART I, LINE 1 & PART III, LINE 1:THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI").
FORM 990, PART VI, LINE 1A:THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING.THE INFIRMARY'S BYLAWS STATE THE FOLLOWING:
FORM 990, PART VI, LINE 7A:THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION").
FORM 990, PART VI, LINE 7B:THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY.
FORM 990, PART VI, LINE 11B:THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE DIRECTOR OF FINANCE OPERATIONS. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING.
FORM 990, PART VI, LINE 12C:MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL AUDITOR OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL AUDITOR REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH.
FORM 990, PART VI, LINE 15:THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS EXECUTIVE SALARIES TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE.
FORM 990, PART VI, LINE 19:SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE ON THE WEBSITE OF THE OFFICE OF ATTORNEY GENERAL AND ARE ALSO AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. FORM 990, PART VII: THE FOLLOWING INDIVIDUALS WORKED AT RELATED ORGANIZATIONS DURING THE YEAR ENDED SEPTEMBER 30, 2012: RICHARD ALDRICH - 2 HOURS DEWALT ANKENY - 5 HOURS JAVIER BALLOFFET - 20 HOURS LILY BENTAS - 9 HOURS JAMES CARLISLE - 2 HOURS CHARLES DE GUNZBURG - 5 HOURS JOHN FERNANDEZ - 24 HOURS SAMUEL FLEMING - 4 HOURS HARVEY FREISHTAT - 4 HOURS WYCLIFFE GROUSBECK - 4 HOURS JOSEPH W. HALEY - 6 HOURS KENNETH HOLMES - 30 HOURS LYLE HOWLAND - 2 HOURS DIANE KANEB - 2 HOURS MAUREEN KELLEY - 10 HOURS JONATHAN KUTCHINS - 4 HOURS ALAN K. LONG - 30 HOURS JEAN E. MACQUIDDY - 30 HOURS VICTORIA MCCULLOUGH - 5 HOURS JOAN MILLER - 33 HOURS JOSEPH NADOL - 31 HOURS ANNETTE NOVA - 5 HOURS MELISSA PAUL - 50 HOURS CHRISTINE REGAN - 10 HOURS WILLIAM ROMAN - 4 HOURS BARBARA J. SCULLY - 30 HOURS JENNIFER STREET - 17 HOURS FREDERICK THORNE - 2 HOURS JONATHAN UHRIG - 7 HOURS KATHRYN VECELLIO - 5 HOURS CAROLANN WILLIAMS - 12 HOURS SUSAN WILLIAMS - 19 HOURS
FORM 990, PART XI, LINE 5:OTHER CHANGES IN NET ASSETS: NET UNREALIZED GAINS (LOSSES) ON INVESTMENTS $433,731 PENSION/POST-RETIREMENT CHARGE ($7,624,694) TOTAL OTHER CHANGES IN NET ASSETS ($7,190,963)
SCHEDULE K, PART I, BOND (A), COLUMN (F):THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS.
SCHEDULE K, PART I, BOND (B), COLUMN (F):THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.
SCHEDULE K, PART I, BOND (C), COLUMN (F):THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.
PART III - PROGRAM SERVICE, LINE 4ARESEARCH OVERALL: (FROM ADVANCING RESEARCH SECTION OF THE PRINTED ANNUAL REPORT) OUR RESEARCHERS CONTINUED TO MAKE ADVANCES THAT HAVE THE POTENTIAL TO CHANGE THE LANDSCAPE OF HEALTHCARE IN THE YEARS TO COME. THE FOLLOWING ARE JUST A FEW EXAMPLES. - ALBERT EDGE, PH.D., DEMONSTRATED FOR THE FIRST TIME THAT HAIR CELLS CAN BE REGENERATED IN AN ADULT MAMMALIAN EAR BY USING A DRUG TO STIMULATE RESIDENT CELLS TO BECOME NEW HAIR CELLS, RESULTING IN PARTIAL RECOVERY OF HEARING IN MOUSE EARS DAMAGED BY NOISE TRAUMA. THIS FINDING HOLDS GREAT POTENTIAL FOR FUTURE THERAPEUTIC APPLICATION THAT MAY SOMEDAY REVERSE DEAFNESS IN HUMANS. - DR. KONSTANTINA STANKOVIC, IN COLLABORATION WITH ANANTHA P. CHANDRAKASAN, PH.D., FROM THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, WAS THE FIRST TO EXTRACT ENERGY FROM THE "BIOLOGIC BATTERY" IN THE INNER EAR TO POWER ELECTRONICS WITHOUT DAMAGING HEARING, SETTING THE STAGE FOR FUTURE DEVICES THAT ARE SELF-POWERING. - A FEW YEARS AGO, SHARON G. KUJAWA, PH.D. AND M. CHARLES LIBERMAN, PH.D., DISCOVERED THAT OVEREXPOSURE TO MODERATE LEVELS OF NOISE CAN CAUSE DEGENERATION OF COCHLEAR NERVE FIBERS, EVEN IF THE HEARING THRESHOLDS (AND COCHLEAR HAIR CELLS) COMPLETELY RECOVER. THIS YEAR, DRS. KUJAWA AND LIBERMAN, ALONG WITH GRADUATE STUDENT ADAM FURMAN, SHOWED THAT THIS DEGENERATION IS SELECTIVE FOR THE HIGH-THRESHOLD NEURONS THAT NORMALLY HELP US HEAR IN A NOISY ENVIRONMENT. WE THINK THIS HELPS EXPLAIN WHY THE ABILITY TO HEAR IN NOISY SETTINGS DETERIORATES IN THE AGING EAR. - DR. KATHRYN COLBY PERFORMED FIRST COLLAGEN CROSS-LINKING IN BOSTON, AN EXPERIMENTAL TREATMENT FOR KERATOCONUS, UNDER THE AUSPICES OF AN FDA-SANCTIONED CLINICAL TRIAL. - RESEARCHERS FROM THE MASS. EYE AND EAR, THE CHILDREN'S HOSPITAL OF PHILADELPHIA, AND LOYOLA UNIVERSITY CHICAGO HEALTH SCIENCES DIVISION AND THEIR COLLABORATORS ISOLATED AN ELUSIVE HUMAN GENE THAT CAUSES A COMMON FORM OF LEBER CONGENITAL AMAUROSIS (LCA), A RELATIVELY RARE BUT DEVASTATING FORM OF EARLY-ONSET BLINDNESS. THE NEW LCA GENE IS CALLED NMNAT1. FINDING THE SPECIFIC GENE MUTATED IN PATIENTS WITH LCA IS THE FIRST STEP TOWARDS DEVELOPING SIGHT-SAVING GENE THERAPY. DR. ERIC PIERCE, DIRECTOR OF THE OCULAR GENOMICS INSTITUTE, IS A CO-SENIOR AUTHOR ON THE STUDY. - RESULTS FROM THE LARGEST GENETIC STUDY OF GLAUCOMA, A LEADING CAUSE OF BLINDNESS AND VISION LOSS WORLDWIDE, SHOWED THAT TWO GENETIC VARIATIONS ARE ASSOCIATED WITH PRIMARY OPEN-ANGLE GLAUCOMA, A COMMON FORM OF THE DISEASE. THE IDENTIFICATION OF GENES RESPONSIBLE FOR THIS DISEASE IS THE FIRST STEP TOWARD THE DEVELOPMENT OF GENE-BASED DISEASE DETECTION AND TREATMENT. RESEARCHERS INCLUDED STUDY LEAD AUTHOR DR. JANEY WIGGS AND CO-SENIOR AUTHOR DR. LOU PASQUALE. MORE THAN 128 RESEARCH PROPOSALS WERE FUNDED THIS YEAR, FOR A TOTAL OF $24,853,997, WITH 69 NEW GRANT AWARDS. IN FY12, MASS. EYE AND EAR ONCE AGAIN RANKED AMONG THE TOP NIH-FUNDED RESEARCH INSTITUTIONS IN THE UNITED STATES. WE ALSO RECEIVED FUNDING FROM CORPORATIONS AND FOUNDATIONS WHICH HELP US ADVANCE THE WORK WE DO TO FIND CURES. WE EXTEND OUR APPRECIATION TO ALL INDIVIDUALS AND ORGANIZATIONS THAT HAVE FUNDED OUR RESEARCH EFFORTS. OPHTHALMOLOGY: OUR RESEARCH EFFORTS FORGED AHEAD MARKED BY TWO SIGNIFICANT MILESTONES - THE FIRST COMBINED MEE/SCHEPENS ANNUAL RESEARCH FACULTY RETREAT AND THE APPOINTMENT OF PATRICIA D'AMORE, PHD, MBA, FARVO TO DIRECTOR OF RESEARCH AT SCHEPENS. WE ARE ALSO MAKING SIGNIFICANT HEADWAY IN ESTABLISHING OUR OCULAR GENOMICS INSTITUTE (OGI) AS A BURGEONING CENTER OF EXCELLENCE FOR GENOMICS AND GENE THERAPY RESEARCH; PROMISING TRANSLATIONAL INVESTIGATIONS ARE UNDERWAY IN THE INSTITUTE AND THE BERMAN GUND LABORATORY FOR THE STUDY OF RETINAL DEGENERATIONS, AND ALREADY YIELDING EXCITING RESULTS. RESEARCH MILESTONE PATRICIA A. D'AMORE, PHD, MBA, FARVO IS NAMED SCHEPENS DIRECTOR OF RESEARCH FOLLOWING AN INTERNATIONAL SEARCH, PATRICIA D'AMORE, PHD, MBA, FARVO WAS NAMED DIRECTOR OF RESEARCH AT SCHEPENS EYE RESEARCH INSTITUTE, EFFECTIVE NOVEMBER 1, 2012. DR. D'AMORE IS PROFESSOR OF OPHTHALMOLOGY AND PATHOLOGY AT HARVARD MEDICAL SCHOOL (HMS), HMS OPHTHALMOLOGY VICE CHAIR OF BASIC RESEARCH, AND SENIOR SCIENTIST AND ANKENY SCHOLAR OF RETINAL MOLECULAR BIOLOGY AT SCHEPENS. AS DIRECTOR, DR. D'AMORE WILL SERVE AS THE SENIOR LEADER AT SCHEPENS AND AS A MEMBER OF THE MASS. EYE AND EAR RESEARCH LEADERSHIP TEAM, REPORTING TO CHIEF AND CHAIR, DR. JOAN MILLER, AND TO THE SCHEPENS BOARD OF DIRECTORS. DR. D'AMORE WILL ALSO BE NOMINATED FOR APPOINTMENT AS THE CHARLES L. SCHEPENS PROFESSOR OF OPHTHALMOLOGY AT HMS. DR. D'AMORE'S SELECTION FOLLOWS A RIGOROUS, EIGHT-MONTH EFFORT BY AN HMS-APPOINTED SEARCH COMMITTEE TO IDENTIFY A HIGHLY ACCOMPLISHED ACADEMIC AND SCIENTIFIC LEADER WHO HAS ACHIEVED SIGNIFICANT SUCCESS IN ADVANCING THE FIELD OF VISION SCIENCE. NEW EQUIPMENT & TECHNOLOGY FOR RESEARCH - SCHEPENS EYE RESEARCH INSTITUTE MORPHOLOGY CORE - LEICA PT 2030 AUTOMATIC TISSUE PROCESSOR FOR USE IN HISTOPATHOLOGY APPLICATIONS. - SCHEPENS EYE RESEARCH INSTITUTE RETINAL GENE TRANSFER CORE - BIOSAFETY CABINETS, ULTRACENTRIFUGE, AND INCUBATORS FOR VECTOR PRODUCTION - SCHEPENS EYE RESEARCH INSTITUTE TWO-PHOTON CONFOCAL MICROSCOPE CORE - MICROVIDEO INSTRUMENTS INTRAVITAL MICROSCOPE - MACPRO TWO AND BITPLANE SCIENTIFIC IMARIS SOFTWARE FOR IMAGE ANALYSIS - OCULAR GENOMICS INSTITUTE - CLIA DIAGNOSTIC LABORATORY AND DNA SEQUENCING CORE - ILLUMINA ISCAN AND MISEQ SYSTEMS AND LIFE TECHNOLOGIES 3730XL DNA ANALYZER - THERMAL CYCLERS FOR RESEARCH AND CLINICAL DNA SEQUENCE ANALYSIS NEW SERVICE/RENOVATIONS - NEW LABORATORIES HAVE BEEN ESTABLISHED AT SCHEPENS FOR LOTFI MERABET, OD, PHD, LUK VANDENBERGHE, PHD, AND PEDRAM HAMRAH, MD, PHD RESEARCH SUCCESSES CORNEA - COMPLETED A CLINICAL STUDY EVALUATING THE EFFICACY OF A TOPICAL COMBINED ANTI-PDGF AND ANTI-VEGF THERAPY IN CORNEAL ANGIOGENESIS. - CREATED AND VALIDATED AN OCULAR REDNESS CONTINUOUS (0.0 - 100.0) SCALE USING A NOVEL, STATE-OF-THE-ART COMPUTER PROGRAM. - RECEIVED A GRANT FROM THE DEPARTMENT OF DEFENSE TO CONDUCT A MULTI-CENTER CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF A ANTI-VEGF IN PATIENTS WHO ARE AT HIGH-RISK FOR GRAFT REJECTION FOLLOWING THEIR CORNEAL TRANSPLANT. - COMPLETED A STUDY ASSESSING THE USE OF TEAR OSMOLARITY AS A NEW METHOD TO DIAGNOSE AND MONITOR DRY EYE DISEASE. - DEVELOPED TELOMERASE-IMMORTALIZED CORNEAL ENDOTHELIAL CELL LINE WHICH WILL PROVIDE A NEW TOOL FOR THE IN VITRO STUDY OF CORNEAL ENDOTHELIAL CELL BIOLOGY AND WILL BE MADE AVAILABLE TO THE NIH COMMUNITY. - DETERMINED THAT DEFICIENCY IN NRF2-REGULATED PATHWAY IS INVOLVED IN THE PATHOGENESIS OF FUCHS ENDOTHELIAL CORNEAL DYSTROPHY. - DETERMINED THAT CORNEAL LIMBAL FIBROBLASTS CAN BE DIFFERENTIATED INTO CORNEAL EPITHELIAL CELLS THUS SERVING AS A NOVEL SOURCE OF CORNEAL EPITHELIUM USUALLY DESTROYED IN LIMBAL STEM CELL DEFICIENCY DISORDERS. - DEMONSTRATED THE PRESENCE OF THE INTEGRIN MADCAM-1 IN THE OCULAR SURFACE VASCULATURE AND DETERMINED ITS ROLE IN THE RECRUITMENT OF CORNEAL IMMUNE CELLS. - FIRST HUMAN IMPLANTATION OF AN INTRAOCULAR DEVICE TO MEASURE IOP BY TELEMETRY. THIS MAY RESOLVE THE INABILITY TO MEASURE IOP IN KERATOPROSTHESIS PATIENTS. - CONDUCTED THE FIRST LARGE SCALE CATARACT SURGERY OUTCOMES REVIEW (18,000 CASES) IN THE UK INDEPENDENT SECTOR. - DEMONSTRATED WITH LIVE CORNEAL IMAGING THAT UNILATERAL CORNEAL INFECTIONS, INCLUDING IN HERPES ZOSTER OPHTHALMICUS, LEAD TO CONTRALATERAL CHANGES IN CORNEAL NERVES IN THE UNAFFECTED EYE, SUGGESTING NEURO-REGULATORY MECHANISMS BETWEEN EYES. - DEMONSTRATED THAT A DRUG-ELUTING CONTACT LENS CAN DELIVER A THERAPEUTIC AMOUNT OF A GLAUCOMA MEDICATION FOR ONE MONTH. - DETERMINED THAT DEVICES USED IN PROSE TREATMENT CAN BE CUSTOMIZED TO ACCOMMODATE ANY EYE WITH KERATOCONUS OR POST-LASIK ECTASIA REGARDLESS OF DISEASE SEVERITY. - PERFORMED FIRST COLLAGEN CROSS-LINKING IN BOSTON, AN EXPERIMENTAL TREATMENT FOR KERATOCONUS, UNDER THE AUSPICES OF AN FDA-SANCTIONED CLINICAL TRIAL.
BOSTON KERATOPROSTHESIS (KPRO)- IN A LARGE WORLDWIDE SURVEILLANCE STUDY, 4610 KPRO IMPLANTATIONS BY 368 SURGEONS, THERE WERE 176 INCIDENTS (3.8%) OF ENDOPHTHALMITIS. IN CONTRAST, IN A BOSTON (LOCAL) SERIES OF 271 KPRO CASES PERFORMED FROM 2000-2009, ONLY 3 CASES (1.1%) OF BACTERIAL ENDOPHTHALMITIS OCCURRED. NEW HIGHLY EFFECTIVE, LOW-COST ANTIBIOTICS COMBINATIONS FOR ONCE-DAILY PROPHYLAXIS HAVE BEEN PROPOSED. - IN A CLINICAL STUDY ON ALKALI BURNS, THE BOSTON KPRO WAS SHOWN TO HAVE GOOD RETENTION, BUT SEVERE GLAUCOMA OFTEN RUINED THE OPTIC NERVE. EXPERIMENTS ON EX VIVO PIG EYES AND IN VIVO MOUSE EYES SHOWED THAT THE GLAUCOMA WAS NOT CAUSED BY BACKWARDS DIFFUSION OF THE ALKALI ITSELF. RATHER, IT SEEMS THAT EASILY DIFFUSIBLE INFLAMMATORY CYTOKINES CAN REACH THE GANGLION CELL LAYER AND CAUSE WIDESPREAD APOPTOSIS WITHIN 24 HOURS. OF POTENTIAL PRACTICAL IMPORTANCE WAS THE ADDITIONAL FINDING THAT INFLIXIMAD (REMICADE) HAS A VERY STRONG PROTECTIVE EFFECT, BOTH ANTERIORLY AND POSTERIORLY. IT IS THUS POSSIBLE THAT PATIENTS WITH SEVERE CHEMICAL BURNS, WHEN THEY REACH AN EMERGENCY ROOM, SHOULD ALSO HAVE AN IMMEDIATE INTRAVENOUS INFUSION OF INFLIXIMAB. - DEMONSTRATED BETTER WOUND ANATOMY FOLLOWING BOSTON KPRO SURGERY USING LARGER BACKPLATES, SUGGESTING ONE SOLUTION TO THE PROBLEM OF RETROPROSTHETIC MEMBRANE FORMATION. RETINA - FOR THE FIRST TIME IDENTIFIED THE MODE OF DEATH OF CONE PHOTORECEPTOR CELLS IN AN ANIMAL MODEL OF RETINITIS PIGMENTOSA. THIS RESEARCH HAS FURTHER IDENTIFIED THE RECEPTOR INTERACTING PROTEIN KINASE PATHWAY AS A POTENTIAL TARGET FOR DEVELOPING TREATMENT FOR VISION LOSS IN PATIENTS WITH RP. - INVESTIGATE THE ANTI-INFLAMMATORY ACTION OF THE EXERCISE MIMETIC ACADESINE, A MEDICATION THAT ACTIVATES AMP KINASE, AND SHOWED THAT IT SUPPRESSES OCULAR INFLAMMATION IN AN ANIMAL MODEL OF AUTOIMMUNE UVEITIS - RESEARCHERS FROM THE ANGIOGENESIS LABORATORY HIGHLIGHTED THAT A COMMONLY USED STRAIN OF LABORATORY ANIMALS USED IN RETINAL RESEARCH EXHIBIT BASELINE PATHOLOGY THAT CAN ALTER THE CONCLUSIONS OF OTHER STUDIES. - DR. DEAN ELIOTT RECEIVED APPROVAL FOR A PHASE I/II TRIAL IS A PROSPECTIVE, OPEN-LABEL STUDY DESIGNED TO DETERMINE THE SAFETY AND TOLERABILITY OF THE HUMAN EMBRYONIC STEM CELLS-DERIVED RPE CELLS FOR SUB-RETINAL TRANSPLANTATION INTO PATIENTS WITH DRY AMD. - RESEARCHERS FROM THE MASS. EYE AND EAR, THE CHILDREN'S HOSPITAL OF PHILADELPHIA, LOYOLA UNIVERSITY CHICAGO HEALTH SCIENCES DIVISION AND THEIR COLLABORATORS HAVE ISOLATED AN ELUSIVE HUMAN GENE THAT CAUSES A COMMON FORM OF LEBER CONGENITAL AMAUROSIS (LCA), A RELATIVELY RARE BUT DEVASTATING FORM OF EARLY-ONSET BLINDNESS. THE NEW LCA GENE IS CALLED NMNAT1. FINDING THE SPECIFIC GENE MUTATED IN PATIENTS WITH LCA IS THE FIRST STEP TOWARDS DEVELOPING SIGHT-SAVING GENE THERAPY. ERIC PIERCE, MD, PHD, DIRECTOR OF THE OCULAR GENOMICS INSTITUTE IS A CO-SENIOR AUTHOR ON THE STUDY. - ADMINISTRATION OF A GENE THERAPY VECTOR CARRYING THE RPE65 GENE TO ONE EYE IN EACH OF 12 PATIENTS WITH CONGENITAL BLINDNESS DUE TO RPE65 MUTATIONS LED TO IMPROVEMENTS IN RETINAL AND VISUAL FUNCTION AND PROVED TO BE A SAFE AND STABLE PROCEDURE. - ANALYZED VISUAL ACUITY DATA FROM THREE CLINICAL TRIALS CONDUCTED INVOLVING PATIENTS WITH TYPICAL RETINITIS PIGMENTOSA TO SHOW THAT A DIET RICH IN OMEGA-3 FATTY ACIDS APPEARS ASSOCIATED WITH SLOWING VISUAL ACUITY DECLINE IN RETINITIS PIGMENTOSA PATIENTS ON VITAMIN A. - DISCOVERY THAT VEGG, WHICH IS KNOWN TO CAUSE BLOOD VESSEL GROWTH, ALSO SEEMS TO UNEXPECTEDLY BIND THE RECEPTOR FOR ANOTHER GROWTH FACTOR KNOWN AS PLATELET-DERIVED GROWTH FACTOR (PDGF), AND PREVENT PDGF FROM BINDING. THIS SUGGESTS THAT VEGF MAY CONTRIBUTE TO THE DEVELOPMENT OF PROLIFERATIVE VITREORETINOPATHY, THE MOST COMMON SERIOUS SIDE-EFFECT OF RETINAL RE-ATTACHMENT SURGERY. GLAUCOMA - IN RESEARCH CONDUCTED WITH DR. JAE HEE KANG FROM THE CHANNING DIVISION OF NETWORK MEDICINE AT BRIGHAM AND WOMEN'S HOSPITAL, DR. PASQUALE REPORTED THAT HEAVY CONSUMPTION OF CAFFEINATED COFFEE IS ASSOCIATED WITH AN INCREASED RISK FOR EXFOLIATION GLAUCOMA OR EXFOLIATION GLAUCOMA SUSPECT. - RESULTS FROM THE LARGEST GENETIC STUDY OF GLAUCOMA, A LEADING CAUSE OF BLINDNESS AND VISION LOSS WORLDWIDE, SHOWED THAT TWO GENETIC VARIATIONS ARE ASSOCIATED WITH PRIMARY OPEN ANGLE GLAUCOMA, A COMMON FORM OF THE DISEASE. THE IDENTIFICATION OF GENES RESPONSIBLE FOR THIS DISEASE IS THE FIRST STEP TOWARD THE DEVELOPMENT OF GENE-BASED DISEASE DETECTION AND TREATMENT. RESEARCHERS INCLUDED STUDY LEAD AUTHOR JANEY WIGGS, MD, PHD, AND LOU PASQUALE, MD, FARVO. - RESEARCHERS FROM THE MASS. EYE AND EAR, BRIGHAM AND WOMEN'S HOSPITAL, AND UNIVERSITY OF MICHIGAN, ANN ARBOR, MICH., SET OUT TO FIND OUT HOW DEMOGRAPHIC AND GEOGRAPHIC RISK FACTORS ARE ASSOCIATED WITH ES. THEIR STUDY, THE "DEMOGRAPHIC AND GEOGRAPHIC FEATURES OF EXFOLIATION GLAUCOMA IN TWO UNITED STATES-BASED PROSPECTIVE COHORTS" WAS PUBLISHED IN THE JANUARY 2012 ISSUE OF OPHTHALMOLOGY. THIS STUDY CONFIRMED ESTABLISHED ASSOCIATIONS WITH AGE AND FAMILY HISTORY AND EXFOLIATION GLAUCOMA OR EXFOLIATION GLAUCOMA SUSPECT (EG/EGS), AS WELL AS PROVIDED NEW DATA ON ASSOCIATIONS WITH GENDER, EYE COLOR AND ANCESTRY. - DR. PASQUALE AND COLLEAGUES DESCRIBED OCULAR INJURY, INCLUDING GLAUCOMA, AFTER LASER PHOTOEPILATION TO REMOVE UNWANTED EYEBROW HAIR. THESE OCULAR INJURIES OCCURRED DESPITE PROTECTIVE EYEWEAR. THE AUTHORS REPORT THAT PREVENTIVE MEASURES THAT ACCOUNT FOR THE ROUNDED CONTOUR OF THE ORBITAL RIM ARE NEEDED TO PREVENT UNWANTED INTERACTION BETWEEN LASER ENERGY EMITTED FROM THE LASER PROBE AND INTRAOCULAR STRUCTURES DURING EYEBROW LASER PHOTOEPILATION. - FOR THE FIRST TIME, DR. TERESA CHEN DESCRIBED A CASE OF BILATERAL SECONDARY ANGLE CLOSURE GLAUCOMA AFTER BUPROPION (WELLBUTRIN) USE. - DR. JANEY WIGGS LED A GROUP OF RESEARCHERS TO DESCRIBE AN ASSOCIATION BETWEEN A COMMON POLYMORPHISM IN THE P53 GENE AND INITIAL PARACENTRAL VISION LOSS IN PRIMARY OPEN ANGLE GLAUCOMA. - WORK FROM THE ANGIOGENESIS LABORATORY INVESTIGATED THE PROTECTIVE ROLE OF THE TNF INHIBITOR, ETANERCEPT (ALSO KNOWN AS ENBREL, A MEDICATION USED FOR AUTOIMMUNE DISEASES SUCH AS RHEUMATOID ARTHRITIS) IN AN ANIMAL MODEL OF GLAUCOMA.
RESEARCH GRANTSTERESA CHEN, MD RECEIVED A HARVARD CATALYST PILOT GRANT AWARD FOR HER PROJECT, "SPECTRAL DOMAIN OCT 3D." JAMES CHODOSH, MD, MPH WAS AWARDED A RESEARCH TO PREVENT BLINDNESS SENIOR SCIENTIFIC INVESTIGATOR AWARD FOR HIS PROJECT, "ADENOVIRUS EVOLUTION & EMERGENCE OF NEW OCULAR PATHOGENS." DR. CHODOSH ALSO RECEIVED A NEW RESEARCH AGREEMENT AWARD FROM JANSSEN BIOTECH, INC. FOR HIS PROJECT: INFLIXIMAB THERAPY TO IMPROVE RETENTION OF THE BOSTON KERATOPROSTHESIS. JOSEPH CIOLINO, MD RECEIVED A 4-YEAR RESEARCH TO PREVENT BLINDNESS CAREER DEVELOPMENT AWARD. KIP CONNOR, PHD, HMS ASSISTANT PROFESSOR OF OPHTHALMOLOGY RECEIVED A NEW SUPPLEMENT FOR HIS R01 GRANT, "COMPLEMENT MEDIATED NEOVASCULARIZATION IN RETINOPATHY." DR. CONNOR WAS ALSO AWARDED A JANSSEN RESEARCH & DEVELOPMENT GRANT FOR HIS PROJECT: "HUTCS IN THE RETINA. REZA DANA, MD, MPH, MSC WAS AWARDED A FOUR YEAR, $2.3 MILLION COOPERATIVE AGREEMENT AWARD WITH THE DEPARTMENT OF DEFENSE: "SAFETY AND EFFICACY OF BEVACIZUMAB IN HIGH-RISK CORNEAL TRANSPLANT SURVIVAL." MICHAEL GILMORE, PHD RECEIVED A NEW RESEARCH AWARD FROM BAUSCH & LOMB FOR HIS PROJECT, "COMPARATIVE GENOMICS OF OCULAR PATHOGENS." TATJANA JAKOBS, MD RECEIVED A RESEARCH TO PREVENT BLINDNESS DOLLY GREEN SPECIAL SCHOLAR AWARD. ANN-MARIE LOBO, MD RECEIVED A GRANT FROM ABBVIE, INC. FOR HER STUDY, "A MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF THE HUMAN ANTI-TNF MONOCLONAL ANTIBODY ADALIMUMAB AS MAINTENANCE THERAPY IN SUBJECTS REQUIRING HIGH DOSE CORTICOSTEROIDS FOR INACTIVE NON-INFECTIOUS INTERMEDIATE-, POSTERIOR-, OR PAN-UVEITIS." GANG LUO, PHD RECEIVED A WILLIAM F. MILTON FUND AT HARVARD UNIVERSITY AWARD, FOR HIS WORK, "SEEING IN BLIND FIELD IN VISUALLY IMPAIRED PEOPLE." RICHARD MASLAND, PHD, RECEIVED A TWO-YEAR GRANT FROM HMS FOR HIS PROJECT, "RETINAL GANGLION CELLS." LOTFI MERABET, OD, PHD, MPH RECEIVED A NEW SUPPLEMENT TO HIS NEI R01 GRANT, "AUDIO BASED NAVIGATION IN THE BLIND" LOUIS PASQUALE, MD, FARVO RECEIVED A GIFT OF $100,000 FROM MASS. EYE AND EAR SUPPORTER, MR. PAUL MARGOLIS FOR HIS PROJECT, "THE GENETICS OF RETINAL VASCULAR DYSREGULATION IN GLAUCOMA." ROBERTO PINEDA II, MD RECEIVED A HARVARD CATALYST PILOT GRANT AWARD FOR HIS PROJECT, "EARLY DETECTION OF CORNEAL EXTASIA THROUGH IN VIVO BRILLOUIN IMAGING." DOUGLAS RHEE, MD RECEIVED A NEW STUDY AGREEMENT AWARD FROM MERCK SHARP & DOHME CORPORATION FOR THE PROJECT, "EFFECT OF OPHTHALMIC PRESERVATIVES ON TRABECULAR MESHWORK OUTFLOW FACILITY." JOSEPH RIZZO III, MD RECEIVED A RESEARCH AWARD FROM THE VA BOSTON HEALTHCARE SYSTEM, FOR HIS PROJECT: "PENETRATING ELECTRODES IN THE BOSTON RETINAL PROSTHESIS." THE NATIONAL EYE INSTITUTE HAS AWARDED RESEARCHERS AT SCHEPENS A FIVE YEAR-GRANT TOTALING MORE THAN $2.4 MILLION TO UNDERSTAND THE ORIGINS OF EYE ALLERGIES, DANIEL SABAN, PHD, MS IS THE PRINCIPAL INVESTIGATOR FOR THE PROJECT ENTITLED "CELLULAR AND MOLECULAR MECHANISMS THAT CONTRIBUTED TO OCULAR SURFACE ALLERGY." LUCY Q. SHEN RECEIVED A YOUNG CLINICIAN SCIENTIST AWARD FROM THE AMERICAN GLAUCOMA SOCIETY FOR HER PROJECT, "USING STRUCTURE-FUNCTION RELATIONSHIP TO AID THE DIAGNOSIS AND MONITORING OF GLAUCOMA." DIMITRA SKONDRA, MD, MASS. EYE AND EAR VITREORETINAL FELLOW, WAS NAMED THE 2012 ALCON CLINICAL RESEARCH SCHOLAR. THIS AWARD IS GRANTED TO A CLINICAL RESEARCH FELLOW TO SUPPORT A CERTIFIED OR BOARD ELIGIBLE SUBSPECIALTY FELLOWSHIP CANDIDATE FOR A ONE-YEAR STRUCTURED CLINICAL AND RESEARCH DEVELOPMENT PROGRAM UNDER MENTORSHIP OF A SENIOR HMS FACULTY MEMBER. LUCIA SOBRIN, MD, MPH RECEIVED AN RO1 GRANT FROM NIH FOR THE PROJECT, "MULTI-ETHNIC GWAS OF DIABETIC RETINOPATHY: ENHANCED POWER USING NEW METHODS." MASS. EYE AND EAR RESEARCH FELLOW IN OPHTHALMOLOGY, ARIEL WEINBERGER, PHD RECEIVED A F32 FELLOWSHIP AWARD GRANT FROM THE NIH FOR HER PROJECT ENTITLED, "THE EVOLUTIONARY DYNAMICS OF PLASMID UPTAKE IN PATHOGENIC BACTERIA." JANEY WIGGS, MD, PHD RECEIVED AN R01GRANT FROM THE NATIONAL EYE INSTITUTE FOR HER PROJECT ENTITLED, "THE NEIGHBORHOOD: POAG HERITABLE OVERALL OPERATIONAL DATABASE." RESEARCH TO PREVENT BLINDNESS HAS AWARDED A GRANT OF $110,000 TO THE MASS. EYE AND EAR TO SUPPORT RESEARCH INTO THE CAUSES, TREATMENT AND PREVENTION OF BLINDING DISEASES. THE RESEARCH WILL BE DIRECTED BY JOAN W. MILLER, MD, FARVO. FOR THE THIRD YEAR IN A ROW, AN APPLICATION TO SUPPORT THE ALCON RESEARCH SCHOLAR POSITION HAS BEEN APPROVED TO SUPPORT THE WORK OF A CLINICAL/TRANSLATIONAL RESEARCH FELLOW IN THE MASS. EYE AND EAR CORNEA SERVICE. THE GRANT IS ADMINISTERED BY REZA DANA, MD, MPH, MSC. MASS. EYE AND EAR CURING KIDS FUND HAS AWARDED GRANTS TO THREE MASS. EYE AND EAR OPHTHALMOLOGY FACULTY, INCLUDING: ERIC PIERCE, MD, PHD (DISEASE GENE DISCOVERY FOR LEBER CONGENITAL AMAUROSIS); DONG FENG CHEN, MD, PHD (EPIGENETIC REGULATION OF CONGENITAL RETINAL DYSTROPHY); AND BRUCE R. KSANDER, PHD (A NEW TREATMENT TO PREVENT THE DEVELOPMENT OF DRUG RESISTANT CANCER STEM CELLS IN RETINOBLASTOMA). CLINICAL TRIAL AWARDS THE DEPARTMENT'S CLINICAL RESEARCH EFFORTS CONTINUE STRONG GROWTH. BETWEEN MARCH 2012 AND OCTOBER 2012 THE DEPARTMENT EXPERIENCED A 23 PERCENT INCREASE IN CLINICAL RESEARCH STUDIES, FROM 132 TO 162. CLINICAL TRIALS (NIH DEFINITION) INCREASED AS WELL DURING THE SAME TIME PERIOD, FROM 29 TO 37. OTOLARYNGOLOGY: RESEARCH SUCCESSES: - RAMON A. FRANCO, JR., M.D., WILL LEAD A MULTI-NATIONAL RESEARCH COLLABORATION TO STUDY THROAT LESIONS THAT CAN LEAD TO CANCER. WORKING IN CONJUNCTION WITH SEVERAL EUROPEAN NATIONS, THE RESEARCH WILL USE THE DNA, RNA AND PROTEIN CHANGES SEEN IN A PATIENT'S BIOPSY SAMPLE AND DEVELOP A DATABASE OF INFORMATION THAT COULD HELP TO PROVIDE MORE INDIVIDUALIZED CARE. THIS PROJECT IS FUNDED BY A GRANT FROM MASSACHUSETTS LIFE SCIENCES CENTER. - IN COLLABORATION WITH SEOK-HYUN YUN, PH.D., FROM THE WELLMAN CENTER FOR PHOTOMEDICINE AT MASSACHUSETTS GENERAL HOSPITAL, JEFFREY TAO CHENG, PH.D., IS DEVELOPING A PROBE THAT CAN BE APPLIED TO OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR A REVOLUTIONARY NONINVASIVE DIAGNOSTIC TOOL FOR MIDDLE EAR DISEASE. - A FEW YEARS AGO, SHARON G. KUJAWA, PH.D. AND M. CHARLES LIBERMAN, PH.D. DISCOVERED THAT OVEREXPOSURE TO MODERATE LEVELS OF NOISE CAN CAUSE DEGENERATION OF COCHLEAR NERVE FIBERS, EVEN IF THE HEARING THRESHOLDS (AND COCHLEAR HAIR CELLS) COMPLETELY RECOVER. THIS YEAR, DRS. KUJAWA AND LIBERMAN, ALONG WITH GRADUATE STUDENT ADAM FURMAN, SHOWED THAT THIS DEGENERATION IS SELECTIVE FOR THE HIGH-THRESHOLD NEURONS THAT NORMALLY HELP US HEAR IN A NOISY ENVIRONMENT. WE THINK THIS HELPS EXPLAIN WHY HEARING-IN-NOISE ABILITY DETERIORATES IN THE AGING EAR. - THE LYNCH CENTER FOR LASER AND RECONSTRUCTIVE SURGERY HAS RECRUITED A RESEARCH FELLOW TO INVESTIGATE THE GENETIC ORIGIN OF VASCULAR MALFORMATION. - JAMES W. ROCCO, M.D., PH.D., HAS BEGUN RECRUITING PARTICIPANTS TO HIS NIH-FUNDED STUDY OF BIOMARKERS FOR PREDICTING OUTCOME IN OROPHARYNGEAL CANCER. WITH EDMUND MROZ, PH.D., HE HAS DEVELOPED A WAY TO USE DNA SEQUENCING OF TUMORS TO MEASURE DIFFERENCES AMONG CANCER CELLS WITHIN INDIVIDUAL TUMORS. THEIR WORK INDICATES THAT SUCH "INTRA-TUMOR HETEROGENEITY" CONTRIBUTES TO POOR OUTCOMES IN HEAD AND NECK CANCER. - KONSTANTINA STANKOVIC, M.D., PH.D., IN COLLABORATION WITH ANANTHA P. CHANDRAKASAN, PH.D. FROM THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, WAS THE FIRST TO HAVE EXTRACTED ENERGY FROM THE BIOLOGIC BATTERY IN THE INNER EAR TO POWER ELECTRONICS WITHOUT DAMAGING HEARING. THIS SETS THE STAGE FOR FUTURE AUTONOMOUS SENSING OF KEY MOLECULES IN THE INNER EAR AND ITS VICINITY TO ESTABLISH DIAGNOSIS AND GUIDE THERAPY. - KONSTANTINA STANKOVIC, M.D., PH.D., IN COLLABORATION WITH ECOLE POLYTECHNIQUE FEDERAL DE LAUSSSANE (EPFL) IN SWITZERLAND, WAS THE FIRST TO HAVE IMAGED CELLS INSIDE THE INNER EAR WITH HIGH RESOLUTION AND WITHOUT CONTRAST DYES USING TWO-PHOTON MICROSCOPY THROUGH THE ROUND WINDOW. THIS SETS THE STAGE FOR ULTIMATE COCHLEAR ENDOSCOPY IN HUMANS TO ESTABLISH CELLULAR DIAGNOSIS.
NEW RESEARCH GRANTS:- BERTRAND DELGUTTE, PH.D., WAS AWARDED A CURING KIDS FUND GRANT FROM MASSACHUSETTS EYE AND EAR INFIRMARY TO STUDY "RESTORING BINAURAL HEARING WITH COCHLEAR IMPLANTS IN EARLY-ONSET DEAFNESS," WHICH WILL STUDY WAYS THAT PERCEPTUAL TRAINING CAN HELP THE BRAIN TO LOCATE SOUNDS IN SUBJECTS WITH EARLY-ONSET DEAFNESS. RESULTS WILL EVENTUALLY LEAD TO NEW SOUND PROCESSORS AND REHABILITATION STRATEGIES FOR PEOPLE WITH BILATERAL COCHLEAR IMPLANTS. - FUXIN SHI, PH.D., WAS AWARDED A CURING KIDS FUND GRANT FROM MASSACHUSETTS EYE AND EAR INFIRMARY TO STUDY "EXPLOITING THE WNT SIGNALING PATHWAY FOR CURING DEAFNESS IN CHILDREN," WHICH WILL TEST THE FEASIBILITY OF CURING DEAFNESS IN CHILDREN VIA REGENERATION OF FUNCTIONING HAIR CELLS. - BENJAMIN S. BLEIER, M.D., RECEIVED TWO GRANT AWARDS THIS YEAR, ONE FROM THE AMERICAN RHINOLOGIC SOCIETY TO FUND HIS PROJECT TITLED "MDR1/P-GP OVEREXPRESSION AND NEGATIVE FEEDBACK INSENSIVITY IN CRSWNP," AND ANOTHER FROM THE MICHAEL J. FOX FOUNDATION FOR HIS PROJECT TITLED "NON-INVASIVE STRIATAL DELIVERY OF GLIAL DERIVED NEUROPATHIC FACTOR (GDNF)." - RAMON A. FRANCO, JR., M.D., RECEIVED A GRANT AWARD FROM THE MASSACHUSETTS LIFE SCIENCES CENTER FOR HIS PROJECT TITLED "BIOMOLECULAR ANALYSIS OF LARYNGEAL DYSPLASIA." - DANIEL J. LEE, M.D., F.A.C.S. AND ALBERT EDGE, PH.D., WERE AWARDED AN R21 AWARD FROM THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS FOR HIS PROJECT TITLED "DELIVERY OF CHANNEL RHODOSPIN FOR OPTOGENETIC CONTROL OF NEURONS IN THE COCHLEA." THE MAJOR GOAL OF THIS GRANT IS TO OPTIMIZE THE EXPRESSION OF CHR2 IN THE AUDITORY PERIPHERY USING BOTH DIRECT TRANSFECTION AND STEM-CELL MEDIATED APPROACHES. BOTH ANATOMIC STUDIES AND PHYSIOLOGIC CHARACTERIZATION OF LIGHT-ACTIVATED RESPONSES WILL BE PERFORMED. - RICHARD F. LEWIS, M.D., WAS AWARDED AN R01 GRANT FROM THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS FOR HIS PROJECT TITLED "VESTIBULAR MIGRAINE INVESTIGATED WITH PSYCHOPHYSICAL AND OCULOMOTOR TESTS." - FELIPE SANTOS, M.D., WAS AWARDED A GRANT FROM THE AMERICAN OTOLOGICAL SOCIETY, FOR HIS STUDY: "EPIGENETIC REGULATION OF HAIR CELL REGENERATION IN ZEBRAFISH." - JEFFREY TAO CHENG, PH.D., WAS AWARDED A HARVARD CATALYST PILOT GRANT FOR HIS PROJECT, "OCT FOR MIDDLE EAR DISEASE." - RUTH ANNE EATOCK, PH.D., RECEIVED AN R01 GRANT FROM NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS FOR HER PROJECT TITLED " SYNAPTIC PROCESSING IN THE VESTIBULAR SYSTEM." - BARBARA HERRMANN, PH.D., CCC-A, BEGAN A NEW CLINICAL STUDY OF INFANT EVOKED RESPONSES TO NEW STIMULI, FUNDED BY NATUS MEDICAL, INC. - M. CHARLES LIBERMAN, PH.D., AND SHARON G. KUJAWA, PH.D., WERE AWARDED A NEW 5-YEAR R01 GRANT FROM THE NIDCD TO CONTINUE THEIR STUDY OF THE ROLE OF NOISE- INDUCED COCHLEAR NEURONAL DEGENERATION IN THE DETERIORATION OF HEARING-IN-NOISE ABILITIES AND IN THE GENERATION OF TINNITUS. DR. LIBERMAN WAS ALSO AWARDED A NEW 2-YEAR R21 FROM THE NIDCD TO STUDY THE IDEA THAT NEONATAL THIAMINE DEFICIENCY CAUSES A SPECIAL TYPE OF SENSORINEURAL HEARING LOSS CALLED AUDITORY NEUROPATHY. - JENNIFER R. MELCHER, PH.D., WAS AWARDED A GRANT FROM THE TINNITUS RESEARCH CONSORTIUM TO FUND HER PROJECT: "TINNITUS, AUDITORY BRAINSTEM RESPONSE, AND CEREBRAL CORTICAL STRUCTURE." DR. MELCHER WAS ALSO AWARDED AN R21 GRANT THIS YEAR FOR HER PROJECT TITLED "SENSORIMOTOR GATING IN HUMANS WITH TINNITUS AND HYPERACUSIS." - DANIEL M. MERFELD, PH.D., M.S.E., WAS AWARDED A GRANT FROM THE NIH-NIDCD FOR HIS PROJECT TITLED, "INNOVATIVE METHODOLOGIES FOR MEASURING BEHAVIORAL VESTIBULAR THRESHOLDS." - JOHN ROSOWSKI, PH.D., WAS AWARDED AN R01 GRANT FROM NIH-NIDCD TITLED "MIDDLE-EAR MECHANICS IN NORMAL AND PATHOLOGICAL EARS. RADIOLOGY: RESEARCH SUCCESSES: - MARY BETH CUNNANE, MD, SERVED AS CLINICAL INVESTIGATOR, "ROLE OF NON-EPI DIFFUSION WEIGHTED IMAGING IN EVALUATION OF CHOLESTEATOMA", IN CONJUNCTION WITH PHILLIPS MRI SCIENTISTS, 2012. ANESTHESIOLOGY: RESEARCH SUCCESSES: - NEW CLINICAL TRIAL
PART III - PROGRAM SERVICE, LINE 4BEDUCATION OVERALL (SUMMARY FROM PRINTED ANNUAL REPORT TEXT): CLINICAL CARE AND RESEARCH ARE ONLY TWO PARTS OF OUR MISSION. WE ALSO TEACH TOMORROW'S LEADERS. MASS. EYE AND EAR CONTINUED ITS ROBUST RESIDENCY AND FELLOWSHIP PROGRAMS. WE HELD SUCCESSFUL MEETINGS TOO NUMEROUS TO LIST. AS A DEPARTURE FROM THE TRADITIONAL MODE OF TEACHING, THE MASS. EYE AND EAR CATARACT MASTER, A NEW AND HIGHLY INNOVATIVE, COMPUTER-BASED SIMULATION TOOL DESIGNED TO TEACH RESIDENTS PHACOEMULSIFICATION CATARACT SURGERY, WAS LAUNCHED IN THE SPRING AND IS NOW AVAILABLE TO OPHTHALMOLOGY RESIDENCY PROGRAMS AND THE OPHTHALMOLOGY COMMUNITY WORLDWIDE. NEARLY A DECADE IN THE MAKING, THE CATARACT MASTER WAS CO-DEVELOPED BY HARVARD MEDICAL SCHOOL RESIDENCY TRAINING PROGRAM DIRECTOR, DR. JOHN I. LOEWENSTEIN, DR. BONNIE AN HENDERSON, ADAM NEAMAN, PH.D., AND COLLEAGUES. MASS. EYE AND EAR LICENSED THE ENGLISH VERSION OF THE PROGRAM TO THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS FOR WORLDWIDE DISTRIBUTION OVER THE INTERNET. WE WELCOMED THREE NEW FACULTY PROFESSORS. RUTH ANNE EATOCK, PH.D., DR. CHRISTOPHER HARTNICK AND DANIEL MERFELD, PH.D., WERE ALL NAMED PROFESSOR OF OTOLARYNGOLOGY AT HARVARD MEDICAL SCHOOL. IN ADDITION, WE ANNOUNCED TWO NEW ENDOWED PROFESSORSHIPS: - MASS. EYE AND EAR ENDOWED THE HARVARD MEDICAL SCHOOL LEFFENFIELD CHAIR OTOLOGY AND LARYNGOLOGY AND APPOINTED DR. RICHARD GLIKLICH AS THE FIRST INCUMBENT. UPON HIS RETIREMENT, THE CHAIR WILL BECOME THE LAURIE AND RICH GLIKLICH PROFESSORSHIP. - MASS. EYE AND EAR ALSO ESTABLISHED THE STEVEN C. AND CARMELLA R. KLETJIAN ENDOWED CHAIR OF GLOBAL SURGERY AND THE OFFICE OF GLOBAL SURGERY. DR. MACK CHENEY WAS APPOINTED DIRECTOR AND FIRST INCUMBENT OF THIS CHAIR. OPHTHALMOLOGY: MASS. EYE AND EAR CATARACT MASTER - THE MASS. EYE AND EAR CATARACT MASTER, A NEW AND HIGHLY INNOVATIVE, COMPUTER-BASED SIMULATION TOOL DESIGNED TO TEACH RESIDENTS PHACOEMULSIFICATION CATARACT SURGERY, WAS LAUNCHED IN THE SPRING AND IS NOW AVAILABLE TO OPHTHALMOLOGY RESIDENCY PROGRAMS AND THE OPHTHALMOLOGY COMMUNITY WORLDWIDE. NEARLY A DECADE IN THE MAKING, THE CATARACT MASTER WAS CO-DEVELOPED BY HARVARD MEDICAL SCHOOL RESIDENCY TRAINING PROGRAM DIRECTOR, JOHN I. LOEWENSTEIN, MD, BONNIE AN HENDERSON, MD, FACS, ADAM NEAMAN, PHD, AND SEVERAL OF THEIR COLLEAGUES. THE CATARACT MASTER RECEIVED AN ENTHUSIASTIC RECEPTION DURING ITS OFFICIAL DEBUT AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY (ASCRS) ANNUAL MEETING IN APRIL 2012. MASS. EYE AND EAR HAS LICENSED THE ENGLISH VERSION OF THE PROGRAM TO ASCRS FOR WORLDWIDE DISTRIBUTION OVER THE INTERNET. - SIMMONS LECTURESHIP WAS ESTABLISHED. THE LECTURESHIP GIVES FIRST PREFERENCE FOR GLAUCOMA OR GLAUCOMA-RELATED TOPICS. THE FIRST LECTURE WAS DELIVERED BY JOEL S. SCHUMAN, MD, FACS, PROFESSOR AND CHAIRMAN OF OPHTHALMOLOGY, AND PROFESSOR OF BIOENGINEERING AT THE UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE. DR. SCHUMAN IS A HIGHLY REGARDED CLINICIAN AND GLAUCOMA SPECIALIST. - THE 2ND INTERNATIONAL BIENNIAL SYMPOSIUM ON AMD (SEPTEMBER 21-22, 2012) LED BY COMMITTEE CO-CHAIRS: PATRICA A. D'AMORE, PHD, MBA; IVANA K. KIM, MD; AND JOAN W. MILLER, MD, FARVO FOLLOWED THE HIGHLY SUCCESSFUL PRECEDENT SET BY THE INAUGURAL 2010 SYMPOSIUM. A DIVERSE AND DISTINGUISHED GROUP OF CLINICIANS AND RESEARCHERS FROM AROUND THE WORLD ENGAGED IN STIMULATING AND OPEN-ENDED PANEL DISCUSSIONS ON A WIDE ARRAY OF AMD TOPICS THAT INCLUDED: RPE/BRUCH'S MEMBRANE/CHORIOCAPILLARIS, INFLAMMATION, LIPIDS/CARDIOVASCULAR DISEASE, IMAGING, ANGIOGENESIS BEYOND VEGF, NEUROPROTECTION/REGENERATION, DRUG DELIVERY, AND NEURODEGENERATIVE DISEASES. THE INTERACTIVE FORMAT AND LIVELY DISCUSSION AND DEBATE DREW KUDOS FROM THE.200+ CLINICIANS, RESEARCHERS, AND TRAINEES IN ATTENDANCE. - THE 27TH CORNEA BIENNIAL CONFERENCE (SEPTEMBER 30-OCTOBER 1, 2011), CO-HOSTED BY SCHEPENS EYE RESEARCH INSTITUTE AND THE MASS. EYE AND EAR, WITH SUPPORT FROM BOSTON UNIVERSITY SCHOOL OF MEDICINE, AND TUFTS UNIVERSITY CENTER FOR VISION RESEARCH FEATURED 29 DISTINGUISHED NATIONAL AND INTERNATIONAL SPEAKERS, AND RAISED OVER $100,000 FOR EYE RESEARCH. - IN MARCH 2012, ROBERT PINEDA II, MD AND SHERLEEN CHEN, MD, TRAVELED TO SHANGHAI, CHINA TO CONDUCT A COURSE IN ADVANCED SKILLS TO PHACOEMULSIFICATION CATARACT SURGEONS. THE "CHINA ALCON ADVANCED CATARACT COURSE," THE FIRST OF ITS KIND IN SHANGHAI, WAS UNDERTAKEN AS PART OF THE DEPARTMENT'S EDUCATIONAL PARTNERSHIP WITH SHANGHAI EYE AND ENT HOSPITAL. - FOR THE THIRD YEAR IN A ROW, WE HELD ANOTHER HIGHLY SUCCESSFUL MASS. EYE AND EAR INTENSIVE VITREORETINAL COURSE (JULY 20-21, 2012), A UNIQUE AND COMPREHENSIVE WORKSHOP COVERING THE THEORY AND PRACTICE OF VITREORETINAL SURGERY. FREE OF CHARGE TO PARTICIPANTS, THE COURSE IS DESIGNED EXCLUSIVELY FOR FIRST-YEAR VITREORETINAL FELLOWS TO PREPARE THEM FOR THE OR EXPERIENCE OF THE CLINICAL FELLOWSHIP. THIS EVENT CONTINUES TO DRAW A DISTINGUISHED CADRE OF EMINENT FACULTY FROM VARIOUS INSTITUTIONS WORLDWIDE. COURSE DIRECTORS ARE JOHN LOEWENSTEIN, MD, DEAN ELIOTT, MD, AND DEMETRIOS VAVVAS, MD, PHD. - THE 5TH MILITARY VISION SYMPOSIUM ON OCULAR & VISION INJURY HELD SEPTEMBER 18-20, 2012 FOCUSED ON MILITARY AND CIVILIAN OCULAR RESEARCH. THE SYMPOSIUM COVERED THE TOPICS OF COMBAT OCULAR READINESS, BLAST INJURY/BLAST EYE, OCULAR PAIN, INFLAMMATION AND INFECTION, TELEHEALTH, TELEPRESENCE & INFORMATICS, REGENERATIVE MEDICINE, AND VISION FUNDING. - DIGITAL JOURNAL OF OPHTHALMOLOGY WILL NOW BE INCLUDED IN PUBMED CENTRAL AND INDEXED IN THE NATIONAL LIBRARY OF MEDICINE'S MEDLINE DATABASE, WHICH SHOULD SIGNIFICANTLY INCREASE ITS PROFILE.
OTOLARYNGOLOGY:EDUCATIONAL HIGHLIGHTS: - UPCOMING CME COURSES - "UPDATE ON TRACHEO-ESOPHAGEAL VOICE RESTORATION AND LARYNGECTOMY CARE," DIRECTED BY DANIEL G. DESCHLER, M.D., F.A.C.S., AND GLENN BUNTING, M.S. - MARCH 15-16, 2013, MASSACHUSETTS EYE AND EAR INFIRMARY. - "LARYNGOLOGY DISORDERS UPDATE," DIRECTED BY RAMON A. FRANCO, JR., M.D., AND PHILLIP SONG, M.D. - MAY 9-10, 2013, MASSACHUSETTS EYE AND EAR INFIRMARY. - PLANNED OTOLOGY COURSE - JUNE 7-8, 2013, MASSACHUSETTS EYE AND EAR INFIRMARY - "12TH INTERNATIONAL FACIAL NERVE SYMPOSIUM," DIRECTED BY TESSA A. HADLOCK, M.D., MACK L. CHENEY, M.D., AND MICHAEL J. MCKENNA, M.D. - JUNE 28-JULY 2, 2013, LIBERTY HOTEL. - THE DEPARTMENT IS CURRENTLY AT WORK IN CONSTRUCTING AN ENT SURGICAL TRAINING LABORATORY AT MASSACHUSETTS EYE AND EAR INFIRMARY THAT IS SET TO OPEN IN JANUARY 2013. THE ENT SURGICAL TRAINING LABORATORY WILL ADVANCE INSTRUCTION CAPABILITIES IN NEARLY EVERY SUB-SPECIALTY OF OTOLARYNGOLOGY, INCLUDING: SKULL BASE SURGERY, GENERAL OTOLARYNGOLOGY, HEAD AND NECK SURGERY, LASER SURGERY, OTOLOGY AND NEUROTOLOGY, FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY, SINUS SURGERY, LARYNGOLOGY, AND PEDIATRIC OTOLARYNGOLOGY. RESIDENTS AND FELLOWS, AS WELL AS EXPERIENCES SURGEONS PREPARING FOR COMPLEX CASES, WILL BENEFIT FROM THE LABORATORY AS A RESOURCE. - NICOLAS Y. BUSABA, M.D., F.A.C.S., LEADS A TEACHING INITIATIVE WITH THE MINISTRY OF HEALTH IN KUWAIT FOR A FIVE-YEAR COLLABORATION WITH THE DEPARTMENT OF OTOLARYNGOLOGY AT THE MASSACHUSETTS EYE AND EAR INFIRMARY. - GREGORY W. RANDOLPH, M.D., F.A.C.S., COMPLETED A SECOND EDITION OF SURGERY OF THE THYROID AND PARATHYROID GLANDS, PUBLISHED BY SAUNDERS/ELSEVIER. THE TEXT WAS NAMED SAUNDERS/ELSEVIER BEST-SELLING BOOK AT THE ANNUAL AAO MEETING IN WASHINGTON, D.C. RADIOLOGY: EDUCATIONAL HIGHLIGHTS: - GUL MOONIS, MD, MARY BETH CUNNANE, MD, AND HUGH D. CURTIN, MD, PUBLISHED AN ARTICLE ENTITLED "PATTERNS OF PERINEURAL TUMOR SPREAD IN HEAD AND NECK CANCER". MAGN RESON IMAGING CLIN N AM. 2012 AUG;20(3):435-6 - MARY BETH CUNNANE, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "CASE RECORDS OF THE MASSACHUSETT GENERAL HOSPITAL, CASE 29-2012-A 49 YEAR-OLD MAN WITH PAIN AND CRANIAL-NERVE PALSIES AFTER TREATMENT OF ORAL CANCER". N ENGL J MED. 2012 SEP 20;367(12):1136-47. - MARY BETH CUNNANE, MD, AND AMY JULIANO, MD, PUBLISHED AN ARTICLE ENTITLED "BENIGN CONDITIONS OF THE THYROID GLAND". SEMIN ULTRASOUND CT MR. 2012 APR;33(2):130-7. - MARY BETH CUNNANE, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "COLOR DOPPLER ULTRASOUND: EFFECTIVE MONITORING OF THE BURIED FREE FLAP IN FACIAL REANIMATION". OTOLARYNGOL HEAD NECK SURG. 2012 MAR;146(3):372-6. - GUL MOONIS, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "SUPERIOR SEMICIRCULAR CANAL DEHISCENCE IN EAST ASIAN WOMEN WITH OSTEOPOROSIS". BMC EAR NOSE THROAT DISORD. 2012 JUL 25;12(1):8. - GUL MOONIS, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "MULTIMODALITY IMAGING OF HYDROGEL SCLERAL BUCKLES". RETINA. 2012 SEP;32(8):1449-52. - LAURA ROMO, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "TAMPON USE IN ADOLESCENCE: DIFFERENCES AMONG EUROPEAN AMERICAN, AFRICAN AMERICAN AND LATINA WOMEN IN PRACTICES, CONCERNS AND BARRIERS". J PEDIATR ADOLESC GYNECOL. 2012 OCT;25(5):328-33. - PAUL CARUSO, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "RISK OF SECOND CANCERS AFTER PHOTON AND PROTON RADIOTHERAPY: A REVIEW OF THE DATA". HEALTH PHYS. 2012 NOV;103(5):577-85. - PAUL CARUSO, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "HYPOPERFUSION PREDICTS LESION PROGRESSION IN CEREBRAL X-LINKED ADRENOLEUKODYSTROPHY". BRAIN. 2012 SEP;135(PT9):2676-83. - HUGH D. CURTIN, MD, MARY BETH CUNNANE, MD, AND AMY JULIANO, MD, PRESENTED MULTIPLE LECTURES AT MRI & CT COURSES THAT WERE HELD WITHIN THE YEAR. ANESTHESIOLOGY: PUBLICATIONS, LECTURES, COURSES - JOSEPH BAYES, MD ANESTHESIOLOGY 2ND EDITION 2012 ED. LONGNECKER DE ET AL. "ANESTHESIA FOR OPHTHALMIC SURGERY" BAYES J, BASTA S. PP 1206-1225. - BIL RAGAN, MD ANESTHESIOLOGY 2ND EDITION 2012 ED. LONGNECKER DE ET AL. "ANESTHESIA FOR OTORHINOLARYNGOLOGIC (ENT) SURGERY" RAGAN B. PP 1226-1247.
PART III - PROGRAM SERVICE, LINE 4CPATIENT CARE OVERALL (FROM THE PRINTED ANNUAL REPORT TEXT): CHANGING LIVES IS WHAT MASS. EYE AND EAR IS ALL ABOUT. OUR DOCTORS, NURSES, AND OTHER CAREGIVERS STRIVE DAILY TO PROVIDE SOLUTIONS FOR COMPLEX MEDICAL ISSUES THAT AFFECT PATIENTS. THE NEW MASS. EYE AND EAR, LONGWOOD, A 90,000 SQUARE FOOT OUTPATIENT AND AMBULATORY SURGICAL CENTER, IS NOW OPEN AT 800 HUNTINGTON AVENUE, BOSTON. BUILT FROM THE GROUND UP IN JUST 12 MONTHS, THIS CENTER ACTUALLY REPRESENTS SEVERAL YEARS OF INTENSE PLANNING. IT IS HOME TO FOUR OPERATING ROOMS AND A STATE-OF-THE-ART SURGICAL CENTER FOR EYE AND ENT PATIENTS, WHICH IS STAFFED BY AN OUTSTANDING MASS. EYE AND EAR ANESTHESIA AND NURSING TEAM. MASS. EYE AND EAR, LONGWOOD IS ALSO HOME TO AN EXPANDED DEPARTMENT OF OPHTHALMOLOGY, WHOSE PHYSICIANS COMPRISE THE EYE SERVICE FOR BRIGHAM AND WOMEN'S HOSPITAL. EYE SERVICES, LOCATED ON THE CENTER'S THIRD FLOOR, INCLUDE ROUTINE CARE, AS WELL AS COMPREHENSIVE EVALUATION AND TREATMENT OF COMPLEX AND SYSTEMIC DISORDERS SUCH AS CATARACTS, DIABETIC RETINOPATHY, GLAUCOMA, MACULAR DEGENERATION, RETINAL DETACHMENT, AND OPHTHALMIC PLASTIC SURGERY. ADDITIONALLY, THE CENTER OFFERS REFRACTIVE SURGERY EVALUATIONS, OPTOMETRY AND CONTACT LENS CARE AND A FULL-SERVICE OPTICAL SHOP. ADDITIONALLY, THE THIRD FLOOR WILL SERVE AS ONE OF TWO HOMES FOR THE MASS. EYE AND EAR COLLABORATION WITH JOSLIN DIABETES CENTER/BEETHAM EYE INSTITUTE. AS PART OF AN INTEGRATED APPROACH, MASS. EYE AND EAR AND JOSLIN HAVE COMBINED FORCES TO TREAT DIABETIC PATIENTS WITH EYE DISEASE. TOGETHER, THEY SEE PATIENTS AT 800 HUNTINGTON AND AT THE BEETHAM EYE CLINIC, 1 JOSLIN PLACE. MASS. EYE AND EAR, LONGWOOD HAS A FULL-SERVICE PARKING GARAGE, ACCESSIBLE FROM FRAWLEY STREET WITH SELF-PARKING AND VALET PARKING AVAILABLE. THE NEW CENTER IS ALSO EASY TO REACH BY GREEN LINE OR BUS, AND IS JUST A FIVE MINUTE WALK FROM BRIGHAM AND WOMEN'S HOSPITAL. THE NEW CENTER IN LONGWOOD IS JUST ONE PART OF A BROADER STRATEGY TO MAKE MASS. EYE AND EAR CARE MORE ACCESSIBLE AND CONVENIENT TO PATIENTS. IN FIVE YEARS, THE NUMBER OF LOCATIONS FOR MASS. EYE AND EAR EYE AND ENT SERVICES HAS GROWN FROM FOUR TO 13! ADDITIONS INCLUDE A BRAND NEW CLINICAL CARE SITE IN CONCORD, WHERE WE HAVE WELCOMED DR. MICHAEL FATTAL TO THE ENT STAFF. ALSO LAST YEAR, WE OPENED A ROBUST RETINA PRACTICE ON WOODLAND ROAD IN STONEHAM; AND MASS. EYE AND EAR SOUTH, WITH MULTIPLE LOCATIONS IN QUINCY, WEYMOUTH, DUXBURY AND EAST BRIDGEWATER CONTINUES TO THRIVE. ON OUR MAIN CAMPUS, WE HAVE COMPLETED SEVERAL RENOVATIONS TO CLINICAL SPACE, AS PART OF AN ONGOING EFFORT TO BETTER SERVE PATIENTS. SOME OF THESE IMPROVEMENTS INCLUDE THE EYE CLINICS ON THE 1ST FLOOR; A NEW SINUS CENTER ON THE 9TH FLOOR; AND A NEW NEURO-OPHTHALMOLOGY SUITE ON THE 9TH FLOOR. SEVERAL RESEARCH LABS, BOTH IN THE MAIN BUILDING AND AT SCHEPENS EYE RESEARCH INSTITUTE, HAVE ALSO UNDERGONE EXTENSIVE RENOVATION. - MASSACHUSETTS EYE AND EAR INFIRMARY CONTINUES ITS COMMITMENT TO DELIVERING EXCELLENCE IN CLINICAL CARE, RESEARCH AND TEACHING WITH THE UNIFIED GOAL OF ADVANCING THE CARE WE PROVIDE TO OUR PATIENTS. - ONCE AGAIN, MASS. EYE AND EAR RANKS AS A TOP SPECIALTY HOSPITAL NATIONWIDE, ACCORDING TO THE 2012-2013 U.S. NEWS & WORLD REPORT "BEST HOSPITALS" SURVEY. MASS. EYE AND EAR OPHTHALMOLOGY IS LISTED #4 NATIONALLY. MASS. EYE AND EAR OTOLARYNGOLOGY RANKED #3 IN THE NATION. BOTH ASSISTED MGH IN ATTAINING THE #1 SPOT IN THE NATION. - HIGHEST QUALITY CARE AS OUR LOCATIONS INCREASED THIS YEAR, SO GREW OUR MEDICAL STAFF. WE ADDED A CADRE OF HOSPITAL-BASED PHYSICIANS TO MEET THE DEMAND OF INCREASED VOLUME IN BOTH THE OPERATING ROOMS AND THE CLINICS. - MASS. EYE AND EAR WELCOMED TERESA BEAN, M.D., ANESTHESIOLOGY; MARK BERNARDO, O.D., LONGWOOD, OPTOMETRY; KATHRIN BOURDEAU, M.D., ANESTHESIOLOGY; JASON COMANDER, M.D., PH.D., RETINA/ERG SERVICE; JAYME DOWDALL, M.D., LARYNGOLOGY; DANIEL ESMAILI, M.D., RETINA SERVICE; MICHAEL FATTAL, M.D., CONCORD, OTOLARYNGOLOGY; AMIR GHOLAMI, M.D., ANESTHESIOLOGY; HILARY KELLY, M.D., RADIOLOGY; DANIEL LEFEBVRE, M.D., OPHTHALMIC PLASTIC/RECONSTRUCTIVE; MONICA LEE, M.D., WEYMOUTH-DUXBURY OTOLARYNGOLOGY; ROBIN LINDSAY, M.D., FACIAL PLASTIC/RECONSTRUCTIVE SURGERY; ZHONGHUI KATIE LUO, M.D., PH.D., COMPREHENSIVE OPHTHALMOLOGY; BENJAMIN MIZELL, M.D., ANESTHESIOLOGY; ALICIA QUESNEL, M.D., OTOLARYNGOLOGY; NITA SAHANI, M.D., ANESTHESIOLOGY; AND DAVID WU, M.D., PH.D., RETINA. - ALL OF MASS. EYE AND EAR'S MEDICAL PROFESSIONALS, WHETHER NEW TO THE STAFF OR WELL-SEASONED, ARE DEDICATED TO PROVIDING PATIENTS WITH THE BEST OUTCOMES AND THE MOST COMPASSIONATE CARE. TO MEASURE THEIR SUCCESS, MASS. EYE AND EAR PUBLISHED ITS SECOND OUTCOMES BOOK FOR OPHTHALMOLOGY AND OTOLARYNGOLOGY. WE CONTINUED OUR SUCCESSFUL SCHWARTZ CENTER COMPASSIONATE CARE ROUNDS WITH STANDING-ROOM-ONLY PARTICIPATION FROM DOCTORS, NURSES, SOCIAL WORKERS AND ADMINISTRATIVE STAFF. THESE EFFORTS HAVE PAID OFF. ONCE AGAIN MASS. EYE AND EAR WAS RECOGNIZED FOR ITS CLINICAL EXCELLENCE IN U.S. NEWS & WORLD REPORT'S "BEST HOSPITALS" SURVEY (THIRD IN OTOLARYNGOLOGY AND FOURTH IN OPHTHALMOLOGY). OPHTHALMOLOGY: NEW SERVICES OPENED: MASS. EYE AND EAR, LONGWOOD - THE NEW MASS. EYE AND EAR MULTI-SPECIALTY AMBULATORY CARE CENTER AT 800 HUNTINGTON AVE OFFICIALLY OPENED OCTOBER 31, 2012. THE LOCATION WILL PROVIDE THE LONGWOOD/MISSION HILL NEIGHBORHOODS GREATER ACCESS TO MASS. EYE AND EAR'S WORLD-CLASS PHYSICIANS AND SURGEONS, AND OUTPATIENT SERVICES. THE FACILITY IS EXPECTED TO BEGIN ACCEPTING PATIENTS IN NOVEMBER. COMPREHENSIVE AND SUBSPECIALTY SERVICES IN RETINA, CORNEA, GLAUCOMA, EYE PLASTICS AND UVEITIS WILL BE AVAILABLE, AND THE SITE WILL BE FULLY EQUIPPED FOR SURGERY, PROCEDURES, IMAGING AND DIAGNOSTICS. MASS. EYE AND EAR WILL CONTINUE TO PROVIDE INPATIENT AND EMERGENCY EYE TRAUMA CARE AT AFFILIATED HOSPITALS. PARTICIPATING MASS. EYE AND EAR FACULTY INCLUDE: CAROLYN KLOEK (MEDICAL DIRECTOR), MD, JOHN LOEWENSTEIN, MD, SHEILA BORBOLI-GEROGIANNIS, MD, FACS, DANIEL LEFEBVRE, MD, ANN-MARIE LOBO, MD, ZHONGHUI KATIE LUO, MD, PHD, DAVID WU, MD, PHD, LUCY SHEN, MD, AND MARK BERNARDO, OD. SEVERAL OPEN HOUSES WILL BE HELD OVER THE NEXT FEW MONTHS TO INTRODUCE THE FACILITY AND STAFF TO THE NEIGHBORING HOSPITAL AND REFERRAL COMMUNITY.
MASS. EYE AND EAR RETINA CONSULTANTS, STONEHAM- IN JANUARY, MASS. EYE AND EAR ACQUIRED A LARGE RETINA PRACTICE AT 3 WOODLAND ROAD IN STONEHAM WHERE IT OPENED A NEW SATELLITE OFFICE, RETINA CONSULTANTS. THE NEW PRACTICE OFFERS SUBSPECIALTY MEDICAL AND SURGICAL CARE FOR MACULAR DEGENERATION, DIABETIC EYE AND ALL CONDITIONS ASSOCIATED WITH THE RETINA. THE NEW PRACTICE EXPANDS THE DEPARTMENT'S REACH IN A SUBURBAN AREA AND MAKES RETINA SERVICES MORE ACCESSIBLE TO PATIENTS. THE SERVICE IS DIRECTED BY DANIEL ESMAILI, MD, WITH PARTICIPATION FROM SEVERAL RETINA PHYSICIANS, INCLUDING: DEAN ELIOTT, MD; LEO KIM, MD, PHD; JOAN W. MILLER, MD, FARVO; AND LUCY YOUNG, MD, PHD. MASS. EYE AND EAR AND JOSLIN DIABETES CENTER FORM CLINICAL AND RESEARCH ALLIANCE - UNDER THE DIRECTION OF LLOYD PAUL AIELLO, MD, PHD, ASSOCIATE CHIEF FOR LONGWOOD, THIS NOVEL NEW PARTNERSHIP WILL PROVIDE A FULL ARRAY OF HIGH QUALITY, COMPREHENSIVE AND SUBSPECIALTY EYE CARE TO OPHTHALMOLOGY PATIENTS, ESPECIALLY TO THOSE WHO ARE AT-RISK FOR DIABETES-RELATED EYE COMPLICATIONS. CLINICAL OFFICES WILL BE CO-LOCATED AT ONE JOSLIN PLACE AND MASS. EYE AND EAR'S NEW AMBULATORY CARE CENTER AT 800 HUNTINGTON AVENUE. COMBINING THE EXPERTISE AND RESOURCES OF THESE INSTITUTIONS WILL ALLOW US TO PROVIDE HIGH QUALITY AND COST-EFFECTIVE CARE WHILE MAKING OUR SERVICES MORE CONVENIENT AND ACCESSIBLE TO MORE PATIENTS. STRENGTHENING OUR RESEARCH COLLABORATIONS WILL MORE RAPIDLY ADVANCE OUR SHARED GOAL OF ERADICATING EYE DISEASE. NEW RECRUITS: CLINICIANS AND CLINICIAN SCIENTISTS - JASON COMANDER, MD, PHD, MASS. EYE AND EAR, RETINA AND ELECTRORETINOGRAPHY SERVICES - DANIEL ESMAILI, MD, MASS. EYE AND EAR, RETINA SERVICE - DANIEL LEFEBVRE, MD, MASS. EYE AND EAR, OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY SERVICE - ZHONGHUI KATIE LUO, MD, PHD, MASS. EYE AND EAR, COMPREHENSIVE OPHTHALMOLOGY SERVICE - DAVID WU, MD, PHD, MASS EYE AND EAR, RETINA SERVICE - MARK BERNARDO, OD, MASS. EYE AND EAR, OPTOMETRY NEW EQUIPMENT AND TECHNOLOGY: CLINICAL - VERIS MULTI-FOCAL ERG FOR THE 3RD FLOOR - VERIS MULTI-FOCAL ERG FOR THE 12TH FLOOR - CIRRIUS OCT MACHINE FOR THE RETINA SERVICE - VU MAX ULTRASOUND UNIT - A SCAN B SCAN UBM - SONOMED ESCALON LENSTAR FOR THE CORNEA SERVICE - 2 OPTOS WIDE ANGLE CAMERAS FOR THE RETINA SERVICE - SPECTRUM MICROSCOPE FOR THE MASS. EYE AND EAR RETINA ASSOCIATES IN STONEHAM NEW SERVICES/RENOVATIONS MASS. EYE AND EAR, LONGWOOD MASS. EYE AND EAR RETINA ASSOCIATES, STONEHAM IN APRIL (2012), THE GLAUCOMA SERVICE MOVED INTO ITS NEWLY RENOVATED CLINICAL SPACE ON THE FIRST FLOOR OF THE MAIN BUILDING. COMMUNITY SERVICE ACTIVITIES LOCAL/REGIONAL - NEIGHBORHOOD CHARTER SCHOOL (17TH) YEAR - PROVIDED VISION SCREENINGS TO 500 CHILDREN. - CAMP HARBOR VIEW, LONG ISLAND, MA (17TH YEAR) - EYE SCREENINGS FOR 149 CAMPERS, AGES 11-14, FROM UNDERSERVED BOSTON NEIGHBORHOODS. - MASS. EYE AND EAR PARTNERED WITH VISION COALITION MA TO PROVIDE VISION EXAMS TO STUDENTS IN THE YEAR UP, BOSTON PROGRAM. - BOOMERS AND SENIORS EXPO AT THE SEAPORT WORLD TRADE CENTER: SHELIA BORBOLI, MD, COMPREHENSIVE OPHTHALMOLOGY SERVICE, PRESENTED "CATARACTS AND BABY BOOMERS." - A GRAVES DISEASE AND THYROID EYE DISEASE SUPPORT GROUP WAS HELD QUARTERLY BY THE OPHTHALMIC PLASTIC SURGERY. - THERESA CHEN, MD, MEDICAL DIRECTOR, OPHTHALMOLOGY QUALITY AND OUTCOMES VOLUNTEERED ON THE LIONS EYE VAN PROVIDING FREE EYE SCREENINGS. - MARK BERNARDO, OD, OF THE MASS. EYE AND EAR OPTOMETRY SERVICE SERVED WITH VOLUNTEER OPTOMETRIC SERVICES TO HUMANITY. - LUCIA SOBRIN, MD, MPH, ASSISTANT PROFESSOR OF OPHTHALMOLOGY AT HMS, WAS A FEATURED GUEST SPEAKER IN JANUARY FOR THE ARTSEMERSON ONE-WOMAN SHOW, "SUGAR," STARRING EMERSON COLLEGE PERFORMING ARTS PROFESSOR AND INTERNATIONALLY ACCLAIMED PERFORMANCE ARTIST ROBBIE MCCAULEY. "SUGAR," EXAMINES THE STRUGGLES AND CONQUESTS OF LIVING WITH "A LITTLE BIT OF SUGAR": DIABETES. A CENTRAL THEME OF THE SHOW WAS TO REFLECT ON DIABETES FROM THE AFRICAN AMERICAN PERSPECTIVE AS THIS DISEASE DISPROPORTIONATELY AFFECTS PEOPLE OF COLOR. AS THE FEATURED GUEST, DR. SOBRIN PARTICIPATED IN A "TALK BACK" SESSION ALONG WITH MS. MCCAULEY AFTER ONE OF THE PERFORMANCES AND DISCUSSED HER PROMISING RESEARCH ON DIABETIC RETINOPATHY THAT MAY ONE DAY LEAD TO CURES TO THIS DISEASE. - ON BEHALF OF THE GLAUCOMA FOUNDATION, LOUIS PASQUALE, MD, DIRECTOR, GLAUCOMA SERVICE AND DIRECTOR, TELEMEDICINE LED A TELECONFERENCE FOR LAY PEOPLE REGARDING LIFESTYLE ISSUES IN GLAUCOMA. OTOLARYNGOLOGY: - IN 2012 THE DEPARTMENT EXPANDED BY RECRUITING FIVE NEW FULL-TIME PHYSICIANS, INCLUDING THREE AT THE MAIN CAMPUS AND TWO AT OUR SUBURBAN CENTERS. ADDITIONALLY, WE NOW OFFER COMPREHENSIVE LASER AND RECONSTRUCTIVE SURGERY AT THE CAROLYN AND PETER LYNCH CENTER FOR LASER AND RECONSTRUCTIVE SURGERY, DEDICATED ON MAY 29, 2012, AND A MULTI-DISCIPLINARY SLEEP CENTER AT MASS. EYE AND EAR, QUINCY. TWO OF OUR PHYSICIANS NOW PROVIDE ADVANCED ROBOTIC SURGERY FOR PATIENTS SUFFERING FROM HEAD AND NECK CANCER. NEW RECRUITS: - JAYME R. DOWDALL, M.D., DIVISION OF LARYNGOLOGY, INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - MICHAEL H. FATTAL, M.D., MASS. EYE AND EAR, CONCORD, CLINICAL INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - MONICA S. LEE, M.D., MASS. EYE AND EAR, WEYMOUTH-DUXBURY, CLINICAL INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - ROBIN W. LINDSAY, M.D., DIVISION OF FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY, ASSISTANT PROFESSOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - ALICIA M. QUESNEL, M.D., DIVISION OF OTOLOGY, INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL NEW EQUIPMENT/TECHNOLOGY: - WITH THE NEW LYNCH CENTER FOR LASER AND RECONSTRUCTIVE SURGERY, DEDICATED ON MAY 29, 2012, WE NOW OFFER STATE-OF-THE-ART LASER EQUIPMENT FOR THE WIDEST RANGE OF SKIN TREATMENTS. - A MULTI-DISCIPLINARY SLEEP CENTER WAS RECENTLY OPENED AT MASS. EYE AND EAR, QUINCY, TO PROVIDE COMPREHENSIVE SLEEP STUDIES AND TREATMENT FOR PATIENTS WHO MAY SUFFER FROM OBSTRUCTIVE SLEEP APNEA, SNORING, INSOMNIA, NARCOLEPSY, OR RESTLESS LEG SYNDROME. - FOR TREATING PATIENTS WITH HEAD AND NECK CANCER, JAMES W. ROCCO, M.D., PH.D. IS WORKING WITH DERRICK T. LIN, M.D., F.A.C.S., TO OFFER ROBOTIC SURGERY FOR MASSACHUSETTS EYE AND EAR INFIRMARY PATIENTS, USING TECHNOLOGY AVAILABLE AT WINCHESTER HOSPITAL. NEW SERVICES/RENOVATIONS: - LASER AND RECONSTRUCTIVE SURGERY - THE SINUS CENTER
- MASS. EYE AND EAR, QUINCY SLEEP CENTER- THE HEAD AND NECK SURGICAL ONCOLOGY DIVISION HOSTED A FREE ORAL, HEAD, AND NECK CANCER SCREENING TO THE PUBLIC AT OUR BOSTON LOCATION, AS WELL AS THE MASS. EYE AND EAR SOUTH LOCATIONS IN QUINCY, MILTON, AND WEYMOUTH, ON APRIL 20TH, 2012. - IN COLLABORATION WITH THE AMERICAN ACADEMY OF DERMATOLOGY, DRS. JESSICA FEWKES AND OON TIAN TAN PROVIDED FREE SKIN CANCER SCREENINGS TO THE PUBLIC ON MAY 15TH, 2012. - THE FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, LED BY TESSA A. HADLOCK, M.D., WENT ON A MISSION TO QUITO, ECUADOR IN MARCH 2012 AND ANOTHER TO ANTIGUA, GUATEMALA IN JULY 2012. DR. TAN WAS INSTRUMENTAL IN INSTALLING A CANDELA/SYNERON ALEXANDRITE LASER AT THE INSTITUTO MEDICO TIERRA NUEVA, QUITO FOR LASER HAIR REMOVAL IN MICROTIA PATIENTS. THE LASER WAS FUNDED BY AN AWARD FROM THE MASSACHUSETTS EYE AND EAR INFIRMARY "CURING KIDS FUND". - THE FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION ALSO CONTINUES THEIR COLLABORATION WITH THE ROSE FUND, OFFERING RECONSTRUCTIVE SURGERY TO VICTIMS OF DOMESTIC VIOLENCE. - GREGORY W. RANDOLPH, M.D., F.A.C.S., LED A SURGICAL GOITER MISSION TO MIGORI, KENYA THROUGH THE KENYA RELEIF AFRICAN AID ORGANIZATION. OTHER MEMBERS OF THE TEAM ARE DR. PAUL KONOWITZ, DR. GREGORY RANDOLPH, DR. DAVID LESNIK, RESIDENT DR. DUNIA ABDUL-AZIZ AND NANCY KOTZUBA, R.N. THE TEAM PERFORMED 25 THYROID SURGERY CASES IN 3 DAYS, INCLUDING 18 GOITERS. - OPERATION AIRWAY IS A NON-PROFIT INITIATIVE DIRECTED BY CHRISTOPHER J. HARTNICK, M.D. OPERATION AIRWAY PROVIDES ANNUAL MEDICAL MISSIONS TO ECUADOR TO HELP CARE FOR CHILDREN WITH AIRWAY DISORDERS. A TEAM OF SURGEONS, ANESTHESIOLOGISTS, PEDIATRIC NURSES, AND ICU PHYSICIANS FROM THE MASS. GENERAL HOSPITAL FOR CHILDREN PROVIDE NEEDED MEDICAL CARE WHILE ALSO SHARING THEIR KNOWLEDGE OF COLLABORATIVE SPECIALTY CARE FOR COMPLEX AIRWAY SURGERIES WITH LOCAL HEALTHCARE TEAMS. - NICOLAS Y. BUSABA, M.D., F.A.C.S., LEADS A TEACHING INITIATIVE WITH THE MINISTRY OF HEALTH IN KUWAIT FOR A FIVE-YEAR COLLABORATION WITH THE DEPARTMENT OF OTOLARYNGOLOGY AT THE MASSACHUSETTS EYE AND EAR INFIRMARY. - MICHAEL COHEN, M.D., SERVED ON A MEDICAL MISSION TO ADDIS ABABA, ETHIOPIA IN OCTOBER 2012, ALONG WITH MEEI AUDIOLOGIST ANNMARIE HENNESSY AND SIX OTHER MEDICAL PROFESSIONALS FROM THE GROUP "HEALING THE CHILDREN," PROVIDING SURGICAL CARE TO CHILDREN WITH EAR DISEASE AS WELL AS BASIC OTOLOGIC CARE TO THE 150 CHILDREN AT THE MAKANISSA SCHOOL FOR THE DEAF. - RAMON A. FRANCO, JR., M.D., CONTINUES HIS BIANNUAL MEDICAL MISSION TO HONDURAS TO PERFORM AIRWAY RECONSTRUCTIVE SURGERY, TO ADDRESS VOICE PROBLEMS, AND TO CARE FOR PATIENTS WITH LARYNGEAL CANCER. DR. FRANCO SERVES AS A MENTOR TO SPECIALISTS IN HONDURAS AND TO TRAINEES IN THE COUNTRY'S ONLY ENT RESIDENCY PROGRAM. - GREGORY W. RANDOLPH, M.D., F.A.C.S. PERFORMED THE 3,000TH CASE OF INTRAOPERATIVE NERVE MONITORING DURING THYROID/PARATHYROID SURGERY, PLACING MASS. EYE AND EAR AT THE FOREFRONT OF NEURAL MONITORING EXPERIENCE WORLDWIDE. THE INTRAOPERATIVE NERVE MONITORING PROGRAM IS A JOINT EFFORT BY THE DEPARTMENTS OF OTOLARYNGOLOGY, ANESTHESIA AND AUDIOLOGY AT MASS. EYE AND EAR. RADIOLOGY: NEW RECRUITS: - HILARY KELLY, M.D., WAS HIRED AS A STAFF RADIOLOGIST AND WILL BE HERE 1 DAY/WEEK. DR. KELLY WILL ASSIST WITH ULTRASOUND EXPANSION PROJECT DUE TO POSITIVE VOLUME GROWTH. NEW EQUIPMENT AND TECHNOLOGY: - SUCCESSFUL IMPLEMENTATION OF A CERETOM-OTO CT SCANNING SYSTEM AT OUR NEW QUINCY SATELLITE IN NOVEMBER 2011. - A TRIAL OF AN INTRA-OPERATIVE CERETOM OTOSCAN CT SYSTEM WAS COMPLETED IN DECEMBER 2011. THE TRIAL WAS ENDED AND EQUIPMENT WAS RETURNED DUE TO LOW VOLUME NEEDS BY MEDICAL STAFF. - A TRIAL OF A 3D ACCUITOMO CT SYSTEM IS SCHEDULED TO END BY THE END OF NOVEMBER 2012. THIS SYSTEM WAS CAPABLE OF GOOD QUALITY TEMPORAL BONE SCANS BUT THE VOLUME OF CASES WAS NOT HIGH ENOUGH TO SUPPORT A CAPITAL PURCHASE. - PLANNING STAGES ARE UNDERWAY TO REPLACE THE EXISTING SIEMENS SOMATOM 40-SLICE CT SYSTEM THAT IS APPROACHING SEVEN YEARS OLD. THIS WILL BE ACCOMPLISHED BY THE END OF FY13. ANESTHESIOLOGY: NEW RECRUITS: - AMIR GHOLAMI, MD STAFF ANESTHESIOLOGIST (JULY) - BENJAMIN MIZELL, MD, STAFF ANESTHESIOLOGIST (AUGUST) - KATHRIN BOURDEU, MD, STAFF ANESTHESIOLOGIST (OCTOBER) - NITA SAHANI, MD, STAFF ANESTHESIOLOGIST (DECEMBER) - TERESA BEAN, MD, STAFF ANESTHESIOLOGIST (FEBRUARY 2013) - CASEY BRACHVOGEL, CRNA, STAFF NURSE ANESTHETIST (AUGUST) NEW EQUIPMENT/TECHNOLOGY: THE ANESTHESIOLOGY DEPARTMENT PURCHASED 8 NEW PENLON ANESTHESIA MACHINES.

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (6 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEINEINPrimary ActivitiesPrimaryActivitiesLegal Domicile StateLegalDomicileStateExempt Code SectionExemptCodeSectionPublic Charity StatusPublicCharityStatusBusiness Name Line1DirectControllingEntityName/BusinessNameLine1Controlled OrgControlledOrg
FDN OF THE MASS EYE & EAR INFIRMARY INC
243 CHARLES STREETBOSTONMA02114042785453PARENTMA501(C)(3)9NAfalse
MASSACHUSETTS EYE & EAR ASSOCIATES INC
243 CHARLES STREETBOSTONMA02114222658209PATIENT CAREMA501(C)(3)9FOUNDATIONtrue
CIRCLE COMPANY INC
243 CHARLES STREETBOSTONMA02114042801791TITLE HOLDINGMA501(C)(25)N/AFOUNDATIONtrue
EMBANKMENT SERVICES INC
14 DAVID G MUGAR WAYBOSTONMA02114043272865SUPPORTNG ORGMA501(C)(3)11 - TYPE 1FOUNDATIONtrue
MASS EYE & EAR INFIRMARY PENSION PLAN
243 CHARLES STREETBOSTONMA02114046067238PENSION PLANMA401(A)N/ANAfalse
SCHEPENS EYE RESEARCH INSTITUTE INC
20 STANIFORD STREETBOSTONMA02114042129889RESEARCHMA501(C)(3)7FOUNDATIONtrue
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents RoyaltiestrueReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other OrgtrueGiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other OrgtrueGiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other OrgfalseLoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other OrgfalseSaleOfAssetsToOtherOrg
Purchase Of Assets From Other OrgfalsePurchaseOfAssetsFromOtherOrg
Exchange Of AssetsfalseExchangeOfAssets
Rental Of Facilities To Other OrgsfalseRentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other OrgsfalseRentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other OrgsfalsePerformOfServicesForOtherOrgs
Perform Of Services By Other OrgstruePerformOfServicesByOtherOrgs
Sharing Of FacilitiestrueSharingOfFacilities
Sharing Of Paid EmployeestrueSharingOfPaidEmployees
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrg
Reimbursement Paid By Other OrgtrueReimbursementPaidByOtherOrg
Other Transfer To Other OrgtrueOtherTransferToOtherOrg
Other Transfer From Other OrgfalseOtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (17 entries)

Transaction TypeTransactionTypeAmount InvolvedAmountInvolvedMethod Of Amt DeterminationMethodOfAmtDetermination
CIRCLE COMPANY INC
A40114CASH
SCHEPENS EYE RESEARCH INSTITUTE INC
B709308CASH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
B10299939CASH
CIRCLE COMPANY INC
B1000000CASH
FDN OF THE MASS EYE & EAR INFIRMARY INC
C8471313CASH
SCHEPENS EYE RESEARCH INSTITUTE INC
C68282CASH
FDN OF THE MASS EYE & EAR INFIRMARY INC
L1554606CASH
FDN OF THE MASS EYE & EAR INFIRMARY INC
M0CASH
FDN OF THE MASS EYE & EAR INFIRMARY INC
N522224CASH
EMBANKMENT SERVICES INC
N1312206CASH
CIRCLE COMPANY INC
N200683CASH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
N8181484CASH
FDN OF THE MASS EYE & EAR INFIRMARY INC
O789326CASH
CIRCLE COMPANY INC
P149000CASH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
P26260018CASH
EMBANKMENT SERVICES INC
P1454000CASH
MASSACHUSETTS EYE AND EAR PENSION PLAN
Q9632277CASH

Form990 Schedule R Part VII Form990ScheduleRPartVII

FieldValueIRS element (for citing)
IdentifierSCHEDULE R, PART V, LINE 15:Identifier
ExplanationCONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY.Explanation